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Abstract
Inherited retinal dystrophies and age-related macular degeneration (AMD) are leading 
causes of blindness. Current treatments only slow disease progression in a minority of 
patients, therefore it is important to develop new treatments that can regenerate lost cells, 
restore retinal function and halt disease progression. Retinal progenitor cells have the 
potential to replace degenerating photoreceptors in retinal diseases. This thesis explores 
the viability of using immortalised human foetal retinal progenitor cells for this purpose, 
and aims to elucidate the trophic factors required, in vitro, to drive these cells towards 
retinal cell lineages. We also examine their potential to survive, integrate and 
differentiate in the diseased and developing rat retina. Two human foetal retinal 
progenitor cell lines were established by infecting retinal foetal tissue with the 
temperature-sensitive tsT-SV40 antigen. The immortalised progenitor cells were 
compared to primary human foetal retinal progenitor cultures, and both were shown to 
express similar markers of neural progenitor cells and early neuronal cell types. Several 
trophic factors were investigated, including serum, retinoic acid and conditioned 
medium, with respect to their ability to influence gene expression. Serum appeared to 
induce expression o f ganglion cell markers, and conditioned medium stimulated cell 
proliferation. Cells were also grafted into neonatal hooded Lister rats and RCS 
dystrophic rats, and neither the primary nor the immortalised progenitor cells 
demonstrated integration into the retina. In the RCS rat, cells were engulfed by host 
macrophage/microglia and showed no signs of integration or expression of neuronal 
markers. Immortalised cells, in vivo, stained positively for Ki67 and low levels o f nestin, 
but exhibited limited ability to differentiate or integrate. These data indicate that 
immortalised progenitor cells maintain many characterisics o f unimmortalised 
progenitor cells, and suggest that immortalisation of retinal progenitors may have long 
term therapeutic possibilities.
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Chapter 1
Introduction
1.1 General introduction
The inherited retinal dystrophies form a large group of diseases that are collectively known 
as retinitis pigmentosa (RP). The recent discovery of mutations in complement factor H and 
factor B that contribute to the development of age-related macular degeneration (AMD), 
means that the genetic basis of blinding eye diseases is beginning to be elucidated. Almost 
50% of blindness in Europe is attributed to AMD alone (Resnikoff et al., 2004), and within 
the UK approximately 1% of the population is affected by the condition (figure from The 
Macular Disease Society). The primary defect lies in the neural retina, where the 
photoreceptors and retinal pigment epithelium (RPE) are mainly affected. Treatments that 
are currently available only manage to slow disease progression in a minority of patients. 
Therefore, it is increasingly important to explore and develop new treatments for retinal 
degenerative diseases that can regenerate lost cells to restore retinal function and halt 
disease progression. An increasingly exciting avenue of research is the use of retinal stem 
and progenitor cells as a replacement for degenerating or dysfunctional cells. This could 
eventually lead to the amelioration of many retinal dystrophies in a significant proportion 
of the population. A major advantage in studying the retina is the accessibility of the intact 
tissue and the fairly autonomous development it exhibits compared to other areas of the 
central nervous system (CNS) (Cepko et al., 1996). Studies investigating the use of cellular 
replacement to recover vision in animal models have shown promise (Gouras et al., 1989; 
Little et al., 1996; Coffey et al., 2002), however several issues need to be addressed such as 
the cell type used for transplantation and how to enhance the survival and integration of 
such cells.
This thesis explores the viability of using immortalised human foetal retinal progenitor 
cells in a degenerative environment, as a possible cellular replacement therapy to alleviate 
the progression of disease. Assessments will be carried out in vitro to examine the capacity 
of such cells to differentiate into retinal cell types, with a particular focus on the rod 
photoreceptor lineage. By trying to understand the mechanisms underlying photoreceptor 
development this knowledge can then be manipulated to ‘direct’ the differentiation of
21
various retinal progenitor cells, in the hope that this strategy may eventually be used to 
repair tissue structures and replace lost function.
1.2 Anatomy of the eye
The eye is an intricate organ (figure 1.1) that converts light energy from our surroundings 
into nerve action potentials, in specialized nerve cells (rods and cones) in the retina. The 
action potentials eventually travel to the brain where they are converted and consciously 
appreciated as vision (Forrester et al., 2002). This process is known as phototransduction, 
and all structures in the eye are necessary to support it. The eye is composed of three tunics 
(layers), these being the corneoscleral layer, the vascular or uveal tract and the neural layer 
(the retina). The corneoscleral layer is a fibrous coat composed of the posteriorly positioned 
opaque sclera, and the transparent cornea covering the anterior surface of the eye. This 
‘coat’ gives protection and structural support to the eyeball. The vascular tunic is formed 
from the choroid, ciliary body and iris. The iris functions to regulate pupil size to obtain 
optimum visual capacity. The retina is the innermost of the three tunics and lines the back 
of the eye. The neural retina, itself, is subdivided into three laminar structures: the ganglion 
cell layer (GCL), the inner nuclear layer (INL) and the outer nuclear layer (ONL).
1.3 Development of the vertebrate eye primordia
The intricate circuitry and structures that form the eye rely on close contact between 
neighbouring cells to enable communication of inductive signals and to enable these and 
other cells to have the functional plasticity to respond to diverse inputs and stimuli (Gilbert, 
2000). The organogenesis of the eye begins in the fourth week post fertilisation. Prior to 
this stage the fertilized zygote undergoes cleavage which involves the successive division 
of cells without any increase in size. This eventually leads to gastrulation, involving the 
movement of cells resulting in the three germ layers, (ectoderm, mesoderm and endoderm) 
situated in the correct locations for ongoing development (Wolpert et al., 1998).
The initial stage of CNS formation begins with the thickening of the dorsal region of the 
surface ectoderm, which results in the formation of neural plates. By day 18, at the mid­
region of the neural plates, neural grooves migrate inwards, causing the bordering neural 
folds to converge towards one another to forms a hollow tube. Neurulation follows,
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The pupil is the opening 
in the centre of the iris. 
The size of the pupil 
determines the amount 
of light that enters the eye.
The lens alters the 
refractive index of 
light entering the 
eye to focus on the 
retina
Fovea
The iris is a circular muscle 
controlling the size of the 
pupil. It is the coloured part 
of the eye.
Iris
The fovea is a tiny area 
in the centre of the macula, 
that has a very high density of 
cone photoreceptors.This region 
is responsible for our central, 
sharpest vision. It allows us to 
see in great detail.
Optic nerve
The optic nerve transmits electrical 
impulses from the retina to the brain.
Ciliary body The ciliary body lies just behind the iris.
Attached to the ciliary body are tiny fibres called zonules.
The crystalline lens is suspended inside the eye by these zonular fibres.
One function of the ciliary body is the production of the vitreous.
It also controls accommodation, changing the shape of the lens.
The Sclera forms part of the 
supporting wall of the eyeball.
Sclera
Transparent external surface, 
covering both the pupil
and the iris Cornea
Choroid
The choroid lies between the retina 
and sclera. It is composed of layers 
of blood vessels that nourish the 
back of the eye.
Retina
The Retina is a thin transparent 
layer of neural tissue. Light 
stimuli are converted into 
neural impulses in the retina.
Figure 1.1 Sagittal section of the human adult eye
Captions identifying the main components of the human 
adult eye and their respective functions.
(Adapted from Webvision; http://www.webvision.med.utah.edu/)
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whereby the convergent neural folds spread along the entire dorsal length, from head to toe, 
to form the neural tube, the embryonic precursor o f the CNS. The anterior segment o f the 
neural tube, the prosencephalon, is subdivided into the anterior telencephalon and the more 
caudal diencephalon. The neural retina arises from a region in the diencephalon called the 
eye primordium or eye anlage. In humans, eye development begins at approximately 22 
days o f development and eventually ends several months after birth (Mann, 1964). Prior to 
the closing of the most anterior part of the neural tube, the anterior neuropore, two lateral 
invaginations termed optic vesicles are formed that will eventually become the future eye 
primordia. As shown in figure 1.2, these vesicles then go on to invaginate further and form 
the optic cups. It is the optic cups that will give rise to the retina. Throughout the forming 
of the optic vesicles the lateral convex regions of the vesicles maintain contact with the 
surface ectoderm (Bron et al., 1997). This region of the surface ectoderm eventually 
differentiates into the lens placode of the eyes when it pinches off from the rest o f the 
ectoderm to become the lens vesicle (Wong, 2006). The thickened portion o f the optic cup, 
that invaginates, is destined to differentiate into the neural retina, while the thinner outer 
layer will form the retinal pigment epithelium (RPE). At the site o f the cup, successive 
rounds of cell division occur to generate a neuroepithelial layer many cells thick. These 
cells, termed neuroblasts, differentiate into all the retinal cell types (Dowling, 1987).
Figure 1.2 D evelop m en t o f  th e  neural retina
(A) Form ation of th e  op tic vesicles during  em bryogenesis leads to  th e  vesicles invaginating to  form 
optic cups. (B) The th ickened  portion  of th e  optic cup  invaginates and  is th e  presum ptive  neural 
retina whilst th e  o u te r wall will differentiate into th e  retinal p ig m en t epithelium . (C) A schem atic of 
th e  developed  neural retina. (A dapted from Dowling, 1987).
Optic cup
outer waiu 
pigment eprtheSum i-  photoreceptors
] |  I 1 epithelium
Neural tube
optic vesicle inner waH-ret na
ventricle
ventricle
A B C
24
1.3.1 Retinal specification
During eye development, inductive cues exist to specify the lineage that individual cells 
adopt, and as development progresses, the lineage options become increasingly restricted as 
partial and then full commitment determine cell fate. The interesting question is when such 
restrictions come into play for cells destined to become part of the pool of definitive retina- 
producing progenitor cells. Exploratory studies using Xenopus and zebrafish embryos, have 
tried to identify the location of eye-forming cells within the embryo. With the use of 
fluorescent dye injections, it was found that prior to gastrulation, tissue contribution from a 
particular blastomere was largely undetermined (Kimmel and Warga, 1987). Following the 
work of Spemann and Mangold it was found that transplantation of the presumptive neural 
ectoderm from one newt embryo to the presumptive epidermis of another embryo, gave rise 
to ectopic neural plates when the transplant was taken from an embryo in the late-gastrula 
stage but not before (Gilbert, 2000). However, quantitative lineage analysis in Xenopus 
embryos, determined that each retina descends from a stereotypic subset of 9 animal pole 
blastomeres at the 32 cell stage (prior to gastrulation), that acquire the competence to 
contribute to the retina (figure 1.3). These blastomeres have been shown to be biased 
towards retinal lineage development, however they are not committed as yet (Zaghloul et 
al., 2005).
It is also noteworthy that not all blastomeres were equally competent, even after 
manipulation. Blastomeres from the vegetal pole that were grafted to the animal pole, 
where retinal competent blastomeres reside, did not have any progeny contributing to the 
retina (Huang and Moody, 1993). Even with the introduction of various signalling 
components involved in neural induction, they lacked the intrinsic maternal determinants 
and cell-cell interactions that bias the animal blastomere counterparts to produce retinal 
progeny (Zuber and Harris, 2006). However equatorial blastomeres seem to be more 
malleable to reprogramming to contribute to retinal progeny when transplanted to the 
animal pole (Huang and Moody, 1993). These experiments have identified a period prior to 
gastrulation where retinal-competence in blastomeres is exhibited, but this does not specify 
the eye field at this stage. Experiments involving the transplantation of different regions of 
the presumptive neural plate, in mid-gastrula Xenopus embryos, have shown that all 
regions of the neural plate are capable of producing eyes. These observations indicate that
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specification of the eye region is not firmly fixed until late gastrulation (Saha and Grainger, 
1992).
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Figure 1.3 Specification of th e  eye prim ordia and retinal stem  cells in the  Xenopus em bryo
Retinal development consists of several steps. (A) First a subset of embryonic blastomeres (green) 
are competent to contribute to the retina, whilst the vegetal blastomeres (blue hatched) are 
inhibited from forming retina. (B) A smaller subset of the com petent blastomeres (yellow) are 
biased to become the definitive retina-producing precursor cells in response to retinogenic signals.
(C) Retinal stem cells (red) become specified from the descendants of the definitive retina-producing 
cells (yellow) and form the eye field at the anterior end of the neural plate (green). (D) During 
neurulation,the retinal stem cells separate into the right and left optic primordia. During neural tube 
morphogenesis each optic primordium will eventually give rise to an optic vesicle which in turn will 
give rise to the optic stalk, retinal pigment epithelium and neural retina, each containing region-specific 
retinal progenitor cells. (Adapted from Zaghloul etal., 2005).
1.3.2 Signalling pathways determining formation of the eye primordia
Retinal tissue is competent prior to gastrulation but is defined during gastrulation, a process 
that involves a plethora o f signalling pathways to orchestrate ocular development. Due to 
the conserved nature and gene expression patterns of the retina from Drosophila to humans, 
a great deal of knowledge has been extracted from studies in lower vertebrates. Wingless- 
Int (Wnt) proteins play a pivotal role during ocular development alongside the antagonism 
of bone morphogenetic protein (BMP). BMP antagonism is necessary for the retinogenic 
animal blastomeres to go on to generate retinal lineages. When ectopic expression o f BMP
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occurs in these blastomeres they fail to produce retinal progeny (Zaghloul et al., 2005). 
This concurs with the need for BMP inhibition in neural induction. The antagonist of BMP 
signalling is the neural inducer noggin. Studies in Xenopus report that over-expression of 
Wnt8b results in complete loss of eye development, thus confirming that inhibition of Wnt 
is required for correct neural plate development (Kim et al., 2007). A conserved set of eye 
field transcription factors (EFTFs) are also essential for normal eye development and are 
transcribed in the eye anlage at the formation of the neural plate stage (Zuber and Harris, 
2006). The EFTFs work in a coordinated fashion whereby they synergistically activate one 
another’s expression. Mutations in any of the transcription factors that include ET, Rxl, 
Pax6, Six3, Lhx2, til and Optx2 result in the malformation of the eye or loss of the eye 
completely (Voronina et al., 2004; Chow et al., 1999 Lagutin et al., 2003; Zuber et al., 
1999; Yu et al., 2000; Porter et al., 1997).
1.3.3 Development of the vertebrate retina and the retinal pigment epithelium
Once the eye primordia have been identified and the invagination of the optic vesicle has 
formed the optic cup, these neuroblasts must make a key choice as to their fate which is to 
be either the neural retina or the retinal pigment epithelium (RPE). The surface ectoderm 
(presumptive lens) plays a role in neural retinal specification, as the removal of the surface 
ectoderm results in inhibition of neural retinal development (Hyer et al., 1998). There exist 
three lines of evidence to suggest that members of the fibroblast growth factor (FGF) 
family contribute to the development of the neural retina. Firstly, the addition of 
neutralizing FGF2 antibodies to chick optic vesicles inhibits neural development (Pittack et 
al., 1997). Secondly, when the surface ectoderm is removed from developing optic vesicle, 
the addition of FGF-coated beads is sufficient for neural development to continue (Hyer et 
al., 1998), implying that one of the factors secreted by the surface ectoderm could be FGF. 
Finally, the presumptive RPE is capable of transdifferentiating into neural retina when 
cultured in the presence of FGF (Park and Hollenberg, 1989). As a result of the inductive 
signals from the surface ectoderm, the expression of one of the first transcription factors, 
ChxlO, a member of the paired-like homeobox gene family, is up-regulated in the 
presumptive neural retina. This transcription factor is essential in eye development as 
mutations result in microphthalmia. The role of ChxlO seems to be in the regulation of cell 
proliferation as opposed to the differentiation of the neural retina (Burmeister et al., 1996).
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However, ChxlO is required for the down-regulation of another transcription factor, namely 
microphthalmia associated transcription factor (Mitf) which is involved in the maintenance 
of RPE cell identity (Vugler et al., 2007). Mitf expression is localized to the presumptive 
RPE and the dorsal aspect of the optic cup, but Chx 10 expression down-regulates Mitf in 
the presumptive neural retina (Chow and Lang, 2001). Conversely, ChxlO is suppressed by 
signals emitted from the mesenchyme surrounding the eye that enhance Mitf expression 
(Fuhrmann et al., 2000). Remarkably, just as the RPE can transdifferentiate into neural 
retina the opposite occurs in Mitf loss-of-function mutants, suggesting that Mitf down- 
regulation is necessary for the specification of the neural retina (Bumsted and Barnstable, 
2000). In the developing retina a dynamic interplay exists between ChxlO and Mitf 
expression that results in an interdependence of specification between the neural retina and 
the RPE.
1.3.4 Development and organisation of the vertebrate retina
The work begun many years ago by Santiago Ramon y Cajal has led to the identification of 
six major classes of neuronal cells (ganglion, amacrine, bipolar, horizontal, cone- and rod- 
photoreceptors) and one type of glia (Muller glia) that comprise the neural retina. The 
neural retina is composed of three layers of cell bodies: the outer nuclear layer (ONL) 
which contains the cell bodies of the photoreceptors (rods and cones), the inner nuclear 
layer (INL) which contains the bipolar, horizontal and amacrine cells, and the third layer, 
comprising ganglion cells (GCL) and displaced amacrine cells. Two layers of synapses, 
found at the outer (OPL) and inner plexiform layers (IPL) connect the three layers of the 
neural retina. Within the OPL, photoreceptors synapse with bipolar cells, which in turn 
synapse with ganglion cells within the IPL. Bipolar cells also synapse with horizontal and 
amacrine cells forming further networks that influence and integrate the ganglion cell 
signals. The visual signal is transmitted from the back of the eye towards the ganglion cell 
axons that carry the signal to the visual cortex of the brain, where it is further processed and 
interpreted (Kolb, 2003). Neurons in the developing retina arise from multipotent 
progenitor cells largely in response to local cell-cell interactions in an evolutionarily 
conserved temporal and spatial pattern (figure 1.4) (Ahmad et al., 2000). Ganglion cells, 
cone photoreceptors, amacrine cells and horizontal cells are bom in the first wave, and 
bipolar neurons, rod photoreceptors and Muller glia are generated in the second wave of 
differentiating cell types (Marquardt and Gruss, 2002).
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Figure 1.4 Stereotypic formation and structure of the  neural retina
(A) Temporal generation of the mammalian retinal cell types showing the stereotypic 
order of retinal cell development with the ganglion cells generated first and the Muller 
glial cells generated last.(B) Schematic representation of the laminar structure of the 
neural retina.The neural retina consists of three laminar layers- GCL: ganglion cell layer; 
INL: inner nuclear layer and ONL: outer nuclear layer.
(Adapted from Ohsawa and Kageyama, 2007).
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1.3.5 Signalling pathways required for neural retinal development
Many secreted factors and signalling pathways are involved in the development of the 
neural retina. Lineage analysis in the rat has revealed that progenitor cells within the retina 
are multipotent and can generate several different retinal cell types up until their final cell 
division (Turner and Cepko, 1987). In order to understand when a cell becomes committed 
to its fate and how determination is controlled, various gene-targeting techniques and mis- 
expression strategies have been devised to manipulate the key transcription factors and 
signalling pathways. Ganglion cells are the first neuronal cell type generated in the neural 
retina, and the proneural gene Math5 has been implicated in the generation of ganglion 
cells. In Math5 mutants there is an 80% loss of ganglion cells within the neural retina 
(Wang et al., 2001). Certain key genes have been identified and shown to be critical for the 
developmental process involved in rod photoreceptor commitment, such as the transcription 
factor Otx2 which is expressed in the neural retina and retinal pigment epithelium 
(Bovolenta et al., 1997). Otx2 regulates expression of the homeobox gene Crx that is 
required for photoreceptor cell fate determination (Hennig et al., 2008). Another 
transcription factor essential in rod photoreceptor determination is Nrl which acts 
synergistically with Crx to activate the rhodopsin promoter (Mitton et al., 2000). Much 
more remains to be understood about the mechanisms involved in rod photoreceptor 
development.
1.3.6 The retinal pigment epithelium
The RPE is derived from the neural tube, and it provides a selectively permeable barrier 
between the choroid and the neural retina. It functions to phagocytose the outer segments of 
photoreceptors, is essential in the phototransduction pathway to regenerate 11-cis retinal 
and transport it back to the photoreceptor cell, it is the site for synthesis of 
interphotoreceptor matrix, and pigment granules reduce light scatter within the eye (Rattner 
et al, 1999; Forrester et al., 2002).
1.3.7 Photoreceptor cells
The human eye contains two types of photoreceptors, rods and cones, which make up the 
outer layer of the neural retina. Rods, which account for approximately 95% of 
photoreceptors in humans, are the cells involved in low light vision, whereas the 5% of 
cone cells are responsible for us visualising objects in bright light. The density of the rod
30
and cone cells varies within the retina. The peripheral regions are dominated by rod cells 
whereas in the centre there is a greater concentration of cones, especially at the region 
exclusive for cone cells in the centre of the macula- the fovea. Each photoreceptor is 
composed of a long narrow cell with an inner and outer segment joined together by a 
connecting stalk or cilium. Contained within the outer segments are the visual pigments, 
rhodopsin in rod cells, and green, red and blue opsins in cones. It is these pigments that are 
responsible for the absorption of light, which leads to the generation of electrical impulses 
to the brain, a series of events collectively known as phototransduction.
1.3.8 Phototransduction
Phototransduction occurs in the outer segment of the retinal photoreceptor cells. The 
reaction cascade amplifies cellular responses to external signals, photons of light, received 
from the environment. The receptor rhodopsin is a heptahelical transmembrane protein, 
which has a covalently linked 11-cis-retinal chromophore. It is the chromophore that 
becomes activated by light and which then enables rhodopsin to activate the G-protein, 
transducin. Transducin is a multi-subunit protein composed of three chains, a , p and y. G- 
proteins are in the OFF state when the a  subunit binds to a GDP molecule, and are 
switched ON when GTP occupies the binding site. Therefore, rhodopsin is the receptor 
necessary to switch on transducin and cause the attachment of GTP to the a  subunit. When 
bound, transducin has the ability to hydrolyse GTP, and this reaction consequently activates 
the effector enzyme cGMP phosphodiesterase (PDE). In its inactive state PDE is a 
heterotetramer consisting of a  and p subunits bound to a y subunit. Upon binding of the 
GTP-bound a-transducin subunit, PDE undergoes a conformational change leading to the 
removal of the inhibitory y subunit. The two remaining subunits hydrolyse cGMP bound to 
the rod photoreceptor cGMP-gated channel, to 5’GMP, a side product of this reduction 
reaction being protons. This reaction induces the closure of Na+ and Ca2+ channels in the 
plasma membrane of the outer segment. The resulting hyperpolarisation of the cellular 
membrane generates the photoreceptor signal. A reduction in the intracellular level of 
calcium stimulates recoverin, which in turn activates guanylate cyclase. Guanylate cyclase 
synthesizes cGMP from GTP thereby restoring the outer segment cGMP level to baseline, 
and consequently the reopening of the cGMP-gated channel. In addition, phosphorylation 
of rhodopsin by rhodopsin kinase (a photoreceptor specific enzyme) leads to its
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inactivation. Both events return rod cells to their ground state. Phototransduction in cones 
utilizes proteins that are homologous but distinct to those found in rods.
1.4 Retinal dystrophies
With such an intricate pathway responsible for vision, it is not surprising that a problem 
within the eye can lead to devastating effects, for which few therapeutic remedies currently 
exist. There are numerous disorders which cause the degeneration of photoreceptors and 
RPE, two that have a major impact on the world’s population are discussed here.
1.4.1 Retinitis pigmentosa
Retinitis Pigmentosa (RP) constitutes a group of heterogeneous inherited dystrophies that 
have an estimated prevalence of between 1 in 3000 and 1 in 5000 worldwide (Haim, 2002). 
The predominant characteristics that all these dystrophies share are a loss in visual acuity 
from the periphery, that gradually progresses towards the macula, and a bilateral 
involvement. Several genes have been implicated in the onset of RP, resulting in a range of 
genetic mutations that cause photoreceptor apoptosis, often leading to functional blindness 
(Kalloniatis and Fletcher, 2004). The predominant gene mutations afflict the rhodopsin 
gene, however there are mutations in genes that are involved in the phototransduction 
cascade such as transducin and rhodopsin kinase. The modes of inheritance in RP range 
from autosomal dominant, x-linked, and simplex to multiplex. The simplex and multiplex 
groups are likely to be due to autosomal recessive inheritance (Tyler et al., 1984). 
However, it is believed that environmental interactions could also play a role in simplex 
forms of RP (Stone et al., 1999). Most patients present with night blindness as the initial 
sign of RP in their early teens, which leads to progressive reduction in peripheral vision. 
The eventual loss of central vision is often observed in the fifth to seventh decades, but in 
severe RP the loss of central vision may be much earlier. Potential therapies for RP include 
the administration of various growth factors including basic fibroblast growth factor 
(bFGF), which has shown to slow photoreceptor loss in a range of rodent models including 
the RCS rat (Faktorovich et al., 1990; Perry et al., 1995). Modifications in diet may be 
useful in some retinal dystrophies.
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1.4.2 Age-related macular degeneration
Age-related macular degeneration (AMD) is a leading cause of blindness in the developed 
world that increases significantly with age (Tuo et al., 2004). AMD affects the macula, the 
region of the eye containing cone photoreceptors that is responsible for visualising detail, 
and when these cells degenerate only peripheral vision remains (Feret et al., 2007). In 
AMD the primary cause is clearly linked to RPE dysfunction (Beatty et al., 2000), leading 
to gradual degeneration of Bruch’s membrane, photoreceptors and the choriocapillaris in 
the macula (Fine et al., 2000). There are two grades of AMD, one being wet AMD, in 
which abnormal blood vessels start to grow behind the retina underneath the macula, 
causing rapid damage to the retina, and the second being dry AMD, when the cone 
photoreceptors in the macula break down, leading to cone atrophy. At least three genes 
have been implicated in AMD; complement factor H (CFH), complement factor B and age- 
related maculopathy susceptibility 2 (ARMS2) (Patel et al., 2007; Kanda et al., 2007). Risk 
factors other than age include positive family history, diet and environmental factors, 
especially smoking (Hyman and Neborsky, 2002). AMD will become more prevalent as the 
life-span of humans continues to increase, and as 30% of 75 year olds and older have a 
form of AMD the incidence of AMD is expected to double within 25 years (Smith et al., 
2001). The therapies available to date to limit disease progression include surgical macular 
translocation, and anti-angiogenesis agents to prevent blood vessel growth and leakage in 
wet AMD. With respect to both RP and AMD, ganglion cell output neurons are largely 
unaffected (Medeiros and Curcio, 2001; Stone et al., 1992). This is important if cellular 
replacement is to become a reality, otherwise functional vision could not be restored.
1.5 Possible therapies
Alongside the administration of drugs and translocation surgery that are currently being 
used to treat the increasing numbers of patients with retinal degenerations, there are newer 
therapies in clinical trials that could one day hold greater promise in treating these 
disorders.
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1.5.1 Gene therapy
Gene replacement therapy is theoretically capable of creating missing cellular components 
when genetic mutations interfere with the development or function of a photoreceptor cell. 
The rds rodent model has mutations in the Prph2 gene resulting in a severe photoreceptor 
dystrophy, and in humans Prph2 mutations lead to the autosomal recessive condition, 
Macular Dystrophy. Using electroretinography (ERG), a diagnostic tool that measures 
photoreceptor cell function, 10 week old rds mice treated with subretinal injections of 
recombinant adeno-associated virus (AAV) encoding a Prph2 transgene, had significant 
ERG recordings, indicating improvements in retinal function (Ali et al, 2000). These 
results were compared with untreated rds mice of the same age, which showed undetectable 
ERG responses. Gene therapy will not be suitable for all retinal degenerative diseases, and 
is only likely to be applicable to autosomal recessive diseases and some x-linked diseases. 
With regards to RP, 31 genes have been implicated, however each known mutation only 
accounts for less than 10% of RP patients (Wang et al., 2005). However in AMD, known 
mutations can now explain more than 50% of disease. Due to the multitude of mutations 
responsible for visual deficits, the application of gene therapy in the long-term may be 
severely constrained.
1.5.2 RNA interference
For dominant autosomal diseases, small interfering RNA (siRNA) may be of therapeutic 
benefit. In dominant forms of a disorder the heterozygous patient carries a mutant allele of 
a gene and a healthy functioning allele of the same gene. Mutant alleles produce 
dysfunctional, sometimes toxic proteins that damage photoreceptors. siRNAs have the 
ability to disrupt the mutant allele’s ability to produce harmful proteins, by precipitating 
cleavage of the target mRNAs (Farrar et al., 2002). siRNAs are 21-23 nucleotide long 
double-stranded RNA (dsRNA) molecules with 2 nucleotide overhang at the 3’ terminal 
end of the structure (Pushparaj and Melendez, 2006). The pathway involved in RNA 
interference (RNAi) mediated by siRNAs involves the introduction of dsRNA into the 
target cells, where the dsRNAs are then converted into siRNA by an RNase Ill-like enzyme 
called Dicer. Subsequently, the siRNAs unwind and enter the RNA-induced silencing 
complex (RISC) that allows the cellular RNA that is complementary to the single stranded 
siRNA, to be targeted to undergo enzymatic degradation or inhibition of translation. This
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results in inhibition of translation of the gene product from the diseased allele, but it allows 
transcripts from the healthy allele to be processed and translated normally and thus 
produces the required protein. Notwithstanding the problems of haploinsufficiency that are 
known to exist for rhodopsin, this approach may nevertheless limit disease progression.
This form of therapy has already shown some benefit in the effective targeting and 
inhibition of vascular endothelial growth factor (VEGF) in a mouse model. The results 
showed that blocking endogenous production of VEGF protected the animals from 
choroidal neovascularization, this being a major problem in the wet form of AMD (Reich et 
al., 2003). However, a limitation to this therapeutic strategy is the method in which the 
delivery of siRNAs into the target cell/tissue is administered. To date the most efficacious 
method has been to use viral vectors because of their high transfection efficiency and 
ability to carry siRNAs into non-dividing cells such as neurons (Pushparaj and Melendez, 
2006). However the use of viral vectors in humans has raised safety concerns. Therefore 
until a safe and reliable delivery method is obtained there is a constraint on RNA 
interference as a therapeutic intervention.
Something neither gene nor siRNA-based therapies can accomplish is the regeneration of 
photoreceptors once the cells have died, however one attractive possibility is to use specific 
cells or tissue to replace lost photoreceptor cells and accessory cells, to reverse the loss of 
function and halt disease progression.
1.5.3 Cellular therapy
The use of neural transplantation as a means of treating disease of the CNS was first 
attempted by Thompson (1890), when neuronal tissue was grafted into an adult dog brain. 
More than a century later, this approach has led to some success in treating Parkinson’s 
disease (PD), by grafting dopaminergic cells into the brains of patients (Gray et al, 1999). 
Ideally, cellular therapy would not only replenish damaged cell types but be a means of 
introducing growth factors to induce a more receptive environment for regeneration. By 
transplanting cells, one would hope this would also activate endogenous growth factors and 
cytokines, and in turn would have a knock-on effect by stimulating the host’s own neural 
stem or progenitor cells to aid the repair of damage and deficit. If cellular therapy could be 
harnessed to fulfil all these requirements, it would provide a therapeutic option even more
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efficacious than originally believed. Unfortunately, the need for transplantable cells far 
outweighs the supply, as the use of adult tissue grafts is neither consistent nor renewable. 
The logical step is to look elsewhere, and there is now an intense interest in embryonic and 
foetal tissues, and in particular stem and progenitor cells that originate from them. 
However, no solution comes without its share of ethical and technical issues. As organisms 
develop, stem cells become an increasingly sparse population, which makes them more 
difficult to locate, as well as to study and understand (Temple, 2001). The ideal cell type 
for cellular therapy should be obtained easily and consistently cultured in vitro, until the 
time came to differentiate the cells into the desired cell type. Once grafted into the host, the 
cells should not elicit a host immunological response or develop into a tumour. Most 
importantly, cells should have the ability to integrate, survive and function in the host tissue 
or organ. This has led the field of transplantation, particularly neural transplantation, to 
advance our understanding of neural stem cells. All the therapeutic methods outlined here 
have potential, though unfortunately, none are yet close to being problem free.
1.5.4 Retinal remodelling and cellular therapy
A degenerating retina typically shows signs of modification within the neural-retinal 
structure, leading to the development of neurite remodelling and the establishment of rogue 
circuitry (Marc et al, 2003a; Marc et al., 2003b). Inevitably, this can lead to problems with 
retinal transplants, therefore the time at which transplantation occurs is paramount. 
However, the ability of the retina to remodel shows the plasticity inherent within the neural 
retina. If these mechanisms were better understood they might be harnessed to benefit 
retinal transplantation studies.
1.6 Stem cells and progenitor cells
There remains a good deal of ambiguity surrounding the exact definition of a stem cell. In 
general, a stem cell has both the capacity to self-renew and to generate differentiated 
progeny by symmetric and asymmetric proliferation (Morrison et al., 1997). Human 
embryonic stem cells are pluripotent by nature, meaning they can give rise to all cells that 
arise from the three germ layers, (endoderm, mesoderm and ectoderm), but not the embryo 
because they are unable to give rise to the placenta and supporting tissues. Stem cells are 
concentrated in specific regions of the developing vertebrate. Consequently, they become
36
established in adult tissues and are continually regenerating host tissue, such as blood, skin, 
nasal epithelium and intestine (Temple, 2001).
Although stem cells are functional in regions of the adult central nervous system, their 
presence until recently has been largely disregarded. How and why would an area 
apparently incapable of regeneration house stem cells and their regenerative capacity? A 
possible reason for this dichotomy is that stem cells exist in microenvironments or niches 
that maintain the cells in a quiescent state, safeguarding them from factors that could 
induce the cells to differentiate (Morrison et al, 1997). Stem cells in the CNS are capable of 
generating neurons, astrocytes and oligodendrocytes, and they can self-renew and undergo 
asymmetric division to give rise to cells other than themselves (McKay, 1997; Gage, 2000). 
However, in this thesis the focus is a class of retinal progenitor cells that possess a more 
restricted potential than stem cells. Retinal progenitor cells are multipotent in that they are 
capable of generating the neurons and glia that make up the neural retina (Ahmad et al., 
1999). During development, after a given number of cell divisions progenitors usually exit 
the cell cycle and differentiate into neurons and glia, however some continue to persist in a 
progenitor state. There has been a mass of activity surrounding the location and identity of 
the progenitor cells capable of neurogenesis in the embryonic and postnatal mammal, 
following Altman’s first observations of neurogenesis in the adult brain (1969).
1.6.1 Discovery of stem cells in the ciliary marginal zone
In 1781, Claude Bonnet discovered that adult newts possess the ability to regenerate their 
eyes following the removal of part of the eye (Leigh-Close and Reh, 2006). This led to the 
discovery that fish and amphibians have the enviable ability to regenerate retina throughout 
their lifetimes, and thus began the investigation into the cell types that mediate this 
regeneration. An intracellular tracer of fluorescent dextran was used to demonstrate that 
individually microinjected cells within the eyes of larval Xenopus gave rise to descendants 
that differentiated into all the major cell types required to compose the retina (Wetts, et al., 
1989). The cells that contributed to the growth of the retina postnatally were found at the 
peripheral margin of the eye known as the ciliary marginal zone (CMZ) or ora serrata 
(figure 1.5). These cells allow the growth of the retina via the addition of concentric circles 
of cells, where the youngest and least developed cells are closest to the CMZ. These cells 
are the self-renewing neural stem cells which then give rise to more multipotent progenitor
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cells directly next to them. This eventually leads to retinoblasts that are restricted in cell 
fate, and finally the furthest cells from the CMZ but still within the region of retinogenesis, 
that have stopped proliferating and started to differentiate (Perron and Harris, 2000). 
Exploratory studies in the avian eye resulted in the detection of mitotically active cells, 
showing that new neurons are generated for at least 2 months after hatching. When these 
cells were further analysed they were found to express markers that are found in retinal 
progenitors including ChxlO and Pax6. This work showed that the chick has ongoing 
neurogenesis at the CMZ similar to that in lower vertebrates. However, one difference that 
exists between the CMZ of post-hatch chicks and lower vertebrates is the inability of the 
chick CMZ to produce all the retinal neurons, unlike the lower vertebrates that can generate 
all the retinal neurons required to regenerate a retina. This discrepancy is not due to an 
intrinsic limitation, but exists because the microenvironment lacks the relevant cues. Once 
certain factors were added, other neuronal cell types were induced (Fischer and Reh, 2000; 
Kubota et al., 2002; Fischer and Reh, 2003).
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Figure 1.5 Localisation of retinal stem cells in various vertebrates
Schema illustrating the position of stem cells in (A) Xenopus, (B) Fish,
(C) post hatched chick and (D) adult mouse retinae. Multipotent retinal 
stem cells are found in the most peripheral region of the ciliary marginal 
zone (CMZ) of Xenopus, zebrafish and chick retinae. In the adult mouse 
retina, cells with stem cell properties (progenitor cells) are found in the 
pigmented ciliary epithelium (PCM). GCL: ganglion cell layer; INL: inner 
nuclear layer; IPL: inner plexiform layer; OPL: outer plexiform layer; RPE: 
retinal pigment epithelium. (Adapted from Amato ef al., 2004)
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1.6.2 Evidence of neural stem cells in mammals
The CMZ is a specialized region for the generation of retinal neurons in Xenopus, fish and 
chick, but subsequent searches for a corresponding region in the mammalian retina have 
been elusive. Studies in mouse mutants have nevertheless provided evidence that 
mammalian retinae may be capable of regeneration, thus mouse mutants with a single 
functioning allele for the Sonic Hedgehog (Shh) receptor gene Patched (ptc), exhibit a zone 
of proliferative cells, situated at the retinal margin, well after the normal termination of 
retinal neurogenesis (Moshiri and Reh, 2004a). These cells have been labelled and express 
markers of retinal progenitors including Pax6 and nestin. Previous studies in the post-hatch 
chick have found high levels of Shh at the CMZ, and shown that inhibition of Shh 
signalling in this region inhibits neuronal proliferation (Moshiri et al., 2004b). This mutant 
partially activates Shh signalling in the retinal margin region, reminiscent of the CMZ in 
lower vertebrates. It is believed that the mammalian retina has lost Shh signalling at the 
peripheral margin of the retina, and consequently the CMZ has itself been lost.
Lack of an identifiable CMZ has not deterred the investigation and search for active 
progenitor cells within the mammalian retina. Mammalian retinal development follows 
Xenopus and fish development, in that neurogenesis begins in the centre of the retina and 
progresses outwards towards the periphery, therefore the last mitotically active cells are 
located at the retinal margin. Adult mouse eyes are now known to harbour rare retinal 
progenitor cells that reside in the pigment epithelium of the ciliary body, a region that lies 
in between the ciliary marginal zone, and the iris and retina (Amato et al., 2004). These 
cells exhibit certain qualities of stem cells such as the ability to proliferate, self-renew and 
express markers of undifferentiated retinal progenitor cells (ChxlO and nestin). Another 
key finding has been the ability of these cells to differentiate into different retinal types 
including bipolar cells, miiller glial cells and rod photoreceptors. However, differentiation 
of ganglion, horizontal and amacrine cells has not been observed in these studies (Ahmad et 
al., 2000; Tropepe et al., 2000). These findings demonstrate the presence of cells with 
retinal stem cell characteristics in the pigmented epithelium of the ciliary body, and the 
results have led to an explosion of new data identifying retinal stem cells/progenitor cells in 
mammalian retinae at various time points from embryonic to foetal development (Ahmad et 
al., 1999; Yang et al., 2002a).
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1.6.3 Retinal pigment epithelium and its regenerative ability
Another source of retinal regeneration, in amphibians, is the RPE, which has been proven 
to generate new retina when transplanted ectopically into the vitreous of another eye (Stone 
and Steinitz, 1957). RPE transdifferentiation into neural retina has also been observed in 
the chick eye when the neural retina has first been removed (Pittack et al., 1991). Several 
signalling pathways have been implicated in the transdifferentation process, e.g., fibroblast 
growth factors cause the transdifferentation of the retinal pigment epithelium (RPE) into the 
neural retina (Park and Hollenberg, 1989).
1.7 Stem cell types
There are three sources from which human retinal progenitor cells could be extracted, each 
with its own advantages and disadvantages. The use of embryonic stem cells, extracted 
from the blastocyst, could be a viable source. The cells would be pluripotent, so would hold 
the greatest level of plasticity of the three; however this may also be a disadvantage, as 
more cues would be required to differentiate these cells to the final photoreceptor 
phenotype. As a second option, foetal stem cells would be partially differentiated so fewer 
steps should theoretically be necessary. Compared to their adult counterparts, the plasticity 
of foetal stem cells presents a greater hope of successful differentiation. The differentiation 
potential of adult stem cells is assumed to be limited, however a large body of evidence 
now supports the idea that certain adult stem cells, particularly bone marrow, can engraft 
alternative locations that are non-haematopoietic in origin. However the field is not without 
its detractors.
1.7.1 Potential of human foetal tissue
The use of foetal cells and tissue has led to some encouraging results. Of relevance to this 
study, several groups have found that human retina from 10-13 week old foetuses harbours 
progenitor cells that can be maintained and expanded in culture (Yang et al., 2002). Further 
analysis of human foetal retinal cultures have proven their ability to respond to growth 
factors and hormones and differentiate towards a photoreceptor lineage (Kelley et al., 
1995).
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1.7.2 Primary cultures versus immortalised cell lines
As development progresses, progenitor cells become an increasingly finite population. The 
use of such cells in a clinical capacity is limited because of the difficulty in obtaining 
sufficient numbers, and the difficulty of maintaining these cells in vitro. Additionally, the 
potential of the cells to replicate in vitro may be limited, and cultures of primary progenitor 
cells frequently comprise a heterogeneous cell population that are at various developmental 
time points. Therefore it is harder to obtain a homogenous population, and in the vast 
numbers required. The factors controlling vertebrate retinal progenitor cells would be more 
accessible to molecular analysis if cell lines with characteristics of the ‘parental’ cells were 
established (Frederiksen et al., 1988). Immortalised stem cells have already been used in 
attempts to repair damage in the brain, and important issues raised from such studies show 
the need for the immortalising gene to be under the control of a regulatable factor, ideally 
one that results in the cell line becoming conditionally immortalised.
The most widely used example of this is the temperature sensitive (ts) mutated allele (A58) 
of the simian virus 40 (SV40) large T antigen (T) oncogene, which is temperature-sensitive 
due to the presence of two point mutations on the tsT gene (Davies et a l , 2003). This is 
stably expressed in cells cultured at 33°C but is down-regulated at normal body temperature 
of 37°C. SV40 is a DNA virus that kills and lyses simian cells, its natural host (Cepko, 
1989). The early region genes of the virus are capable of disturbing cell cycle pathways, 
specifically interfering with cell cycle inhibitor genes. This causes loss of cell senescence, 
leading to the immortalisation of the transfected cell. The actual vehicle for immortalisation 
is the large T antigen, which disables two tumour suppressor genes, one being p53, which 
functions as a transcription factor (Camero et al., 2000) that normally restrains proliferation 
by inducing the expression of genes which lead to growth arrest. The second target of S V40 
is the retinoblastoma gene (Rb), a tumour-suppressor that regulates a cell cycle checkpoint. 
Following transfection of the S V40 virus into the cell, the tsT protein binds to a domain on 
Rb that leads to the dissociation of Rb cellular factors that regulate cell cycle progression.
Neural transplantation using immortalised stem cells or progenitor cells has shown 
significant promise, and there has been no evidence of tumour formation or gross disruption 
of host brain tissue after grafting (Gray et al., 1999). Transplantations into the developing
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rat brain have shown integration and differentiation into both neurons and glia, using tsT- 
SV40 immortalisation in hippocampal cells (Renfranz et al., 1991). Alternatively the 
oncogene v-myc which can be used to infect human embryonic brain cells, may be 
conditionally regulated with tetracycline. The removal of tetracycline switches on v-myc 
which results in the differentiation of some cell lines towards neuronal and glial lineages 
(Sah et al., 1997). With specific reference to the work undertaken in this thesis, other 
groups have shown the ability of immortalised human foetal retinal cell lines to undergo 
neuronal differentiation with a subset of cells expressing opsin protein (Dutt et al., 1994). 
However, this study did not use a conditionally immortalised SV40 antigen. Therefore, it 
will be interesting to examine whether differentiation occurs when the SV40 oncogene is 
‘switched o ff in this study.
1.8 Aims of the thesis
The focus of this thesis is to characterise clonally immortalised human foetal retinal 
progenitor cell lines, generated by ReNeuron from 10-13 week aborted foetuses, and to 
ascertain their potential to differentiate in vitro, with particular emphasis towards rod 
photoreceptor differentiation. In doing so, the aim is to determine the developmental cues 
required to drive these cells towards retinal cell-specific lineages. A secondary goal is to 
transplant these cells into developing and diseased rat retinae in order to assay their 
potential to survive, integrate and differentiate in vivo. The fundamental aim of this 
research is therefore to establish whether immortalised progenitor cells could play a role in 
future clinical trials for cellular therapy, and perhaps alleviate the blindness caused by 
retinal dystrophies.
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Chapter 2 
Materials and Methods
2.1 Generation of immortalised cell lines
2.1.1 Derivation of human retinal progenitor cell lines
Two foetal human retinal progenitor cell lines were derived from 10-13 week old gestation 
foetal eye tissue that was obtained from the MRC Tissue Bank, Hammersmith Hospital, 
London in accordance with national, legal and ethical guidelines. The following cell line 
derivation of the progenitor cells was carried out by ReNeuron. Tissue was collected in ice- 
cold HBSS without Ca2+/Mg2+ (Gibco), containing 1 mM N-acetyl cysteine (Sigma). The 
neural retina was removed from the eyes and cleaned of debris under a dissection 
microscope (Leica). The tissue was dissociated by first dicing with a scalpel followed by 
incubating in 0.25% w/v trypsin (Cambrex Biosciences, Belgium) in DMEM:F12 (Gibco) 
containing 0.025 U/ml Benzonase (Merck) for 15 min at 37°C. Following dissociation, 
twice the volume of trypsin inhibitor solution (5.5 mg/ml soybean trypsin inhibitor, Sigma, 
dissolved in DMEM:F12, containing 1% human serum albumin, Grifols, and 0.025 U/ml 
Benzonase) was added. Cells were centrifuged at 800 x g for 5 min, then resuspended in 
serum-free human media comprising DMEM:F12 supplemented with human serum 
albumin (0.03%); human transferrin, (100 pg/ml, Sigma); putrescine dihydrochloride (16.2 
pg/ml Sigma); human insulin (5 pg/ml, Sigma); L-thyroxine (T4) (400 ng/ml, Sigma); tri- 
iodo-thyronine (T3) (337 ng/ml, Sigma); progestrone (60 ng/ml, Sigma); L-Glutamine (2 
mM, Gibco); sodium selenite (selenium) (40 ng/ml, Sigma); heparin sodium salt (10 U/ml, 
Sigma); corticosterone (40 ng/ml, Sigma) and Gentamycin (50 pg/ml, Gibco) in the 
presence of basic fibroblast growth factor, bFGF, (10 ng/ml, Invitrogen) and epidermal 
growth factor, EGF (20 ng/ml, Sigma). The yield of cells isolated from the neural retina of 
two eyes was approximately 3xl06, with 90% viability as judged by trypan blue exclusion.
Cells were plated in 2 wells of a 6-well plate (Falcon) coated with laminin (Sigma, coated 
at 5 pg/ml in DMEM:F12 for 1 h at 37°C followed by one wash with DMEM:F12) and 
maintained at 37°C in a humidified atmosphere of 95% air and 5% CO2 . Upon reaching 
confluency cells were passaged to laminin-coated flasks using trypsin and trypsin inhibitor 
solutions, detailed above. Following two passages (P3) cells were infected at 50%
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confluency for 8 h with fresh media containing retrovirus carrying the temperature- 
sensitive TsT-SV40 antigen gene (pLNCX-SV40-U19tsA58) in the presence of 4 pg/ml 
polybrene. Three successive 8 h infections were carried out. Following infection, cells were 
placed under antibiotic selection (150 pg/ml Geneticin, Gibco). Clonal isolation was carried 
out using the cloning ring method by plating 2,000-10,000 cells in a 15 cm laminin-coated 
round tissue culture dish and picking isolated colonies after 2 to 3 weeks growth using 8 x 8  
mm cloning rings (Sigma). A total of 11 clones were isolated, expanded and frozen down in 
10% DMSO (Wak-Chemie), human medium in the presence of bFGF and EGF. Two stable 
clonal cell lines were used in this study, namely GuRt09 and GuRt05. Cells were routinely 
cultured at the permissive temperature of 33°C, at which temperature the cells proliferate 
but do not differentiate. To induce differentiation the cells were transferred to the non- 
permissive temperature of 37°C.
2.2 Cell culture
2.2.1 Retinal progenitor cell culture
Unless otherwise stated, cells were cultured in T75 tissue culture flasks (Nunc, UK) and 
incubated at 33°C in water-saturated air with 5% CO2 . Human foetal retinal progenitor cell 
lines GuRt09 and GuRt05 were obtained from ReNeuron (Guildford, UK) as described 
above in section 2.1.1 and were incubated at 33°C in DMEM:F12 media minus L- 
Glutamine (Gibco) supplemented with 0.03% (v/v) human serum albumin (Grifols, UK), 
100 pg/ml human transferrin, 16.2 pg/ml dihydrochloride putrescine, 5 pg/ml human 
recombinant Insulin, 400 ng/ml L-Thyroxine (T4), 337 ng/ml Tri-Iodo-Thyronine (T3), 60 
ng/ml progesterone, 2 mM L-Glutamine, 40 ng/ml sodium selenite, 10 units/ml heparin, 40 
ng/ml corticosterone and 50 pg/ml Gentamycin (Gibco). Cells were provided with fresh 
medium twice weekly with 10 ng/ml bFGF (Peprotech) and 20 ng/ml EGF (Peprotech) 
along with a full media change. In addition to the growth factors the culture flasks were 
coated with laminin (Sigma). Laminin was dissolved in cold DMEM:F12 media minus L- 
Glutamine and applied to the flasks at a coating concentration of 1-5 pg/cm2. The flasks 
were incubated overnight at 37°C and washed with warmed medium the following day. The 
cells were passaged once a week or when required. For passaging, cells were washed once 
in PBS without Ca2+/Mg2+ (Gibco) and incubated with trypsin (2.5 ml for a T75 and 1 ml 
for a T25) (Cambrex Biosciences, Belgium) at 37°C until the cells detached. Trypsin was
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inactivated with a soybean trypsin inhibitor by dilution with double the quantity used for 
trypsin. The cells were then pelleted by centrifugation at 12000 x g for 5 minutes. Cells 
were usually seeded at a density of 0.5 x 106 cells per T25 and 1.0 x 106 cells per T75. For 
all experiments cells were seeded at a density of 10,000 cells/ cm2 and either placed in a 
33°C or 37°C incubator as required.
The unimmortalised GS076 cells were cultured in the same way as outlined above with 
three main differences. Culture flasks were coated with fibronectin at a coating 
concentration of 1-5 pg/cm as opposed to laminin, and the human medium was 
supplemented with 5% Foetal Bovine Serum (FBS) in addition to all the above 
components. The cells were incubated at 37°C, as opposed to 33°C, in water-saturated air 
with 5% C 02.
2.2.2 Culture of other cell lines
All other cell types used in this thesis were cultured in T25 or T75 tissue culture flasks 
(Nunc, UK) and incubated at 37°C in water-saturated air with 5% C 02. The ARPE19 cell 
line were maintained in DMEM:F12 media plus L-GlutaMAX™ (Invitrogen) 
supplemented with 10% (v/v) Foetal Bovine Serum (FBS) and 1.0% (v/v) 
Penicillin/Streptomycin (Gibco). For passaging, ARPE19 cells were washed with PBS 
(Gibco) and incubated with 1 ml trypsin at 37°C until the cells detached. Trypsin was 
inactivated by dilution with 2 ml of full DMEM:F12 medium and the cells pelleted at 
12000 x g. Cells were split 1:5 once a week and fed twice weekly.
2.2.3 Determination of cell number
The number of viable cells was assessed by diluting 10 pi of cell suspension in culture 
medium with 10 pi of a 0.4% trypan blue solution (Sigma). The cell mixture was left for 2- 
3 min at room temperature after which an aliquot was placed into a haemocytometer. Cells 
were examined under a microscope and the number of viable, unstained cells within the 1 
mm x 1 mm x 0.1 mm grid counted. This number was multiplied by 1 x 104 and the dilution 
factor to give the number of million cells per ml.
2.2.4 Cryopreservation
Detached cells were centrifuged at 12000 x g for 5 min and resuspended in a freezing 
solution comprising 0.2 pm filter-sterilised complete human growth medium and 10% (v/v)
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dimethylsulfoxide (DMSO), at a final cell density of approximately 1 x 106 cells/ml. The 
suspension was quickly dispensed in 1 ml aliquots into labelled cryovials (Nunc, UK). The 
vials were held at -80°C for 24 h in a polystyrene box, and then transferred to liquid 
nitrogen for long term storage. To thaw, cells were warmed quickly in a 37°C water bath, 
diluted in their respective growth media, pelleted by centrifugation and resuspended in the 
appropriate volume of media into a T25 flask. Fresh medium was applied to the cells the 
following day.
2.2.5 Treatment with all-/ra«s-retinoic acid
Stock solutions of 10 mM all-trajw-retinoic acid (RA) (Sigma) were prepared in low light 
by reconstituting in dimethylsulfoxide (DMSO) and stored in foil-wrapped 50 pi aliquots at 
-80°C. Human foetal immortalised retinal progenitor cells were seeded onto a series of 
laminin coated 35-mm tissue culture dishes at a density of 1.0 x 104 cells/cm2. The standard 
cell culture medium of DMEM:F12, minus L-Glutamine was supplemented with 50 pg/ml 
Gentamycin and either 500 nM, 1 pM or 3 pM a\\-trans-RA, which was diluted to the 
appropriate concentration in the culture medium just prior to use. Due to the light sensitive 
nature of RA and DMSO used during this experiment, all medium changes were carried out 
in minimal light. During the culture period, the dishes were covered with aluminium foil. 
The experiment was performed for a duration of three days with daily medium changes.
2.2.6 Treatment with all-Z/wis-retinoic acid in the presence of 3% charcoal/dextran 
treated FBS
Cells were also cultured with dXX-trans-RA. in the presence of 3% charcoal/dextran treated 
foetal bovine serum (FBS) (Hyclone) as s supplement to the culture medium. Instead of 
adding the all-fra«s-RA when the cells were seeded, a different methodology was applied 
as described in a previous study (Chen et al., 2003). Briefly, cells were seeded on culture 
dishes and grown in human medium with 20 ng/ml EGF and 10 pg/ml bFGF at 37°C. After 
1 day the medium was replaced with DMEM:F12 minus L-Glutamine and 3% 
charcoal/dextran treated FBS. After 24 h, cells were treated with 0.5-3 pM sAX-trans-RA 
diluted in DMEM:F12, minus L-Glutamine and 3% charcoal/dextran treated FBS. This was 
considered day 1 of the experiment and daily medium changes were carried out for up to 7 
days when the cells were fixed and immunoassayed.
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2.3. Reverse-transcription polymerase chain reaction
2.3.1 Isolation of total RNA
Total RNA was isolated using TRIzol reagent (Invitrogen, UK), according to the 
manufacturer’s instructions. Briefly, cells were cultured in a 60 mm culture dish and seeded 
at a density of 10,000 cells per cm2 and grown for 7 days or as described in the results 
sections. The cells were then lysed directly from the culture dish by first removing the spent 
media and then adding 0.5 ml TRIzol reagent directly on to the cells. A cell scraper was 
then used to remove the cells and gather a viscous lysate. The viscous cell lysate was 
triturated several times, transferred to a sterile Eppendorf tube and incubated for 5 min at 
room temperature.
Next, 0.1 ml chloroform was added for every 0.5 ml of TRIzol reagent used, in order to 
extract the nucleic acids. The solution was vigorously mixed by hand for 15 s and then 
allowed to incubate at room temperature for 3 min. Subsequently, the solution was 
centrifuged at 12000 x g  for 15 min at 4°C.
The upper, aqueous phase containing the RNA was carefully transferred to a fresh 
Eppendorf tube and the RNA precipated by adding 0.5 ml of isopropanol for every 1 ml 
TRIzol reagent added, and 1 pi glycogen (Ambion, TX, USA) to help visualise the eventual 
pellet. The mixture was briefly mixed, incubated on ice and the RNA pelleted by 
centrifugation at 12000 x g for 10 min at 4°C. The pellet was washed in 1 ml 75% ethanol 
for every 1 ml of TRIzol reagent used. The mixture was vortexed to loosen the pellet from 
the side of the tube and then centrifuged at 7,500 x g for 5 min at 4°C. The resulting 
supernatant was aspirated and the pellet was allowed to dry at room temperature for 3-4 
min. The RNA pellet was resuspended in 16 pi DEPC-treated water and dissolved by 
incubating at 65°C for 10 min with intermittent vortexing.
2.3.2 Quantification of RNA
RNA was quantified using a spectrophotometer (Eppendorf BioPhotometer). For 
quantification 1 pi of the RNA sample was diluted with 99 pi DEPC-treated water, and the 
A260nm reading recorded. The concentration of RNA was calculated using the following 
equation:
RNA concentration (pg/ml) = A260nm reading x 40 xlOO
49
where 40 is the pg/ml RNA equivalent to an A260nm of 1 and 100 is the dilution factor. The 
concentration of RNA was derived as a mean of three measurements. After quantifying the 
RNA it was stored at -80°C in 4 pi aliquots.
2.3.3 RNA analysis by agarose formaldehyde gel electrophoresis
Unlike DNA, RNA has a high degree of secondary structure therefore it has to be denatured 
by treatment with formamide and separated by electrophoresis through agarose gels 
containing formaldehyde (Sambrook et al., 2001). This method was used to ascertain the 
quality of RNA extracted using the TRIzol extraction method. Briefly, a 1.2% (w/v) 
agarose gel was made with RNase free water and boiled in the microwave. The solution 
was allowed to cool for approximately 30 min at which point the 10 x MOPS 
electrophoresis buffer (0.2 M MOPS, 20 mM NaAc, 10 mM EDTA, pH 7.0), formaldehyde 
and ethidium bromide were added. The RNA samples were mixed with RNA loading mix 
in the ratio of 2:1, denatured at 65°C for 15 min and quenched on ice for a further 2 min. 
Samples were centrifuged for 5 s before adding 6x loading buffer, loaded onto the gel and 
resolved at 100 V for 2 h. RNA bands were visualised on a UV light box.
2.3.4 DNase treatment
A commercially available DNase treatment kit (Promega, Madison WI) was used to 
degrade any remaining double- or single-stranded DNA that could interfere with the 
subsequent RT-PCR reactions. Briefly, 1-8 pi of RNA was added to a sterile Eppendorf 
tube, to which 1 pi RQ1 RNase-Free DNase 10 x Reaction Buffer and 1 pi RQ1 RNase- 
Free DNase I Endonuclease were added. If required the final volume was made up to 10 pi 
with nuclease-free water and incubated at 37°C for 30 min. In order to terminate the 
reaction, 1 pi of RQ1 DNase STOP solution was added and incubated at 65°C for 10 min to 
inactivate the DNase. This 11 pi reaction could then directly be used for cDNA synthesis.
2.3.5 First-strand cDNA synthesis
Single-stranded cDNA was prepared from the extracted total RNA, pre-treated with DNase 
I Endonuclease using an oligo(dT) primer, and reverse-transcribed using Moloney Murine
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Leukemia Virus (M-MLV) Superscript™ III reverse transcriptase (Invitrogen) following 
the manufacturer’s protocol. Briefly, 1 pi oligo (dT)2o (50 pM), 1 pi 10 mM dNTP mix and 
the 11 pi DNase treated total RNA were placed into a nuclease-free Eppendorf 
microcentrifuge tube and the reaction made up to a total volume of 13 pi, if required, with 
sterile water. The mixture was heated to 65°C for 5 min and then transferred onto ice before 
the addition of 4 pi 5 X first strand buffer, 1 pi 0.1 M DTT, 1 pi RNaseOUT™ 
Recombinant RNase Inhibitor (40 units/pl) and 1 pi Superscript™ III Reverse 
Transcriptase (200 units/pl). The contents were briefly mixed by gentle pipetting and 
incubated at 50°C for 50 min before inactivation of the reaction at 70°C for 15 min. 
Alongside the synthesis of cDNA a control was run simultaneously from the same RNA 
sample that was treated in exactly the same way minus the addition of Superscript 
Superscript™ III Reverse Transcriptase. Throughout this thesis this control is referred to as 
a “no RT” control. The cDNA template was used in a standard PCR using a Mastercycler® 
Gradient Thermocycler (Eppendorf, UK). The primers (Table 2.1) used were designed 
against human cDNA sequences or were from previously published papers.
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O ptimal G enbank
Gene
Name
Prim er Sequence 5 ’-3 ’
Annealing
Tem perature
(°C)
Amplicon
Size
Accession
Num ber/
Reference
Nestin
F:GAATCACTGAAGTCTGCGGGAC
R:TCCAGGAGTCTGAATGTCTCTTGG 61.5 176bp
X65964
NF160
FiTGCTCCCTCCTCAGTCTTTGG
R:TCGTTTATTGTTTTTGGCTCAGTTG 61.5 155bp BC 096757
NF200
F: GCCAAGGTGGAGGTGAAGGA 61.5 271 bp NMR: TGGTCTGTGCTGGAGGATTTTT 021076
Rccovcrin
F: GGAAAAGCGAGCCGAGAAGA 61.5 282bp NMR: CCTGGGGTGGATGTGTGTGT 002903
Rhodopsin F: AACTGCTCCCCCTTCTCCAT R: GCTTGGCTCTGCTCATTGCT 61.5 227bp
NM
000539
p m F:GCGAGATGTACGAAGACGAC 56.5 115bp Mozzetti etTubulin R:TTTAGACACTGCTGGCTTCG al., 2005
Sox2
F:CGCCCCCAGCAGACTTCACA 59.6 170bp TsukamotoR:CTCCTCTTTTGCACCCCTCCCATTT et al., 2005
Hesl
F:CAGCCAGTGTCAACACGACAC 56.3 307bp Klassen etR:TCGTTCATGCACTCGCTGA al., 2004
Ki67
F:TACGTGAACAGGAGCCAGCA
58.8 246bp NMR:CAGCTGCATrTCTGCCATTA 002417
Nrl
FrGGCTCCACACCTTACAGCTC
60.0 212bp
NM
R.GGCCCATCAACAGGGACTG 006177
Crx
F:CCTCAGTGTCCCCGAAGAT
60.0 1059bp NMR: CTGAACACCGAGCTGTCAGA 000554
S-Opsin
F: TAGCAGGTCTGGTTACAGGATG  
R: GAGACGCCAATACCAATGGTC 60.0 148bp
Lawrence 
et al., 2007
GAPDH
F:CTTTGGTATCGTGG A AGG ACTC
58.8 550bp
Yu et al.,
RiTCTTCCTCTTGTGCTCTTGCTG 2004
Human p F:ACACCTTCTACAATGAGC 58.8 600bp Wong et
Actin R:ACGTCACACTTCATGATG al., 2004
GAPDH
F:TGCACCACCAACTGCTTAG
R:GGATGCAGGGATGATGTTC
60.0 200bp XR 015759
Table 2.1 List of primers used throughout this study
Primers were used a t the specified annealing tem peratures to  amplify 
markers in unimmortalised and immortalised human foetal retinal 
progenitor cells and the  cDNA from a human retinal library as a 
positive control.
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2.3.6 Polymerase Chain Reaction (PCR)
PCRs were carried out using Go Taq Flexi Kit (Promega), with amplification conditions as 
follows: 95°C for 5 min followed by 35-40 cycles of 94°C for 1 min, annealing temperature 
appropriate to primer pair (Table 2.1) for 1 min and 72°C extension for 1 min, followed by 
a final extension at 72°C for 4 min. PCRs of retinal progenitor cell cDNA were carried out 
alongside both water (no-template control) as well as no-reverse transcriptase (no RT) 
controls. Prior to use on retinal progenitor cDNA, the specificity of all primers was tested 
on a phage (X GT10) human retinal cDNA library (a kind gift from Dr A. Hardcastle).
PCR reaction
0.5 pi cDNA
0.5 pi primer forward (10 pmol/pl)
0.5 pi primer reverse (10 pmol/pl)
2.5 pi Taq reaction buffer 
0.5 pi 10 mM dNTPs
2.0 pl-2.5 pi 25 mM MgCh (dependent on primer pair)
2 Units Taq polymerase 
Sterile ddfhO to 25 pi
2.3.7 Agarose gel electrophoresis
PCR products were separated and analysed by horizontal agarose gel electrophoresis, as 
described elsewhere (Sambrook et al., 2001). DNA samples were routinely resolved on a 
2% (w/v) agarose gel prepared by adding 3 g of agarose to 150 ml 1 x Tris-acetated-EDTA 
(TAE) buffer (2 mM Tris-HCl, pH 8.0, 50 mM EDTA, pH 8.0, 5.7% acetic acid) and 
dissolved by boiling in a microwave and cooled to approximately 50°C. Ethidium Bromide 
(0.5 pg/ml) was added to the gel solution before being cast. PCR products were prepared by 
the addition of DNA loading buffer (80% glycerol, 0.25% bromophenol blue, 0.25% xylene 
cyanol FF). The gel was electrophoresed at 100 V for 1-2 h or until the DNA fragments 
were sufficiently resolved, appropriately sized DNA markers (New England Biolabs, UK) 
were also electrophoresed on the gel to determine sample fragment size. The ethidium
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bromide stained gel was visualised using an UV transilluminator and images obtained using 
Gene Snap (Syngene).
2.4. Immunocytochemistry
Primary antibodies used, optimal dilutions and source are shown in table 2.2. Cells were 
cultured in 35 mm dishes at a density of 10,000 cells per cm2 and grown for 1 week in the 
various conditions. Spent medium was aspirated and cells fixed immediately with 4% 
paraformaldehyde for 30 min at 4°C. Following several washes with 0.1 M PBS pH 7.4 (10 
x PBS; 80.9g NaCl, 2.9 g KC1, 2.9 g KH2P 04, 11.5g Na2HP04, pH 7.3) cells were 
incubated in a series of solutions, all made up in 0.1 M PBS containing 0.3% Triton X-100 
(Sigma). Cells were permeabilised in 0.3% Triton X-100 (Sigma) in 0.1 M PBS for 2 min 
at room temperature. After permeabilisation, cells were washed with 0.1 M PBS three times 
for 5 min each, and then blocked in 5% normal donkey serum (NDS) (Jackson 
Immunoresearch) for 30 min at room temperature. Samples were then incubated with the 
primary antibody, or combination of antibodies, made up at the appropriate dilution (table
2.2) in the presence of 1% NDS at 4°C overnight. The following day, after three successive 
washes with 0.1 M PBS the cells were incubated in the secondary antibody, diluted at 1:200 
with 2% (v/v) blocking solution for 30 min, in the dark. Following the removal of the 
secondary antibody solution, at least 4 washes were performed to rinse the cells, to 
minimise background staining. After washing, excess moisture was removed from the edge 
of the dish with a tissue, and a drop of Vectashield mounting media containing DAPI 
[nuclear stain] (Vector Laboratories, Peterborough UK) was placed on to the centre of the 
dish. A coverslip was placed on top of the mounting media; care was taken to avoid the 
formation of air bubbles. To secure the coverslip in place, nail vamish was applied around 
the edges and allowed to air dry.
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Target Protein Reactivity OptimalDilution
Catalogue No. 
& Source
Target cells/ 
other features 
identified
Nestin Goat Polyclonal 1:200
sc-21247  
Santa Cruz Neural Stem Cells
NF160 Mouse
Monoclonal
1:1000
MAB5254
Chemicon
Retinal Ganglion 
Cells/ Horizontal 
Cells
NF200 Rabbit Polyclonal 1:5000
AB1982
Chemicon
Retinal Ganglion 
Cells/ Horizontal 
Cells
Recoverin Rabbit Polyclonal 1:1000 AB5585Chemicon
Rods, Cones and 
Bipolar Cells
Rhodopsin Rabbit Polyclonal 1:200
sc -15382 
Santa Cruz Rods
P III Tubulin
Mouse
Monoclonal 1:1000
MAB1637
Chemicon
Retinal Ganglion 
Cells
Sox2 Goat Polyclonal 1:500
sc-17319  
Santa Cruz
Retinal Progenitor 
Cells
Nrl
Crx
Rabbit Polyclonal 
Goat Polyclonal
1:500
1:500
sc-33183 
Santa Cruz
sc-22381 
Santa Cruz
TF involved in rod 
photoreceptor 
differentiation 
TF involved in rod 
photoreceptor 
differentiation
Rhodopsin
Kinase
Mouse
Monoclonal
1:1000 R 3276 Sigma
Rod and cone 
photoreceptors
S-Opsin Goat Polyclonal 1:500
sc -14363 
Santa Cruz
Blue light 
sensitive cones
ChxlO Goat Polyclonal 1:500 sc-21690  Santa Cruz
Eye Field TF and 
bipolar cells
GFAP
Mouse
Monoclonal
1:500 G 3893 
Sigma
Astrocytes and 
other glial cells
Ki67 Rabbit Polyclonal 1:2000
NCL-Ki67p
Novocastra
Laboratories
Active phase o f  
cell cycle
Human
M itochondria
Mouse
Monoclonal 1:1000
MAB1273
Chemicon
Human
Mitochondria
Table 2.2 List of primary antibodies used throughout this study
All antibodies were used at the  specified dilution in PBS and 0.3% 
Triton X-100 with 1 % normal donkey serum, unless otherwise stated. 
TFrTranscription Factor.
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2.4.1 Confocal microscopy
Fluorescently stained cells were examined and images captured using a Zeiss confocal laser 
scanning microscope with LSM 510 software. Images in figures are stacked confocal 
images unless otherwise stated.
2.5 Subretinal transplantation surgery
All animal care was in accordance with Institutional and Home Office (UK) regulations and 
the UK Animals (Scientific Procedures) Act, 1986. For the transplantation procedure rats 
were anaesthetised with intraperitoneal injections of Ketamine (5 mg/kg) and Xylazine (10 
mg/kg) and the pupil was dilated using Tropicamide (1% Mydriacyl®, Alcon Labs., Hemel 
Hempstead, UK). Prior to transplantation, cultures of the immortalised cells were 
trypsinized, washed and counted into a suspension of approximately 5 x 104 cells/pl in 
DMEM:F12 minus L-Glutamine (Gibco). Cell suspensions were stored on ice prior to the 
transplantation procedure.
The grafting of cells into the eye was visualised using an operating microscope (Olympus). 
Cells were injected through a fine glass pipette (internal diameter 200 pm) attached to a 10 
pi Hamilton syringe. Following the back-filling of injection equipment with carrier medium 
(DMEM), a small opening was made in the eyelids using fine microsurgical scissors. Then, 
using a trans-scleral approach, either sham or cell suspension injections, approximately 1-2 
pi per eye, were made unilaterally into the vitreous chamber or subretinally of the left eye. 
Upon completion of surgery, the animals were given a second intraperitoneal injection 
consisting of the anaesthetic antidote Antisedan® (atipamezole hydrochloride 5 mg/kg). 
Once fully conscious, pups were returned to the home cage. All animals were killed at 
various time points post-transplantation either 5 or 26 days post graft or 9 weeks post graft. 
Animals were placed on ad libitum oral cyclosporine A (concentrate infusion, Sandimmun, 
Sandoz, Camberley, UK; 210mg/l of drinking water) from 2 days before transplantation 
until killing to limit the possibility of immune rejection of the grafted cells.
2.5.1 Tissue extraction and preparation
Animals were deeply anaesthetised with Pentobarbital Sodium (200 mg/kg) and perfused 
transcardially with 0.1 M PBS, followed by 4% paraformaldehyde. Eyes were removed, 
cornea punctured and orientation noted before placement in the same fixative overnight at
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4°C. The following day eyes were washed in PBS and cryoprotected in 30% sucrose 
solution (in PBS). Following one further day in sucrose at 4°C the lens was carefully 
removed from each eye, which was orientated prior to freezing. The eyecup was then 
embedded in Optimal Cutting Temperature Compound (OCT;Tissue Tek®, Miles, 
Raymond Lamb, London, UK), rapidly frozen in a freezing mixture of dry ice and acetone 
and stored at -70°C. Frozen blocks were sectioned (12 pm-14 pm) using a Leica CM3050 
Cryostat and mounted on charged glass slides (BDH) in 5 consecutive series. The slides 
were allowed to air dry for 2 hours and stored at -80°C and used for immunohistochemical 
studies. Prior to staining, frozen sections were brought to room temperature and dried in a 
current of air for one hour.
2.5.2 Immunohistochemistry
Slides were placed in a humidity chamber and blocked with for 1 h with 5% NDS in lx 
PBS (+ 0.3% Triton-XlOO). Primary antibodies were prepared in PBS containing 0.3% 
Triton X-100 with 1% NDS, and 500 pi was incubated on the slides overnight. The 
following day the primary antibody solution was washed off with 3 x 10 min washes in 
PBS. Secondary antibodies were made up in PBS (plus 0.3% Triton X-100) with 2% NDS 
and applied to tissue for 2 h. Once the secondary antibody was removed cell nuclei were 
counterstained with DAPI (1:5000 dilution; Sigma). Slides were washed once in PBS for a 
duration of 5 min, and then extensively in Tris buffer (0.05 M pH 7.4), prior to being cover- 
slipped with vectashield (Vector labs) and secured with nail varnish.
2.5.3 Immunolabelling of retinal sections to distinguish xenografted human cells from 
host macrophage/microglia
Previous experience has shown that host macrophages/microglia is responsible for an 
autofluorescent staining artefact that may lead to false positive identification of grafted 
cells (A.Vugler, personal communication). In order to control for this and to 
unambiguously identify grafted human cells a protocol visualising the EDI antibody 
(specific for CD68 on rat macrophages and microglia) with peroxidase was employed prior 
to labelling other relevant antibodies with fluorescent markers. After blocking with 5% 
normal horse serum (NHS) in 0.1 M PBS with 0.3% Triton X-100 sections were incubated 
in mouse anti-EDl antibody in PBS (plus 0.3% Triton X-100) with 1% NHS overnight at
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room temperature. After washing in PBS, sections were incubated for 2 h in PBS-TX 
containing biotinylated horse anti-mouse secondary antibody (Vector, 1:200), washed again 
and incubated for 1 h in a 1:50 dilution of Avidin-Biotin-Peroxidase Complex (Vector, 
ABC Elite kit) in PBS plus 0.3% Triton X-100. Following a PBS wash, sections were 
reacted in a 0.05% solution of 3,3’-diaminobenzidine (DAB, Sigma) with nickel and 
cobaltous chloride added for signal intensification. Slides were incubated for 30 s in this 
solution containing 0.03% hydrogen peroxide. The peroxidase reaction was terminated by 
extensive washing. Once treated in this manner the mouse anti-EDl antibody is not 
detectable by fluorescently tagged anti-mouse secondary antibodies. Slides were then 
blocked with 5% normal donkey serum (NDS, Jackson ImmunoResearch) in PBS for 1 h 
followed by overnight application of the relevant combination of primary antibodies (Table
2.2) as detailed above.
2.6 Flow cytometry
2.6.1 Background
Flow Cytometry is a method that allows the quantification of the physical and chemical 
characteristics of cells whilst passing through a fluid stream (Weaver, 2000). Therefore, a 
heterogeneous population composed of thousands of cells can be characterised with respect 
to cellular characteristics (Patkar et al., 2002). A light beam intersects the fluid stream at a 
point where a number of fluorescence and other detectors are positioned in order to obtain 
readings for forward scatter (FSC) and side scatter (SSC) fluorescence. As the cell passes 
through the light beam it scatters the light to some degree, additionally the fluorescent 
molecules labelling the cells are excited into emitting light. The light and scattering 
information are collected and converted to digital values that reveal certain characteristics 
of that individual cell.
A flow cytometer can measure several parameters simultaneously, these include forward 
scattered light (FSC) which is proportional to cell size, and side scattered light (SSC) which 
is proportional to cell granularity. Fluorescence intensities are measured at different 
wavelengths simultaneously for each cell. The primary goal of flow cytometry is to obtain 
data that quantify the percentage of cells expressing markers under investigation. Flow 
Cytometric measurements were performed with a BD FACS Calibur, 488nm argon ion
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laser (BD Biosciences). Ten thousand events were collected per sample and stored for 
analysis. Two colour live gating was used to optimize for each fluorochrome. Data analysis 
was carried out using WinList, Verity software.
2.6.2 Fluorescent stains
Fluorescence intensities were measured at different wavelengths simultaneously for each 
cell. The argon ion laser is commonly used in flow cytometry because at 488nm it can 
excite more than one fluorochrome. The combination of fluorescein isothiocyanate (FITC) 
and phycoerythrin (PE) were used in these experiments as both are excited at 488nm, and 
yield fluorescence emission spectra with peak emission wavelengths that are easily 
resolved.
2.6.3 Gating
Gating defines the cells of interest based upon the physical characteristics of a cell 
determined by the FSC and SSC signals. This allows the exclusion of dead cells and cell 
debris from the analysis. Gates are drawn in the dot plot as a polygon encircling the 
population of interest (Nunez, 2001). Cells within the boundary are analysed for expression 
of protein markers under investigation.
2.6.4 Quadrant setting
Quadrant settings were established by running a negative control cell sample in which the 
primary antibody is omitted to indicate the non-specific binding of the secondary antibodies 
used. The quadrants were set such that 98-99% of all events were included into the lower 
left quadrant representing cells that bind neither antibody. Subsequently, these quadrants 
were used for all further analysis of the cells, on that day, with no alterations. A negative 
control was run prior to each experiment in order to eliminate variability.
2.6.5 Immunocytochemistry on cells in suspension
Briefly, cells in the monolayer culture were trypsinized and counted so that just over 1 x 
106 cells were aliquoted into individual sterile Eppendorf tubes. The cells were centrifuged 
at 4,000 x g for 5 min and then fixed with 100 pi cold 4% paraformaldehyde and left at 4°C 
for 30 min. After further centrifugation, the fixative was removed and the cells were 
washed once in 100 pi of PBS. Due to the nature of immunostaining cells in suspension,
59
between each step cells were centrifuged at 4,000 x g for 5 min each. Following a further 
round of centrifugation cells were permeablised with 0.3% Triton X-100 for 2 min and then 
washed with PBS. Prior to antibody incubation, cells were blocked for non-specific binding 
in PBS containing 5% Normal Donkey Serum (Jackson Laboratories), 0.3% Triton X-100 
for 30 min at room temperature. Cells were then centrifuged and incubated with appropriate 
dilutions of antibodies (Table 2.2) and left overnight at 4°C. The following day the cells 
were centrifuged and then washed once with PBS. The secondary antibody solution was 
composed of 2% NDS diluted in 0.3% Triton X-100 in PBS and the appropriate dilution of 
secondary antibody. The cells were incubated in the secondary antibody solution for 30 min 
then foil wrapped and left at room temperature. Following this incubation cells were 
centrifuged and then washed one last time before a final centrifugation. The cells were then 
resuspended into 300 pi of PBS and kept in the dark at 4°C until run on the flow cytometer.
2.7 Use of standard error of the mean
The standard deviation (SD) is a useful estimate of the dispersion of samples, whilst the 
standard error of the mean (SEM) is used in inferential statistics to estimate the SD of the 
means of a population. The main aim of this thesis has been to compare and contrast the 
effects of differently treated cell populations. In order to make a statistical comparison 
between both groups the calculation of the mean and estimation of its variability (SEM) are 
required for each sample set. In order to visually illustrate this comparison, data has been 
plotted on graphs with error bars that represent the SEM throughout this thesis. Therefore, I 
believe that the use of the SEM, as a measure of dispersion of the mean of each group, 
would be more appropriate than the SD of the samples in this case.
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Chapter 3 
Characterisation of immortalised and unimmortalised 
human foetal retinal progenitor cells
3.1 Introduction
Retinal development is a highly specialised process that is conserved spatially and 
temporally (Ahmad et al., 1999). There exists a basic understanding of the mechanisms 
controlling retinal histogenesis, however much remains to be elucidated. There are two 
principle aims of work on retinal development, one being to enhance our understanding 
of the mechanisms involved in retinal developmental, and the other to harness this 
knowledge to explore the use of such cells in the application of cellular therapy. As 
therapeutic tools, these cells may replace and restore lost cell types in various retinal 
diseases.
Experiments using human retinal progenitor cells from 10-13 week old foetal neural 
tissue have shown their potential, in the correct microenvironment, to differentiate 
towards neuroretinal cell types (Kelley et al., 1995; Yang et al., 2002a). While effective 
in increasing our understanding of retinal development, these cells have a limited 
application clinically, given the vast numbers of patients that could benefit from such a 
therapy and the finite number of cells available at present.
The aim of this thesis was to characterise and evaluate the differentiation potential of 
two human foetal progenitor cell lines that have undergone immortalisation. 
Immortalised cells escape the controls of the cell cycle that would otherwise constrain 
proliferation and therefore grow and divide continuously, usually well beyond the limits 
of primary cells (Stacey and MacDonald, 2001). In this study a temperature-sensitive 
mutant of the SV40 large T antigen was used for immortalisation, which enables the 
cells to proliferate at the permissive temperature of 33°C and in principle differentiate at 
the non-permissive temperature of 37°C. SV40 is a DNA virus that kills and lyses 
simian cells, its normal host, however when in cells from other species it may integrate 
and express large T antigen, an immortalising oncogene (Cepko, 1989).
By investigating the potential of, and characterising these SV40 immortalised retinal 
progenitor cell lines, it was hypothesised that the cells would the express critical 
characteristics and antigens of their unimmortalised counterparts, and have the potential
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to respond to environmental cues by differentiating towards a photoreceptor or other 
retinal cell lineage. If immortalisation was shown to be compatible with the cells 
retaining their ability to differentiate, this would lead to vast numbers of clonal cells 
being generated that could provide new understanding of the mechanisms involved in 
retinal histogenesis and perhaps be the basis of immortalised cells (using techniques that 
do not rely on oncogene introduction) being used in the clinics.
To fully understand the development and differentiation of these cells in vitro a variety 
of markers were investigated to identify the developmental stage that the cells exhibit. It 
was also important to understand what a 10-13 week old foetal retina expresses at this 
developmental stage (figure 3.1) in order to properly evaluate the expression patterns of 
the cells in vitro. Another important step was to run a comparative study between 
unimmortalised cells of the same age as those that have been immortalised, to identify 
differences and similarities between both cell types.
3.1.1 Immimocytochemical and PCR markers
Much of the work in this thesis uses a number of markers to evaluate the developmental 
and lineage-specific characteristics of these cells, and here a brief overview will be 
given as to what they are and why they were used.
3.1.1.1 Nestin
Nestin is an intermediate filament protein expressed in mitotically active central 
nervous system progenitor cells (figure 3.1 A) during early stages of development 
(Cattaneo and McKay, 1990; Hockfield and McKay, 1985). It is first expressed in the 
developing rodent neural tube at El 1 after the neural tube has closed, when 98-100% of 
these cells are nestin positive. After only two days some cells are already nestin 
negative in regions where post-mitotic neurons are known to reside (Hockfield and 
McKay, 1985). An important feature of nestin as a marker, is that it discriminates 
between stem cells and more differentiated cells in the neural tube (Lendahl et al., 1990). 
Nestin mRNA is known to be down-regulated at the end of neurogenesis (Lendahl et al., 
1990) and replaced by tissue specific filament proteins (Zimmerman et al., 1994). This 
gene has thus helped the study of early developmental processes by the identification of 
specific progenitor cell types.
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Figure 3.1 H um an fo e ta l re tin a  a t  12 w eeks g e s ta tio n
Human foetal retina was sectioned and stained for several markers to  identify th e  expression 
profile of cells within the  developing retina, with particular regard to  som e of th e  antigens 
used for im m unocytochem istry on the  hum an foetal retinal progenitor cells ob tained  from 
ReNeuron. (A) Section th rough  a 12 week hum an retina stained for nestin and Ki67.
(B) Human retina stained for nestin and DAPI to  reveal the  nuclei. (C, D) At this tim e point 
cells adjacent to  the  RPE (retinal p igm ent layer) and the  INL (inner nuclear layer) are positive 
for recoverin. PRL: photoreceptor layer; ONL: outer nuclear layer; NBZ: Neuroblastic zone. 
Scale bar = 50 pm and 20 pm in th e  boxed region of im age D. (Courtesy of Dr. A.Vugler).
3.1.1.2 Neurofilament markers
Almost all neural cells contain neurofilaments (NF) composed of three subunit 
polypeptides, namely the 70kD, 160kD and 200kD neurofilament proteins, of which the 
latter two are specifically stained for in this work. In the human retina the expression of 
these neurofilaments is present in the axons of the retinal ganglion cells (Kivela et al., 
1985). As the retina matures NF200 is up-regulated compared to the other two triplet 
proteins.
3.1.1.3 Short wavelength cone opsin
The short wavelength cone opsin (S-opsin) is one of the specific photopigments for 
cone photoreceptors and is first detected in the human foetal retina (around the 
developing fovea) from week 11, with expression gradually spreading throughout the 
entire retina by week 20 (Cornish et al., 2004). Short-wavelength sensitive cones (S 
cones) have been detected in foetal, postnatal and adult human retinae (Xiao and 
Hendrickson, 2000) and are responsible for blue colour vision (Dacey, 1999). In many 
mammals, cones constitute less than 5% of the entire population of photoreceptors 
(Carter-Dawson and LaVail, 1979), and because of the sequential order of ‘birth’ that 
exists in retinal development (Cepko et al., 1996) cones appear relatively early after 
appearance of the first cell type (ganglion cells).
3.1.1.4 Rhodopsin kinase
Rhodopsin kinase is a rod and cone photoreceptor specific enzyme that contributes to 
the termination of the phototransduction pathway by phosphorylating the photoactivated 
opsin photopigments (Young et al., 2003). Mutations in the rhodopsin kinase gene 
cause Oguchi disease, a form of night blindness (Sokal et al., 2002).
3.1.1.5 Recoverin
Recoverin is a 23kDa calcium-binding protein expressed in retinal photoreceptors 
(Wiechmann, 1996) that regulates the phototransduction cascade by inhibiting 
rhodopsin kinase at high calcium levels, thus preventing the phosphorylation of 
photoexcited rhodopsin (Ames et al., 2006). Recoverin immunoreactivity has been 
localised to photoreceptor cells, a subpopulation of cone bipolar cells, and a sparse 
population in the ganglion cell layer (Wiechmann, 1996; Yan and Wiechmann, 1997). 
In humans, by week 13 in gestation, recoverin expression is clearly evident (figure 3.1) 
and gradually reduces until birth (Yan and Wiechmann, 1997).
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3.1.1.6 6 III tubulin
B III tubulin is a neuron-specific microtubule protein that is a marker for immature 
neurons and ganglion cells. The expression of B III tubulin coincides with the onset of 
differentiation (Sharma and Ehinger, 1997). Recent evidence suggests that certain 
horizontal, amacrine and cone photoreceptors also stain positively for this protein. 
These cells all belong to the early phase of cell birth in the neural retina (Sharma and 
Netland, 2007).
3.1.1.7 Rhodopsin
Rhodopsin is the photopigment that mediates phototransduction in all rod 
photoreceptors. It is a G-protein-coupled receptor that is chemically linked to the 
chromophore 11-cis-retinal (Maeda et al., 2003; Palczewski and Saari, 1997). 
Rhodopsin is the most reliable marker of rod photoreceptors, however its synthesis only 
occurs 30 days after the birthdate of the photoreceptor itself (Cepko, 1996). This 
suggests that the expression of rhodopsin is determined by the position it has in the 
retina and not the birthdate, implying that neighbouring cells or local signals influence 
the expression of rhodopsin.
3.1.1.8 Ki67
Gerdes et al., (1983) identified a human nuclear protein Ki67 that was expressed within 
the nuclei of all human cells in all active parts of the cell cycle (G l, S, G2 and mitosis) 
but was absent in non-dividing cells (GO). As Ki67 is confined to the nucleus and is 
present during the cell cycle it suggests an essential role in the regulation of cell cycle 
division, this has been confirmed by the introduction of Ki67 antigen-specific antisense 
oligonucleotides that results in the inhibition of proliferation in the cell line targeted 
(Schiilter et al., 1993).
3.1.1.9 Nrl
The Neural Retina Leucine zipper (NRL) transcription factor is essential for the 
development and differentiation of rod photoreceptors through its role as an activator of 
various target genes. N r l_/' null mutant mice lack any sort of rod photoreceptor function 
and rhodopsin immunoreactivity (Mears et al., 2001), demonstrating the importance of 
NRL in functional rod photoreceptor formation.
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3.1.1.10 Crx
The Crx (Cone rod homeobox) gene encodes a 299 amino acid protein. In the adult, Crx 
is expressed in photoreceptors and pinealocytes. In E l2.5 mice, Crx expression is 
detectable within the retina, where its main function is to bind to promoter regions of 
rhodopsin and several other photoreceptor-specific genes in order to activate these 
genes. Crx therefore plays an important role in retinal development. There is also 
evidence that Crx and Nrl act synergistically to activate rhodopsin expression (Chen et 
a l,  1997).
3.1.1.11 Sox2
The SRY box (SOX) proteins comprise a family of transcription factors that contain 
DNA-binding High Mobility Group (HMG) domains that are generally expressed 
during early cell fate decisions (Pevny and Lovell-Badge, 1997). Soxl, Sox2 and Sox3 
are initially expressed in the anterior neural plate and invaginating optic vesicle. During 
the formation of the optic cup, Soxl and Sox3 are down-regulated, while Sox2 is 
maintained and restricted to neural retina cells (Kamachi et al., 1998). However, as 
neural precursors differentiate, the expression of Sox2 is down-regulated (Pevny and 
Lovell-Badge, 1997). To date, the importance of Sox2 in the nervous system has been 
highlighted by mis-expression studies in mouse, chick and Xenopus that suggest the 
role of Sox2 is to maintain neural progenitor identity.
3.1.1.12 ChxlO
ChxlO, a homeobox gene expressed in the presumptive neural retina is essential for eye 
development as mutation in the gene results in microphthalmia. ChxlO regulates the 
proliferation of retinal progenitor cells, rather than influencing the differentiation of the 
neural retinal cells (Burmeister et al., 1996). ChxlO also specifies the neural retinal 
region and inhibits other transcription factors in order to specify this region.
3.1.1.13 Hesl
Hesl is a member of the basic helix-loop-helix (bHLH) transcription factor family and 
acts as a key regulator of the proliferation process in retinal progenitor cells. In Hesl 
mutant mice embryos, cell proliferation in the retina is severely impaired (Ohsawa and 
Kageyama, 2008).
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3.2 Experimental design and objectives
The purpose of this set of experiments was to characterise the GuRt09 and GuRt05 
clonally immortalised cell lines, and to elucidate their potential to exhibit progenitor cell 
proteins and properties. In order to fully characterise the cell lines a comparative study 
was run in parallel whereby primary cells were taken from 10-13 week old neural retina 
without undergoing immortalisation. Due to the finite nature and restricted number of 
the unimmortalised cells, there was a limitation on the range of experiments that could 
be undertaken. All cells were cultured at a density of 10,000 cells /cm2 on laminin- 
coated dishes (for the immortalised cell lines) and fibronectin-coated dishes (for the 
unimmortalised cells) for a 7 day period prior to immunocytochemical analysis or total 
RNA extraction using Trizol reagent according to manufacturer’s instructions. 
Specificity of immunostaining was tested by omission of the primary antibody, and 
absence of positive staining indicated specificity of the secondary antibody. Where 
possible, pre-incubation of primary antibody with immunising peptide was also 
undertaken. A positive control sample of human retinal cDNA from a library was used 
as a template for the primers used in the RT-PCR reactions to further confirm the 
primers’ specificity.
The first aim of this thesis was to examine the characteristics of the cell lines supplied 
to us by ReNeuron. This was performed by examining the immortalised cells at the 
permissive and non-permissive temperatures, to determine whether there were any 
visible differences when the cells were permitted to exit the cell cycle at the non- 
permissive temperature of 37°C.
3.2.1 Substrate considerations
Throughout the thesis it was decided that the immortalised cells would be grown on 
laminin-coated flasks and dishes. The rationale for this was the report that plating 
retinal progenitor cells on laminin matrices causes an increase in rod photoreceptor 
differentiation (Levine et a l , 2000).
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3.3 Results
In this study, the immortalised human foetal retinal progenitor cell lines, GuRt09 and 
GuRt05, were characterised individually and in comparison with an unimmortalised 
retinal progenitor cell culture, GS076. All cell types were analysed morphologically 
(figure 3.2) and appeared to exhibit differences. While the GuRt09 and GuRt05 cell 
lines tended to be spindle-like, the GS076 cells had a larger cytoplasm and were more 
rounded in morphology. This could be a consequence of the immortalisation procedure 
of the GuRt09 and GuRt05 cell lines. In this study the GuRt09 and GuRt05 cell lines 
were passaged long term (up to 35 passages), whereas it was very difficult to culture the 
primary unimmortalised cells beyond 10 passages, even when they were maintained on 
fibronectin-coated flasks, and cultured in serum-defined medium. In addition, selection 
pressure under culture conditions would probably lead to less heterogeneity within the 
GS076 cells, making it more difficult to compare early and late passage cultures.
In immunocytochemical analysis, GuRt09 cells, cultured at 33°C expressed the 
intermediate neurofilament protein nestin, a marker of neural progenitor cells (figure 3.3 
and 3.4). This expression was also apparent at 37°C (figure 3.5), the non-permissive 
temperature, at which cells should exit the cell cycle and potentially differentiate. At the 
permissive temperature, conducive with proliferation, the cells expressed Ki67, NF160, 
NF200, recoverin and rhodopsin kinase. The expression of rhodopsin, Crx and Nrl was 
not detected at 33°C. Interestingly, the cells did not express Sox2, the transcription 
factor expressed early in the developing neural retina. However as neural precursors 
differentiate, the expression of Sox2 is down-regulated (Pevny and Lovell-Badge, 1997) 
consistent with the notion that these cells used here may be beginning to differentiate. 
To further characterise the cells, they were cultured at 37°C to determine whether 
inactivation of the immortalising oncogene would be sufficient to permit signs of 
differentiation or morphological differences. The results showed that markers of a more 
differentiated state such as B III Tubulin (figure 3.5), an early neuronal and ganglion cell 
marker, could not be detected, nor was the expression of rhodopsin, S-opsin, Crx or Nrl 
detectable. The expression patterns of nestin, NF160, NF200, rhodopsin kinase and 
Ki67 were apparently no different from these observed in GuRt09 cells cultured at 33°C. 
The detection of Ki67, a proliferation marker, was unexpected at 37°C because at this 
temperature the SV40 oncogene should be conditionally switched off, therefore 
allowing cells to exit the cell cycle.
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GS076 P9
GuRt09 P15
GuRt05 PI 4
Figure 3.2 Primary and immortalised human foetal retinal progenitor cells
Phase contrast images of progenitor cells taken from the neural retina of 10-13 
week old aborted foetuses. (A) GS076 (P9) cells are primary cultures, whilst (B,C) 
are cells that have undergone clonal immortalisation to generate GuRt09 and 
GuRt05 cell lines.The immortalised cells appear more spindle-like whilst the 
GS076 (A) appear more flattened with larger cytoplasms.
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Figure 3.3 Expression profile o f GuRt09 at th e perm issive tem perature
Confocal images of GuRt09 (PI 5-P20) cells grown on laminin at 33°C in human 
medium for 7 days. (A) Cells stained for human mitochondrial marker (HMIT) 
and NF200. (B) Expression of NF200 alone. (C) Expression of the neuroectoderm al 
marker nestin. (D) Recoverin expression. (E, F) Cells are positive for the  proliferation 
antigen of Ki67. Nuclei were counterstained with DAPI and are blue in all images. 
Scale bar = 20 pm.
Figure 3.4 Expression profile o f GuRt09 at th e  perm issive tem perature
Confocal images of GuRt09 (PI 5-P20) cells grown on laminin at 33°C in human 
medium for 7 days. (A) ft III Tubulin and Sox2 were undetectable in the  GuRt09 
cell line. (B) Cells were positive for the  rhodopsin kinase antigen, however Nrl 
was undetected via immunocytochemistry.(C) Rhodopsin expression was not 
detectable at this stage, neither was S-opsin (D). (E,F) Run in parallel with all 
staining samples were negative controls where the primary antibody was 
omitted from the protocol to detect any non-specific staining.
Scale bar = 20 pm.
Figure 3.5 Expression profile of GuRt09 at the non-permissive temperature
Confocal images of GuRt09 (PI 8-21) cells grown on laminin at 37°C in human medium 
for 7 days. (A) Cells stained for nestin. (B) Expression of NF200 alone. (C) Expression of 
NF160 and Ki67. (D) Rhodopsin and G III Tubulin were undetectable. (E) Cells are positive 
for rhodopsin kinase, but Nrl was not detected. (F) Cells were positive for recoverin and 
S-opsin was not detected. Nuclei were counterstained with DAPI and are blue in all images. 
Scale bar = 20 pm.
Similar expression patterns were observed for the GuRt05 clonal cell line, at both 
permissive and non-permissive temperatures the cells were immunoreactive for the 
same sets of markers (figures 3.6 and 3.7) as the GuRt09 cell line. Again there was no 
detection of B III tubulin, the neural progenitor transcription factor Sox2, S-opsin, or 
later proteins involved in rhodopsin expression, Crx and Nrl, or rhodopsin itself.
The GS076 primary unimmortalised cells showed some similarities with the 
immortalised cell lines as they expressed nestin, NF160 and NF200 (figure 3.8). 
Interestingly, not all cells expressed Ki67, indicating that a proportion of cells were 
either senescent or post-mitotic. This was in contrast to the GuRt09 and GuRt05 cell 
lines where all cells were positive for this marker. In comparison to the immortalised 
cell lines, the primary cells were immunoreactive for a subset of later neuronal markers 
including B III tubulin and S-opsin, however rhodopsin expression was not detected.
Further analysis of the genes expressed by the cell lines and primary cells was 
determined by RT-PCR. All primers were first tested to amplify cDNA from a human 
retinal library as a positive control, and indeed were able to amplify the correct size 
amplicon from the retinal library (figure 3.9), with the exception of nestin, which could 
be due to the lack of expression in the retinal library. The nestin primers were 
nevertheless used, and as the correct size amplicon was amplified from immortalised 
and unimmortalised cell types without any band appearing in the no RT or no template 
controls, these primers were judged to be specific.
Interestingly, all the cells expressed the mRNAs for S-opsin and B III tubulin (figure 
3.10), despite the fact that the gene products were not detected at the protein level. The 
cells were also positive for other transcription factors that are important to neural 
progenitor maintenance, including Hesl. There was no detection of rhodopsin, Crx, Nrl 
at the transcriptional level. Overall, there were no apparent differences in the expression 
patterns of genes examined in the GS076 cells and the immortalised cell lines, and when 
the cell lines were cultured at 33°C and 37°C the RT-PCR analysis similarily showed no 
apparent differences.
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Figure 3.6 Expression profile of GuRt05 at the permissive temperature
Confocal images of GuRt05 (PI 7-20) cells grown on laminin at 33°C in human medium 
for 7 days. (A) Cells stained for Human Mitochondrial Marker (HMIT). (B) Cells expressing 
NF160 and Ki67. (C) Rhodopsin and R III Tubulin were undetectable. (D) Cells were positive 
for nestin and NF200 and the majority of cells co-expressed both neurofilament proteins. 
(E) Cells were positive for rhodopsin kinase, but Nrl was not detected. (F) Cells were positive 
for recoverin and S-opsin was not detected. Nuclei were counterstained with DAPI and are 
blue in all images. Scale bar = 20 pm.
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Figure 3.7 Expression profile of GuRt05 at the non-perm issive tem perature
Confocal images of GuRt05 (P15-20) cells grown on laminin at 37°C in human medium 
for 7 days. (A) Cells were positive for nestin and NF200. (B) Cells expressed NF160 and 
Ki67. (C) Rhodopsin and R III Tubulin were not detected. (D) Negative controls were 
run in parallel with all samples to ensure no non-specific staining. (E) Cells were positive 
for rhodopsin kinase, but Nrl was not detected. (F) Cells were positive for recoverin and 
S-opsin was not detected. Nuclei were counterstained with DAPI and are blue in all 
images. Scale bar = 20 pm.
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Figure 3.8 Expression p a tte rn s  of retinal m arkers in GS076, unim m ortalised  hum an 
foetal retinal p rogen ito r cells
Cells were obtained from 10-13 week old foetuses and cultured on fibronectin-coated dishes 
in 5% FBS supplem ented human medium at 37°C. These confocal images were taken of 
GS076 (P10) cells. (A) Cells were positive for nestin and a portion of these cells were positive 
for ki67 antigen (B), however not all cells were actively proliferating. Cells were also positive 
for (C) NF160, (D) NF200,(E) Recoverin, (G) R III Tubulin and (H) S-opsin. (I) Negative control 
run in parallel with this sample of immunocytochemistry, the absence of positive staining 
dem onstrates the specificity of the  secondary antibodies used. (F) Rhodopsin was not 
detected by immunocytochemistry. Scale bar = 20 pm.
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Figure 3.9 PCR analysis of discriminatory markers in human retinal cDNA library
The cDNA from a human retinal library was used to  screen the primers prior to  RT-PCR 
analysis of th e  GuRt09, GuRt05 cell lines and primary GS076 primary cells. The retinal 
cDNA was used as a positive control to  ensure th a t the  primers w ere able to  amplify 
th e  correct sized amplicons. All PCR reactions performed using the  retinal cDNA were 
run using stock solutions of cDNA, a 1:10 dilution of the stock cDN A and a no tem plate 
control (only shown in A). (A) The specific markers amplified were recoverin (282bp), 
NF160 (155bp), NF200 (271 bp), S-Opsin (148bp),a positive GAPDH control (550bp),
Crx (1059bp) and Nrl (212bp). (B) Amplicons for Sox2 (170bp), Hesl (307bp) and 
B III Tubulin (115bp) were also detected. (C) Rhodopsin (227bp) was amplified from 
the  retinal cDNA, however nestin (176bp) was no t detected  with this cDNA sample.
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Figure 3.10 RT-PCR analysis in GS076 primary cells and GuRt09 and GuRt05 cell lines
RNA was extracted from cells cultured in medium for 7 days and cDNA was used to  amplify 
particular genes or markers. GAPDH was used as a positive control throughout. As an internal 
control a sample of RNA that had not been reverse transcribed was used as a no RT control 
in order to  distinguish genomic contamination. GS076 cDNA was run in parallel with GuRt09 
cDNA cultured at 37‘C.Crx, Nrl and Rhodopsin were not detected via RT-PCR.
79
Immortalised and unimmortalised cells were routinely cultured on laminin or 
fibronectin coated dishes respectively. This was due to the finding reported elsewhere 
that plating retinal progenitor cells on laminin matrices causes an increase in rod 
photoreceptor differentiation (Levine et al., 2000). However, cells were also cultured on 
plastic to ascertain any differences in expression patterns or morphology (figures 3.11 
and 3.12). No apparent differences were observed with regard to expression profiles of 
the various cell types, however when cultured for 2-3 weeks cells began to aggregate 
forming small clusters known as neurospheres (figure 3.13). Growth as neurospheres is 
a defining characteristic of neural stem/progenitor cells (Sheedlo et al., 2007). Within 
the neurosphere both the immortalised and unimmortalised cell types expressed nestin, 
but this was not seen in all cells. Interestingly, the expression of Ki67 was down- 
regulated in the GS076 neurospheres as opposed to the GuRt09 cells that contrived to 
actively proliferate.
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33°C Plastic 37°C Plastic
F igure  3.11 E xpression  p ro file  o f G uR t09  cell lin e  on  p lastic
Confocal im ages of GuRt09 (PI 8-22) cells grow n on plastic a t 33 °C and  37°C in h u m an  m edium  
for 7 days. (A, B) Cells s ta ined  for nestin  show ing similar levels o f expression a t b o th  tem p era tu res . 
(C, D) Cells w ere positive for th e  Ki67 an tigen . (E,F) Cells w ere positive for NF200 expression. Nuclei 
w ere coun te rsta ined  with DAPI and  are  b lue in all im ages. Scale bar = 20 pm.
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Figure 3.12 Expression profile of GuRt09 cell line on plastic
Confocal im ages o f GuRt09 (PI 8-22) cells g row n on  plastic a t 33°C an d  37°C in h u m an  m edium  
for 7 days. (A, B) Cells w ere  positive for NF160 a t b o th  tem p era tu res . (C,D) R hodopsin  an d  8 III 
tu bu lin  w ere  n o t d e te c te d  a t e ith e r  cond ition . (E,F) Cells w ere  positive for recoverin , how ever 
S-opsin w as u n d e te c te d  via im m unocy tochem istry . Nuclei w ere c o u n te rs ta in e d  w ith  DAPI an d  
are  b lue in all im ages. Scale b ar = 20 pm .
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Figure 3.13 Formation of neurospheres by GuRt09 and GS076 cells
GuRt09 an d  GS076 cell cu ltu res w ere seed ed  on  to  plastic d ishes an d  left for a d u ra tio n  o f 2-3 w eeks, 
a t w hich po in t th e  cells b eg an  to  form  neu rospheres. (A) Phase-con trast im age o f th e  GS076 cell cu ltu re  
form ing m ultip le n eu ro sp h eres . (B) Confocal im ages o f GS076 neu ro sp h eres  sta in ing  positively  for nestin  
an d  very w eakly for Ki67. (C) The im m ortalised  retinal p ro g en ito r cells also re ta in ed  th e  ability  to  form  
spheres. (D,E) Confocal im ages o f th e  GuRt09 spheres expressing  nestin  and  Ki67. All nuclei w ere  sta ined  
w ith DAPI. Scale bar = 20 pm.
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3.4 Discussion
In summary, these studies have shown that the immortalised human foetal retinal 
progenitor cells express numerous retinal markers, including nestin, a protein widely 
used as a marker of neural progenitor cells. As cells begin to differentiate the expression 
of nestin is down-regulated (Lendahl et al., 1990), therefore the continuous expression 
of nestin could be due to the fact that the cells have not been cultured in an environment 
that is conducive towards differentiation. Although one would expect down-regulation 
of nestin at 37°C, where the SV40 oncogene is switched off and therefore the cells 
should theoretically exit the cell cycle and begin to differentiate, without the appropriate 
cues perhaps the cells remain within the cell cycle, which would be consistent with the 
expression of Ki67 at the non-permissive temperature.
The primary GS076 cells are similar in expression patterns to the immortalised cell lines, 
in that they all express nestin, recoverin, NF160 and NF200. Interestingly, not all the 
GS076 cells were positive for Ki67, implying that many had stopped dividing, whilst 
the immortalised cells continued to remain in the cell cycle. The analysis of Ki67 
protein expression is considered in more detail in subsequent chapters. Another 
difference between the immortalised cells and the primary cells was the expression at 
the protein level of the later neuronal markers, B III tubulin and S-opsin in the GS076 
cells, whilst these markers were not detected in the immortalised cell lines. This 
illustrates the possibility that even though the cells were taken from foetal neural retinal 
tissue at the same developmental stage, there could be significant differences in the 
potential of individual cells.
The GS076 cells are a heterogeneous population in which inevitable differences must 
exist in the potential of individual cells, whilst in comparison the immortalised cells are 
clonally derived. This could account for some of the differences in expression patterns 
as some cells within the primary culture were apparently more differentiated than either 
of the cell lines. However, the potential of the cell lines is clearly illustrated by the 
expression of S-opsin and B III tubulin at the transcriptional level. Given that the cell 
lines express the mRNAs for these markers, it would be interesting to elucidate what 
molecular mechanisms and trophic factors might enable their translation and subsequent 
differentiation.
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Chapter 4 
The roles of fibroblast growth factor and epidermal growth factor on 
immortalised human foetal retinal progenitor cell lines
4.1 Introduction
There is a great deal of interest in the effects protein growth factors have on precursor 
cell behaviour, as they play a major role in determining cell fate (Giordano et al., 2007). 
The presence of peptide growth factors have been shown to have mitogenic properties 
either by enhancing neuronal survival, neurite outgrowth or even neuronal 
differentiation in cell cultures in vitro (Kelley et al., 1995). Due to these findings, 
importance has been placed on defining the role mitogenic growth factors exert on 
progenitor cell development. For instance a link between Fibroblast Growth Factor 
(FGF) and neural retinal differentiation in the developing embryo has been highlighted 
(Pittack et al., 1997). This chapter will specifically concentrate on two such factors, the 
aforementioned FGF and Epidermal Growth Factor (EGF), in order to elucidate whether 
the removal or addition of these growth factors would influence the proliferation or 
differentiation of the immortalised retinal progenitor cell lines. Note that because of the 
potential of these factors and other mitogens to stimulate proliferation, the cells are 
normally grown in the presence of 10 ng/ml bFGF and 20 ng/ml EGF.
4.1.1 Basic fibroblast growth factor
Heparin binding growth factors (HBGF) make up a family of mitogens that have a high 
affinity for heparin (Hicks et al., 1992a). Acidic and basic fibroblast growth factors 
(aFGF and bFGF) are the two main members of this family. Both factors are essential 
regulators of mitogenesis and differentiation of precursors cells in the CNS (Brickman, 
et al., 1998). Basic Fibroblast Growth Factor (bFGF) is the most widely expressed of 
the two growth factors and is found at an earlier stage of development, E2 in the avian 
embryo (Guillemot and Cepko 1992; Mascarelli et al., 1987).
4.1.1.1 Basic fibroblast growth factor and the neuroepithelium
During retinal histogenesis the neuroepithelium of the optic vesicles gives rise to two 
distinct tissues- the outer retinal pigment epithelium (RPE) and the inner neural retina 
layer. The development of both is controlled by the exact timing of specific interactions 
and signalling systems which include Bone Morphogenetic Protein (BMP) signalling 
responsible for specifying the RPE and fibroblast growth factors (FGFs) (see Figure 4.1)
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that specify the neural retina (Dias da Silva et al., 2007; Zuber and Harris, 2006). The 
role of FGF in neuronal histogenesis was further elucidated by observations in 22-24 
stage chick embryos. Following retinectomy, beads were implanted into the eye with 
slow release bFGF that resulted in the transdifferentation of the retinal pigment 
epithelium (RPE) into the neural retina (Park and Hollenberg, 1989), even after it had 
begun to differentiate into RPE (Coulombre and Coulombre, 1965).
FGF in 
ectoderm
optic veskte
neural
retina
pigment
epitheliumextraocularmesenchyme
Figure 4.1 Model showing the anlage of the future neural retina and retinal pigment 
epithelium and the role bFGF plays in neural retinal induction
The optic vesicle is in close contact with the overlying ectoderm. A localised source of FGF 
from the ectoderm (stippled region) promotes neural retina development in this region.
The presumptive retinal pigment epithelium (medial surface of the optic vesicle) does not 
receive this signal and therefore must rely on other signalling systems to promote differentation. 
(Adapted from Pittack etal., 1997).
FGF has been detected in many organisms during embryonic development, including 
the chick eye (Mascarelli et al., 1987) and the bovine and dogfish eyes (Lagente, 1986). 
In situ hybridisation studies led to the finding that cells within the developing rat retina 
(embryonic day 12 and postnatal day 1 embryos) express the mRNA for the FGF- 
receptor (FGF-R) (Wanaka, et al., 1991). The use of neutralising antibodies to inhibit 
bFGF (also known as FGF2) in optic vesicles from embryonic day 1.5 chick resulted in 
the inhibition of neural differentiation in the presumptive neural retina but did not 
hinder the differentiation of the RPE (Pittack, et al., 1997). These findings illustrate that 
FGF is not required for RPE differentiation from the optic vesicles and reinforces the 
importance of FGF in eye development.
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4.1.1.2 Fibroblast growth factor and neural retinal development in vitro
Having established the importance of bFGF in vivo, studies were undertaken to observe 
the effects of bFGF on dissociated retinal cell types in vitro. In 1992, Guillemot and 
Cepko observed that dissected RPE explants, from 17-18 or 24-25 stage chick embryos 
cultured in the presence of aFGF and bFGF, lost their epithelial appearance and adopted 
a neuronal morphology after 3 to 4 days in culture. Immunocytochemical analysis 
confirmed the appearance of differentiation markers for retinal cell populations, 
including amacrine, horizontal and ganglion cell types. If differentiation of explanted 
RPE tissue was induced, then perhaps retinal precursor cells in the presence of 
exogenous FGF could respond in a similar manner?
The presence of bFGF mRNA in photoreceptors (Noji et al., 1990) suggests that bFGF 
plays a role in photoreceptor development. This was investigated with the use of 
dissociated newborn rat retinal cells that were maintained as a monolayer in the 
presence of bFGF. These cells exhibited significant increases in rhodopsin expression 
compared to controls (Hicks and Courtois, 1992b). However, with increasing age of the 
cells, the effectiveness of bFGF in inducing rhodopsin expression diminished. This 
study found the effect of bFGF to be dose-dependent, with maximal effectiveness at 10 
ng/ml. Other factors including EGF were without effect. The timing of induced 
differentiation is paramount, as is evident by the reduction in responsiveness to bFGF, 
as the cells get older (from newborn to 3 day postnatal). Therefore it is not only 
important to identify the most effective trophic factors, but also the juncture at which 
they should be administered.
4.1.2 Epidermal growth factor
In addition to being able to induce differentiation, FGF has also been shown to enhance 
the proliferation rate of neuronal precursor cells (Gensburger et al., 1987). This is also 
an attribute shared by the other growth factor examined in this chapter, namely EGF. 
EGF is a potent mitogenic peptide, which stimulates cell growth and differentiation in a 
variety of cultured cells via specific EGF receptors (EGF-R) (Gray et al., 1983; Werner 
et al., 1988). In contrast to FGF, the activity of EGF is biased towards increased cell 
growth rather than differentiation. This point has been illustrated in dissociated neuronal 
progenitor cells from embryonic and neonatal rat retinae treated with 20 ng/ml EGF. 
The cells exhibit an increase in total cell numbers after the first 2 days in culture 
compared to control cells (Anchan et al., 1991). Of particular relevance to work in this
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thesis was the effect both bFGF and EGF had on human foetal retinal cells. In cultures 
with FGF or EGF alone the proliferative effects would diminish after a 2 month period, 
whilst in the long term the combined EGF and bFGF treated cultures continued to 
proliferate in excess of 3 months (Kelley et al., 1995).
4.2 Experimental design and objectives
The aim of work in this chapter was to test whether in foetal retinal progenitor cultures a 
combination of EGF and bFGF could either induce rod photoreceptor differentiation or 
activate the expression of late neuronal markers e.g. S-Opsin, Nrl, Crx, etc. Their effect 
on cell proliferation and survival was also evaluated. Cells were seeded at a density of
1.0 x 104 cells/cm2 on laminin-coated dishes and cultured with or without the addition of 
10 ng/ml bFGF and 20 ng/ml EGF to the culture medium. These cultures were either 
maintained for 7 days with medium changes every other day until the eventual fixation 
and immunocytochemical analysis was undertaken, or were trypsinised daily and cells 
counted using a haemocytometer.
4.3 Results
Cell proliferation studies yielded broadly similar results for both the GuRt05 and 
GuRt09 cell lines (figures 4.2 and 4.3). Both cell lines exhibited an initial drop in 
numbers during the 24 h immediately following plating. The cultures then stabilised 
before slowly increasing in number from about day 3. The presence o f EGF and bFGF 
increased the proliferative rate in both cell lines, though after 7 days the GuRt05 cells 
appeared to lose viability. This may have been due to overgrowth, although the GuRt09 
cells were still in log phase growth at this time, and the cultures did not appear 
especially dense. The doubling time of the GuRt05 cells during log phase growth was 
approximately 4 days in the presence or absence of bFGF and EGF, though the growth 
factors appeared to initiate proliferation some 2 days earlier than cultures in medium 
alone. The later response of the cells cultured in the absence of growth factors could be 
due to the cells conditioning their own medium. The GuRt09 cells took longer to 
respond to bFGF and EGF, remaining constant in cell number from day 2 to 4. After 
this point, cells proliferated rapidly for 48h, with a doubling time of less than 2 days, 
before numbers eventually declined. Taken together, these results show that bFGF and
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Figure 4.2 GuRt09 P23 cells cultured in the presence and absence of bFGF and EGF for 7 days
(A) Representative phase contrast images showing the GuRt09 cells on consecutive days in the presence or absence of growth factors.
(B) EGF and bFGF promoted proliferation of the immortalised human foetal retinal progenitor cells in vitro when exposed to 10ng/ml bFGF 
and 20ng/ml EGF. All cultures were started with 70,000 cells seeded per well (10,000 cells/cm2).The data is presented as the mean total number 
of cells tSEM .
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Figure 4.3 GuRt05 PI 5 cells cultured in the presence and absence of bFGF and EGF for 7 days
(A) Representative phase contrast images showing the GuRt05 cells on consecutive days in the presence or absence of growth factors.
(B) bFGF and EGF promoted the proliferation of the immortalised human foetal retinal progenitor cells in vitro when exposed to10ng/ml bFGF 
and 20ng/ml EGF. All cultures were started with 70,000 cells seeded per well (10,000 cells/cmJ).The data is presented as the mean total number 
of cells ± SEM.
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EGF stimulate the proliferation of both cell lines, both of which nevertheless exhibit 
slow population growth when compared to many routinely cultured lines. However, 
caution is required in the interpretation of these results since numbers of viable cells in a 
culture are determined not only by proliferation rate but also by cell death. It is possible 
that the apparent slow growth rate of these cell lines is at least partly attributable to a 
high rate of apoptosis.
Immunocytochemical analysis of cells cultured in the presence or absence of bFGF and 
EGF did not reveal any observable differences, nor was there induction of rhodopsin 
expression in either of the cell lines (figure 4.4 I and J, and figure 4.5 E and F). There 
was a marked difference in cell numbers between the treated cultures compared to the 
controls (figure 4.4), consistent with the results in figure 4.2. All cells visualised were 
positive for the cell cycle marker Ki67, providing evidence of proliferation. Cells were 
also stained for Sox2, Crx and 13 III Tubulin, all of which were negative. A similar 
analysis of GuRt05 cells (figure 4.5) shows no apparent difference in expression 
patterns between the treated and control cells. The cell numbers were not greatly 
dissimilar at this stage.
Cells were also analysed by flow cytometry to determine the percentages of Ki67 
positive cells in bFGF and EGF cultured cells compared with cells cultured in medium 
alone. Ki67 is a cell cycle marker, and an indicator of a mitotically active cell. An 
average of 45% of bFGF and EGF treated cells were mitotically active (Figure 4.6) 
compared to 38% in the untreated cells. Values given are for the GuRt09 P23 cell line. 
Even though there is a slight increase in Ki67 expression in the treated cultures the 
difference was not significant, p= 0.399 as analysed by the Student t-test, where p= 
<0.05 is significant.
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Figure 4 .4  G uR t09 ce lls  trea ted  in th e  p resen ce  an d  a b se n c e  o f  bFGF an d  EGF
GuRt09 (PI 9) cells were treated in the presence or absence of bFGF and EGF for 7 days 
at 37'C on laminin coated dishes. (A, C, E, G and I) Cells cultured in medium and 10 ng/ml 
bFGF and 20 ng/ml EGF for 7 days. (B, D, F, H and J) Confocal images of cells cultured 
in medium without added growth factors.The panels on the left show greater numbers 
of cells than those on the right, consistent with enhanced proliferation. Nuclei in all images 
were counterstained with DAPI. Scale bar = 20 pm.
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Figure 4.5 GuRt05 cells treated  in th e  presence and ab sen ce o f bFGF and EGF
GuRt05 (PI 5) cells were cultured In the presence or absence of bFGF and EGF for 
7 days at 37°C. (A,C and E) Cells cultured in medium and growth factors (10 ng/ml 
bFGF and 20 ng/ml EGF). (B, D and F) Images of cells cultured in medium alone. 
Cells were negative for rhodopsin, S-opsin and ft III tubulin.There was no apparent 
difference in expression patterns of nestin, NF200,NF 160 and Ki67. All nuclei were 
counterstained blue with DAPI. Scale bar = 20 pm.
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F igure 4 .6  E ffect o f  bFGF an d  EGF o n  Ki67 e x p r e ss io n
GuRt09 cultured for 7 days were analysed via flow cytometry 
for the percentage of Ki67 positive cells. There is a higher 
percentage of mitotically active cells in cultures treated with 
bFGF and EGF than in those treated in medium alone.
However, there is no significant difference between the cells 
treated with growth factors and those without, as analysed by 
the Student t-test ( p = 0.399) (n = 3), where p < 0.05 is significant.
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4.4 Discussion
Basic fibroblast growth factor and epidermal growth factor are well characterised 
mitogenic peptides that effect cell proliferation and retinal development to varying 
degrees. In this chapter, immortalised human foetal retinal progenitor cell lines, GuRt09 
and GuRt05 were cultured in the presence or absence of bFGF and EGF at 10 ng/ml and 
20 ng/ml respectively. The aim was to observe whether or not bFGF in combination 
with EGF would drive proliferation or differentiation, and in the case of the latter 
whether it would be possible to detect rhodopsin expression.
Total cell counts were determined over a period of 7 days, to quantify the effect of both 
factors on cell growth and proliferation. As the cells are normally grown in human 
medium supplemented with bFGF and EGF, it was of interest to see whether exclusion 
of these factors significantly affected cell growth and survival. Both cell lines exhibited 
a more robust cell proliferation when grown in bFGF and EGF as opposed to medium 
alone. Despite this the cells grown in the absence of growth factors looked 
morphologically similar to their treated counterparts. Quantitative analysis of the 
percentage of cells expressing Ki67 showed a 7% difference between the treated cells 
and the un-treated cells which is suggestive of a higher rate of proliferation, though the 
difference was not significant.
A link has been established between the age of a retinal cell culture and its 
responsiveness to FGF. When cells are taken from late embryonic to early postnatal 
retina, higher concentrations of the mitogens are required compared to early embryonic 
cultures, where maximal effects are observed with the lowest of mitogen concentrations 
(Lillien and Cepko, 1992). This seems to imply that foetal cells that are 
developmentally mid-way between these time points may require higher concentrations 
of growth factors to elicit maximal effects. However, the experiments were carried out 
at concentrations for both bFGF and EGF found to be effective in previous studies 
(Hicks and Courtois, 1992b). The possibility remains that with higher concentrations of 
both growth factors there could have been significantly higher proliferation rates in the 
treated cultures. These data indicate that the combination of bFGF and EGF functions 
primarily to prevent cells from dying, and thereby promotes cell survival in the treated 
cultures.
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As bFGF has been shown to induce opsin expression (Hicks and Courtois 1992b), it was 
possible that this might occur in the foetal retinal progenitor cell lines. However, the 
cells continued to express the same selection of markers with and without bFGF and 
EGF, with no discemable difference in expression patterns. It is known that the age of a 
cell is of utmost importance along with the factors added to the culture medium. With 
regards to the work carried out by Hicks and Courtois (1992), they found increased 
opsin expression in the presence of aFGF and bFGF, although the age of the cells had a 
contributing role. The cells were derived from postnatal rat retinae, and as a majority of 
photoreceptors develop postnatally in rodents these cells probably had far fewer cell fate 
decisions to undertake before differentiating into rod photoreceptors. It therefore seems 
likely that the immortalised human foetal progenitor cell lines may be far less capable of 
responding in the same way.
In conclusion, EGF and bFGF were found to have mitogenic effects on the 
immortalised retinal progenitor cell lines, but to have no effect on the differentiation of 
these cell lines. It could be that the concentrations of both factors were inappropriate 
with regard to the age of the cell lines. Thus, establishing a cocktail of trophic factors in 
the cellular microenvironment itself is a major challenge, and knowing the best possible 
developmental time point at which to model the environment is quite another.
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Chapter 5
The effect of foetal bovine serum on immortalised retinal
progenitor cells
5.1 Introduction
Foetal Bovine Serum (FBS) is routinely used when maintaining cell lines in culture, this 
is because of the plethora of trophic factors present within the serum that are required 
for in vitro culturing systems. The withdrawal of bFGF and addition of FBS to the 
medium of some human retinal progenitor cells (taken from the same time point as the 
immortalised human foetal retinal progenitor cells) has led to the differentiation of these 
cells (Yang et al., 2002a). Yang and colleagues (2002b) began to explore the use of 
FBS as a means to differentiate rat retinal progenitor cells, and concluded that in the 
presence of 10% FBS cells began to express early neuronal marker such as B III Tubulin, 
and more mature markers such as rhodopsin and S-opsin, suggesting that the in vitro 
microenvironment, containing FBS, induced the cells to mature. FBS has been shown to 
induce differentiation not only towards a neuronal phenotype but also towards cardiac 
differentiation in human embryonic stem cells (Bettiol et al., 2007). However these 
findings are at odds with other studies where the addition of FBS to human foetal retinal 
cells led to continuous cell proliferation without any evidence of differentiation (Kelley 
et al., 1995). Therefore there is still a great deal of ambiguity as to the trophic effects 
FBS has with respect to the differentiation of retinal progenitor cells towards a neuronal 
lineage.
5.2 Experimental design and objectives
The aim of work in this chapter was to observe whether or not FBS has any effect on 
differentiation of the immortalised human foetal retinal progenitor cells lines, and could 
possibly activate photoreceptor differentiation. Cells were seeded at a density of 1.0 x 
104 cells/ cm2 on laminin-coated dishes and cultured at 37°C, in DMEM:F-12 medium 
alone, or supplemented with 5% FBS or 10% FBS. Cells were incubated for 7 days with 
medium changes every other day. At the end of this period cells were fixed and 
immunoassayed for various markers and imaged using a confocal microscope.
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5.3 Results
Growth in the presence of FBS led to far greater numbers of cells per dish compared to 
the cells cultured in medium alone. However, there was no obvious difference in 
expression patterns for nestin and NF200 (figures 5.1 and 5.2) at all three conditions. 
Nestin did not seem to decline, as might have been expected if  cells were beginning to 
differentiate, and there was no apparent difference in the expression patterns of NF200 
in both cell lines.
Following 7 days in culture, the GuRt09 and GuRt05 cell lines both expressed NF160 
and Ki67 (figure 5.3) with no clear difference in expression patterns for all three 
conditions investigated. The increase in cell numbers is evident in figure 5.3 C and F 
compared to the cells cultured in the plain medium alone (figure 5.3 A and D).
The expression of recoverin was also observed in all three conditions, with no apparent 
difference in expression patterns (figure 5.4), however S-opsin expression was not 
detected in any of the conditions tested, for either of the clonal cell lines. Therefore cells 
had not begun to differentiate towards a cone photoreceptor lineage.
In summary, the cells did not respond as one would expect of multipotent retinal 
progenitors, and induction of rhodopsin expression was not observed (figure 5.5 G-L) 
for either of the cell lines in any of three conditions tested. Rhodopsin kinase, a protein 
involved in the termination of phototransduction in rod and cone photoreceptors, was 
nevertheless positive in the control cells and in the 5% and 10% FBS treated cultures. 
The expression of Nrl and Crx transcription factors was not detected via 
immunocytochemistry in either cell line.
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Figure 5.1 Expression of nestin  and  NF200 in th e  presence of FBS for GuRt09 cell line
GuRt09 (P24) cells cultured in media with the addition of 5% FBS or 10% FBS for 7 days 
prior to fixation and staining. (A-D) Control cells were cultured in medium only for 7 days. 
(E-H) Cells cultured in 5% FBS were positive for nestin and NF200 markers. (I-L) Cells cultured 
in 10% FBS were also positive for nestin and NF200.There was no apparent difference in 
expression patterns of these two markers. However, as FBS contains a plethora of growth 
factors the num ber of cells increased for those cells cultured in FBS compared to the control 
cultures. Scale bar = 20 pm.
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Figure 5.2 Expression of nestin  and  NF200 in th e  presence of FBS for GuRt05 cell line
GuRt05 (P24) cells cultured in media with the addition of 5% FBS or 10% FBS for 7 days prior 
to fixation and staining. (A-D) Control cells were cultured in medium only for 7 days. (E-H) Cells 
cultured in 5% FBS were positive for nestin and NF200. (I-L) Cells cultured in 10% FBS were 
also positive for nestin and NF200.There was no apparent difference in expression patterns 
of these two particular markers. However, as FBS contains a plethora of growth factors the 
number of cells increased for those cells cultured in FBS compared to the control cultures. It 
is also interesting to note that cells that are positive for NF200 (C,G,K) tend to express lower 
levels of nestin (D,H,L) and vice versa. Scale bar = 20 pm.
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Figure 5 .3  E xpression  o f  N F160 and  Ki67 in G uR t09 an d  G uRt05 ce lls  tr e a te d  w ith  FBS
Confocal images of the immortalised retinal progenitor cell lines treated for 7 days with 5% 
FBS or 10% FBS at 37°C on laminin-coated dishes for 7 days. (A,B,C) Images of GuRt09 cells 
in (A) control medium without FBS, (B) 5% FBS or (C) 10% FBS. Markers for NF160 and Ki67 
were positive at all three conditions. (D,E,F) Confocal images of GuRt05 cells in (D) control 
medium, (E) 5% FBS or (F) 10% FBS. All cells were positive for NF160 and Ki67.There was no 
apparent difference in expression patterns of NF160 and Ki67 between all cell cultures 
and between cell lines.Scale bar= 20 pm.
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Figure 5.4 Recoverin an d  S-Opsin exp ressio n  in FBS tre a te d  cell cu ltu res
GuRt09 and GuRt05 cell lines w ere cultured in th e  presence of medium , 5% FBS or 
10% FBS for 7 days and  subsequently  fixed and stained for recoverin and S-Opsin. 
(A,B,C) GuRt09 cells w ere positive for recoverin expression at all th ree  conditions, 
however S-Opsin was undetected . (D,E,F) The expression patterns for recoverin 
w ere similar a t all th ree  conditions in GuRt05 cells, th e  only visible difference was 
th a t there  were m ore cells p resen t in cells cultured with 10% FBS. (G) A negative 
control minus th e  primary antibodies show ed no non-specific staining.
Scale bar = 20 pm.
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Figure 5 .5  E xpression o f rh od op sin  k inase, rh od op sin , Nrl and  Crx in FBS trea ted  cu ltures
GuRt09 an d  GuRt05 cells w ere cu ltu red  in m ed ium  alone, or su p p le m e n te d  w ith 5% or 10% FBS 
for 7 days. (A-F) R hodopsin  k inase expression  w as d e te c te d  in all th re e  co n d itio n s for b o th  cell 
lines w ith no  a p p a re n t d ifference in expression  patte rn s . Nrl expression  w as n o t d e tec tab le . 
(G-L) R hodopsin  an d  Crx w ere also  im m u n o sta in ed  b u t n e ith e r m arker w as d e te c te d  in any  of 
th e  cond itions te s ted . Scale b a r = 20 pm.
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Both cell lines were found to be immunoreactive for the B III Tubulin antigen which is a 
marker for immature neurons as well as ganglion cells (figures 5.6 and 5.7). In the cells 
cultured in medium without FBS there was no detection of B III Tubulin expression or 
Sox2 expression, however when treated with 5% and 10% FBS there was a clear 
activation of B III Tubulin expression which appeared to be present in 100% of the cells. 
Therefore, at both concentration of FBS, even though there were more cells present at 
10% FBS than at 5% FBS there was no difference in the percentage of cells expressing 
B III Tubulin. There was no detection of Sox2 expression at 5% and 10% FBS.
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Figure 5 .6  A ctivation  o f  G III tubu lin  ex p ressio n  in G uRt09 ce lls  u n d er th e  in flu en ce o f FBS
GuRt09 (P24) cells w ere  cu ltu red  in 5% FBS or 10% FBS for 7 days. (C-F) This resu lted  in th e  
d e tec tio n  o f G III tu b u lin  expression  in b o th  cu ltu re  conditions, w hich  w as a b s e n t from  
th e  cells in th e  contro l cu ltu re  (A). (B) Im age o f neg a tiv e  contro l, w h ere  th e  prim ary  
an tib o d ies  w ere  o m itted  from  th e  sta in ing  pro toco l in o rd e r to  o b se rv e  an y  non-specific  
stain ing. Sox2 w as u n d e te c ta b le  in contro l an d  tre a te d  cell cultures. Scale bar = 20 pm .
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Figure 5 .7  A ctivation  o f  B III tu b u lin  ex p ressio n  in GuRt05 ce lls  u n d er th e  in flu en ce o f FBS
GuRt05 (P24) cells w ere  cu ltu red  in 5% FBS or 10% FBS for 7 days. (C-F) This resu lted  in th e  
d e tec tio n  o f G III tubu lin  expression  in b o th  cu ltu re  cond itions, w hich  w as a b s e n t from  th e  cells 
in th e  contro l cu ltu re  (A). (B) Im age o f a n ega tive  contro l, w h ere  th e  prim ary  an tib o d ies  w ere 
o m itted  from  th e  sta in ing  p ro toco l in o rd er to  observe  any  non-specific  sta in ing . Sox2 w as no t 
d e te c te d  in contro l an d  tre a te d  cell cu ltures. Scale bar = 20 pm .
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5.4 Discussion
FBS has been shown to effect cell differentiation in human and mouse retinal progenitor 
cells and to induce 13 III Tubulin, S-Opsin and rhodopsin expression in certain cases. In 
this chapter, immortalised human foetal retinal progenitor cell lines, GuRt09 and 
GuRt05 were cultured in the presence of 5% FBS, 10% FBS or plain medium to 
observe whether or not FBS could induce differentiation in the cell lines, with a 
particular interest in rhodopsin induction.
Immunocytochemical analysis revealed expression of the same selection of markers 
with and without FBS, with no striking difference in expression patterns. Rhodopsin, S- 
opsin, Sox2, Nrl and Crx expression were not detected in the control or FBS-treated 
cells. However, with regard to the immature neuronal marker and ganglion cell marker, 
13 III Tubulin, both cell lines cultured in 5% FBS and 10% FBS expressed this protein. 
This is the first time that 13 III Tubulin expression had been detected in these cell lines. 
In Chapter 3, 13 III Tubulin mRNA expression was detected via RT-PCR but not with 
immunocytochemistry. This implies that these cells may have the potential to 
differentiate towards a ganglion cell fate and is consistent with the additional expression 
of NF160 and NF200, both of which are expressed in the axons of ganglion cells.
Cell differentiation in the vertebrate retina is initiated by the sequential production of 
cell types in a well defined histogenetic order (Marquardt and Gruss, 2002). Retinal 
neurogenesis begins with the differentiation of ganglion cells and the behaviour 
exhibited by the GuRt09 and GuRt05 cell lines seems to comply with this histogenetic 
order. Thus the cells are capable of committing towards a particular lineage even though 
they are not fully differentiated, as the expression of nestin would be expected to 
diminish. It may be that the cells would only terminate nestin expression following a 
longer culture period in the presence of FBS.
This chapter has shown that the immortalised human foetal retinal progenitor cells are 
capable of responding to FBS in the same manner as unimmortalised human foetal 
retinal (Yang et al., 2002a) by beginning to differentiate towards a ganglion cell fate. 
Even though the cells did not respond with the induction of rhodopsin expression, 
perhaps more specific trophic factors especially involved in the induction of rhodopsin 
expression will induce these cell lines to differentiate further. This will be explored in 
more detail in subsequent chapters.
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Chapter 6
Retinoic acid and the immortalised retinal progenitor cell lines
6.1 Introduction
Vitamin A plays a crucial role in the development of the Central Nervous System (CNS) 
and is required at specific levels in order for development to occur properly (Maden et al., 
1992). Vitamin A is also an important component of the visual system. The aldehyde form 
of the vitamin (retinal or retinaldehyde) is the chromophore of all opsin pigments (Hyatt 
and Dowling, 1997). It plays an essential role in the phototransduction pathway, whereby 
the 11 -cis retinal isomer becomes activated by light and is converted to the all-trans form, 
initiating excitation of the photoreceptor cells. Due to the essential role retinal plays in 
vision, it has been discovered that the acid form of vitamin A, retinoic acid (RA), is critical 
for early eye development and aids photoreceptor differentiation by the activation of a large 
family of transcription factors (Drager and McCaffery, 1997).
6.1.1 Retinoic acid signalling pathway
When RA enters a cell, it binds to nuclear receptors that act as ligand-dependent 
transcription factors (Mangelsdorf and Evans, 1995) that subsequently go on to activate or 
inhibit gene transcription. There are several forms of RA and two families of receptors, the 
RARs (a, 6, and y and their isoforms a l, a2, 61 to B4, and yl and y2) and RXRs (a, 6, and 
y) (Kastner et al., 1994) which are activated by the different forms of retinoic acid. The 
retinoic acid receptors (RARs) bind to both all-/ra«s-RA and 9-cis-RA, whereas the 
retinoid X receptors (RXRs) only bind to 9-cis-RA (Klaassen et al., 1999). For example, 
dX\-trans-RA is the ligand for the RAR family of receptors, and once bound the receptor 
forms heterodimers with RXR, which in turn acts as a transcription factor targeting 
particular regulatory elements of key genes. The regulatory regions of the target gene are 
known as the RA-responsive DNA elements (RAREs), and when bound to the RARE the 
active RAR/RXR can then control gene expression and induce or repress the transcription 
and eventual translation of the target protein.
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6.1.2 Retinoic acid and ocular development
The role of retinoic acid in ocular development was discovered using transgenic indicator 
mice (Balkan et al., 1992). A recombinant reporter gene comprised of three copies of the 
RARE sequence, originally from the RAR6-2 promoter, and the herpes simplex virus 
thymidine kinase promoter coupled to a bacterial B-galactosidase reporter gene was created 
to detect activated RA in vivo (figure 6.1). RARE sequences from the RARB-2 promoter 
were used in this construct due to their increased sensitivity towards the presence of RA- 
bound RAR receptors. The injection of this recombinant B-galactosidase reporter into 
mouse ova produced a visible method to identify areas in which activated RXR and RAR 
receptors were situated and hence where retinoic acid signalling was most prevalent during 
embryonic development. At day 12.5 in gestation, the embryos exhibited two clear regions 
containing the highest levels of B-galactosidase activity, the first area being the dorsal 
aspect of the embryo, the second being the eye. In comparative studies between control 
embryos and RA-treated embryos, both displayed high levels of 6-galactosidase activity in 
the neural retina, lens, and to a smaller extent in the pigmented retinal layer.
CYTOPLASM
%
— | — | — | TKpr I B-galactosidase j mnwu-pA |
RARE
NUCLEUS
Figure 6.1 Schem atic representation o f th e  recom binant reporter g en e  used to  d etect activated  
RARs in transgenic mice
In the  transgenic mice, expression of th e  reporter gene, B-galactosidase, serves as an indicator for 
activated receptors.These receptors are activated either by endogenous Retinoic Acid (RA) or w hen 
fem ales carrying transgenic mice are gavage-fed RA. A constitutively active RAR vector is produced 
com prising of th ree  copies of th e  RA response DNA elem ents (RARE), th a t are coupled to g e th er with 
th e  herpes simplex virus thym idine kinase prom oter (TKpr), th e  reporter gene, and  finally an SV40 
intron plus th e  poly(A) addition signal. (Adapted from Balkan eta!., 1992).
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This study revealed the existence of activated RARs and RXRs within these regions, and 
consequently the existence of natural RA interactions during eye development in vivo.
6.1.3 Retinoic acid and rod photoreceptor development
The vital role of RA in eye morphogenesis has also been confirmed by modifying the levels 
of RA during early eye development in zebrafish (Hyatt et al., 1996). This study 
highlighted the role RA plays in the induction of rod photoreceptor differentiation and 
survival in vivo. In RA treated embryos, in situ hybridisation for rhodopsin mRNA showed
an increased level of expression in the ventral region of the eye as the experiment
progressed. This effect was not observed in retinol- or retinal-treated embryos. 
Immunohistochemical staining for rhodopsin correlated with the pattern of rhodopsin 
mRNA expression. Conversely, treatment with Citral, an inhibitor of RA synthesis, in the 
ventral region of the retina, resulted in a dose-dependent inhibition of rhodopsin expression. 
It has also been found that RA acts upon a post-mitotic population to induce rhodopsin 
expression (Wallace and Jensen 1999; Hyatt et al., 1996).
Retinoic acid thus has the characteristics of a morphogen, namely the ability to drive the 
pattern of tissue development, as it induces photoreceptor differentiation in vitro, in a dose- 
dependent fashion (Stenkamp et al., 1993; Kelley et al., 1994). In dissociated cells from 
embryonic and neonatal rat retinae, the concentration of a\\-trans-RA demonstrated to have 
a proven effect was 500 nM (Kelley et al., 1994). This concentration also produced the 
same effect in human foetal retinal cell cultures (Kelley et al., 1995). However, 
concentrations of RA up to 10 pM did not generate an appreciable effect on embryonic 
chick neural retinal cells (Stenkamp et al., 1993).
6.1.4 Retinoic acid and NRL expression
The Neural Retina Leucine zipper (NRL) transcription factor has been implicated in the 
development and differentiation of rod photoreceptors by activating various rod specific 
genes. Nrl "A null mutant mice lack any rod photoreceptor function and rhodopsin 
immunoreactivity (Mears et al., 2001), which demonstrates the importance of NRL in 
functional rod photoreceptor formation. Importantly, a link has been identified between RA 
and the RAREs situated within the NRL promoter region (Khanna et al., 2006), suggesting 
that retinoic acid signalling can regulate NRL expression via the RARE, and therefore
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identifies a RA-signalling pathway driving rod photoreceptor determination and 
differentiation.
6.2 Experimental design and objectives
The purpose of the experiments described in this chapter was to examine the effects of all- 
/raws-retinoic acid (RA) on the retinal progenitor cell lines and to observe any 
differentiation patterns. In particular, we were especially interested in any differentiation 
towards rhodopsin expression and rod photoreceptor phenotype. According to the studies 
conducted by Kelley et al., (1994), 500 nM of a\\-trans-RA was determined to be the 
optimal concentration for photoreceptor induction in rat and human retinal cells, therefore 
three different concentrations of RA were investigated; 500 nM, 1 pM and 3 pM. Human 
foetal immortalised retinal progenitor cells were seeded onto a series of laminin-coated 35- 
mm tissue culture dishes at a density of 1.0 x 104 cells/cm2. DMEM:F12 minus L- 
Glutamine was supplemented with all-/ra«s-RA, which was diluted to the appropriate 
concentration in the culture medium just prior to use. In parallel with the experiment, a 
vehicle control was conducted whereby a volume of DMSO equivalent to that used in the 
highest RA treatment was added to the cells (4.8 pi) in lieu of a\\-trans-RA. The 
experiment was performed for a duration of three days with daily medium changes. At this 
point the cultures were fixed.
During the course of the experiment it was apparent that the cells were unable to survive for 
prolonged periods in the presence of retinoic acid treatment alone. Therefore a different 
method was also employed in order to sustain a greater number of cells for analysis. Both 
cell lines were cultured with the same concentrations of RA but with the addition of 3% 
charcoal/dextran treated foetal bovine serum (FBS) (Hyclone) added to the culture medium. 
FBS was used to increase the survival rate of the cells, however it was essential that the 
FBS itself did not induce any effect. Charcoal/dextran treatment is used to lower the level 
of trophic factors present within serum and should therefore minimise effects on the cells 
other than enhancing survival. After 7 days of a\\-trans-RA treatment in the presence of 3% 
charcoal/dextran treated FBS, cells were fixed and immunoassayed. All experiments in this 
chapter were repeated four times. As inter-experimental variability was minimal, results of 
representative experiments are shown to simplify data presentation.
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6.3 Results
Figure 6.2 shows phase-contrast images of the GuRt05 cells grown for 3 days at 37 °C in 
the presence of either DMSO vehicle control (Fig. 6.2A), 500 nM dW-trans-RA (Fig. 6.2B), 
1 pM alF/nms-RA (Fig. 6.2C) or 3 pM a\\-trans-RA (Fig. 6.2D). Initial observations 
showed that all cultures were unable to survive for the initial seven day period in the 
presence of all-fraw.s-RA. Only the cells cultured in the presence of the vehicle control 
exhibited sufficient cell survival to enable further analysis, therefore the experiment was 
shortened from seven to three days. Unlike the neurite outgrowth observed by Kelley et al, 
(1994), the cells did not exhibit rounded cell bodies with long branching neurites, but 
retained a similar morphology to the vehicle control cells. With respect to the 3 pM treated 
cultures, some cells had apparent shrunken cytoplasms that resembled those of dying cells. 
At no point in the experiment did cells exhibit characteristic photoreceptor morphology
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Figure 6 .2  AII-trans-R etinoic Acid (RA) tr e a te d  G uR t05 ce lls  in c u b a te d  a t 37°C for 3 d ays
P h ase -co n tras t im ag es GuRt05 (P22) cells a fte r  3 days o f t re a tm e n t w ith  all-frans-retinoic acid 
a t  varying c o n c e n tra tio n s  (A) DMSO vehicle  con tro l, (B) 500 nM all-frans-RA, (C) 1 pM all-frans-RA 
a n d  (D) 3 pM all-frans-RA tre a te d  cells. Cells cu ltu red  w ith  all-trans-RA sh o w ed  a d ram atic  
d ec re a se  in cell n u m b e rs  c o m p a re d  w ith  th e  veh icle  con tro l. At th is  tim e  p o in t th e  cells w ere 
fixed a n d  im m u n o cy to ch em ica l analysis w as c o m p le te d .
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Figure 6 .3  Confocal im age analysis o f  th e  im m unocytochem ical expression  patterns of GuRt09 
cell line treated with different concentrations o f all-frans-RA for 3 days.
GuRt09 (P28) cells w ere trea ted  with 0.5-3.0 pM all-frans-RA for 3 days a t 37°C. (A-D) All cells were 
positive for nestin with a small subset expressing NF200.(E-H) All cells w ere positive for NF160 and 
Ki67 antigens. Regardless of th e  high levels of dying cells, th e  surviving cells w ere still proliferating. 
(I-L) All cells viewed w ere positive for recoverin bu t there  was no positive staining for S-opsin.
(M-P) Even though  NRL has been  show n to  be up-regulated in th e  p resence of RA this w as no t the  
case for this cell line. However, they  still rem ained positive for rhodopsin  kinase. Com pared to  th e  
DMSO vehicle control the  all-frans-RA trea ted  cells show ed a dram atic loss in cell num bers. Nuclei 
are counterstained with DAPI and are blue in all images. Scale bar= 20 pm.
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Figure 6 .4 Expression patterns of GuRt05 cell line treated with all-trans-RA for 3 days
GuRt05 (P24) cells were treated  with different concentrations of all-trans-RA for a duration of 3 days. 
(A-D) Cells were positive for nestin with a small subset expressing NF200. (E-H) All cells were positive 
for NF160 and Ki67 antigens. (I-L) All cells viewed w ere positive for Recoverin bu t there  was no positive 
staining for S-Opsin. Cells were positive for rhodopsin kinase (data no t shown) and were negative for 
rhodopsin, Crx and Nrl. Scale bar= 20 pm.
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After 3 days treatment with all-trans-RA, GuRt09 (P28) (figure 6.3) and GuRt05 (P24) 
(figure 6.4) showed no change in the expression patterns of the proteins under examination. 
Results indicated that the addition of all-trans-RA caused a decrease in the number of cells 
over the course of the experiment, and that there was no induction of rhodopsin, Nrl, B III 
tubulin, S-opsin or Crx expression. Attempts to perform RT-PCR analysis to determine 
whether rhodopsin was present at the mRNA level were abandoned due to the limited 
number of cells.
In order to sustain a greater number of cells for analysis, the cell lines were cultured in the 
presence of 3% charcoal/dextran treated FBS and the same concentrations of all-trans-RA 
used in the previous experiment. From the results in figures 6.5 and 6.6, the number of cells 
dramatically increased with the addition of FBS to the culture medium, enabling the 
experiment to be run for 7 days. Furthermore, and in contrast to the previous experiment, 
cells showed some putative neurite outgrowth as indicated by the arrows in figure 6.5. 
When immunocytochemical analysis of the GuRt05 (P22) cell line was performed, the cells 
were positive for nestin, NF200, NF160, Ki67, rhodopsin kinase and recoverin.
Strikingly, the cells also expressed 8 III tubulin, a marker for immature neurons and 
ganglion cells, but because the DMSO control was also positive for this protein it appeared 
that the FBS and not the all-trans-RA was responsible for this up-regulation (see Chapter 
5). Even with a prolonged incubation with all-trans-RA the cells did not express later 
neuronal markers e.g. S-Opsin, Crx, Nrl and most importantly rhodopsin. Further analysis 
of Nrl, Crx and rhodopsin by RT-PCR (figure 6.7) also failed to reveal the presence of 
corresponding mRNAs. The results in figure 6.6 are representative of both cell lines.
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Figure 6.5 Phase Contrast im ages o f GuRt05 cells treated with all-frans-RA 
and 3% charcoal/dextran FBS.
GuRt05 (P22) cells were cultured in the presence of 0.5-3 pM all-trans RA and 3% 
charcoal/dextran treated FBS for a duration of 7 days. Phase contrast images were 
taken at each concentration after 3 days (A-D) or 6 days of treatm ent (E-H). Note 
the appearance of cells with neurite-like processes (arrows).
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Figure 6.6 Immunocytochemicai characterisation of GuRt05 cell line trea ted  with different 
concentrations of all-frans-RA in the  presence of 3% charcoal/dextran trea ted  FBS for 7 days in vitro
GuRt05 (P22) cells w ere  tre a te d  w ith d ifferen t c o n cen tra tio n s  o f all-frans-RA an d  3% charcoal/dex tran -trea ted  
FBS. (A-D) Cells co n tinue  to  express th e  n eu ro ec to d erm a l s tem  cell marker, nestin . N ote th a t  all trea ted  
cells had  a m inority of NF200 positive cells (as iden tified  by th e  arrows). (E-H) all o f th e  cells im m unolabelled  
for NF160 and  w ere actively in th e  cell cycle as ind ica ted  by th e  positive expression o f Ki67 an tigen .
(I-L) All cells rem ained  recoverin positive b u t n o n e  w ere  im m unoreactive  for th e  c o n e  p h o to recep to r marker, 
S-opsin. (M-P) R III tubu lin  w as p re se n t in th e se  cell lines b u t a b se n t from  th e  cells tre a te d  w ith all-frans-RA 
alone .T here  w as no  expression o f Sox2 tran scrip tio n  factor. (Q-T) N ote th a t th e re  w as no  expression  of Nrl 
w hich is expec ted  to  b e  up -reg u la ted  by all-frans-RA trea tm e n t. All cells a t  all co n cen tra tio n s expressed  
rhodopsin  kinase. Cells w ere negative  for rh o d o p s in  a n d  Crx (data n o t show n). Scale bar=  20pm .
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Figure 6 .7  RT-PCR analysis o f rhodopsin , Nrl and Crx in GuRt09 cells treated  with  
all-trans-RA in th e  p resen ce  o f  3% charcoal/dextran treated  FBS
GuRt09 (P28) cells w ere trea ted  for 7 days with d ifferent concen tra tions of all-frans-RA 
in th e  p resence of 3% charcoal/dex tran  FBS. RNA was ex trac ted  from  th e  cells and 
cDNA was synthesised  in o rder to  evaluate  th e  expression of (A) rhodopsin  (227bp)
(B) Crx (1059bp) and  Nrl (212bp).GAPDH (200bp) was run as a positive control to  
ensure  th e  quality  of mRNA ex trac ted  and  synthesized into cDNA. Rhodpsin, Crx and 
Nrl w ere no t d e tec ted  via RT-PCR a t any concentration of all-frans-RA te s ted  or in th e  
DMSO vehicle control.
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6.4 Discussion
In this chapter the immortalised human foetal retinal progenitor cell lines, GuRt09 and 
GuRt05, were cultured in the absence or presence of a\\-trans-RA at three different 
concentrations, 500 nM, 1 pM and 3 pM. Morphologic development and cell-specific 
immunocytochemical markers were examined. In previous studies a dose-dependent effect 
was observed of RA on opsin expression in retinal chick and rat re-aggregated cell cultures. 
The rationale behind the use of a\\-trans-RA over 9-cis-RA was the proven effect all-trans- 
RA had in promoting human foetal retinal cells to differentiate into photoreceptors (Kelley 
et al., 1995).
This study shows that varying the concentrations of a\\-trans-RA had no effect on the cell 
lines, and that the primary objective of inducing rhodopsin expression or photoreceptor 
differentiation was unsuccessful. The treated cells, minus charcoal/dextran treated FBS, did 
not exhibit neurite outgrowth, especially at 3 pM a\\-trans-RA, where shrunken cell bodies 
reminiscent of dying cells were observed. Not only were the cell lines unable to 
differentiate but a high degree of apparent apoptosis was observed in the both cell lines 
when cultured in a\\-trans-RA alone. Studies carried out in human dermal fibroblasts found 
that retinoids administered at the far higher concentration of 20 pM caused cell damage in a 
time dependent manner, with maximal apoptosis observed between 24-48 hours (Gimeno et 
al., 2004). In comparison, the concentrations of a\\-trans-RA used in these experiments 
were considerably lower but still induced a similar effect.
To remedy the problem of excessive cell death, the experimental protocol was adjusted by 
culturing the cells in all-/ra«s-RA with 3% charcoal/dextran treated FBS, which allows the 
cells to be treated with all-/ra«s-RA for longer periods. A previous study has shown that 
the addition of FBS to medium results in a slower rate of RA uptake by cells (Klaassen et 
ah, 1999), it is possible that this may increase cell survival. Unlike previous studies where 
RA treatment was shown to induce rhodopsin expression after 1-3 days (Stenkamp et al, 
1993; Kelley et al., 1994), there was no visible difference in the expression patterns of 
rhodopsin observed after RA treatment in either cell line after 7 days. All cells, including 
the DMSO-treated cells expressed nestin, NF160, NF200 and rhodopsin kinase. 
Furthermore, RT-PCR analysis failed to show the presence of Crx, Nrl or rhodopsin mRNA 
being transcribed by the treated cells. This seems to suggest that although the cells express
123
markers of photoreceptor precursors (recoverin and rhodopsin kinase), treatment with all- 
trans-RA is not sufficient to induce differentiation towards a photoreceptor lineage.
Retinoids help regulate cell proliferation in the nervous system by balancing the degree of 
mitosis and apoptosis that occurs within neural tissues (Soderpalm et al., 2000). By 
controlling cell proliferation, RA regulates the transfer of cells from a proliferative to a 
differentiative state, but this change is highly context-specific ((Drager and McCaffery, 
1997). Moreover, RA can only have an effect on differentiation when the cells are 
postmitotic (Wallace and Jensen, 1999). Due to the prevalence of Ki67 expression in the 
cell lines at the non-permissive temperature of 37°C, this could provide an explantation as 
to why the cells are unable to respond to the exogenous a\\-trans-RA, and in turn, why RA 
was shown to have no effect on either cell line. In conclusion, even with prolonged 
treatment with d\\-trans-RA there may be no visible effect unless the cells are able to exit 
the cell cycle and become post-mitotic, whereupon a\\-trans-RA may then induce the 
transcription factors required for rod photoreceptor determination.
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Chapter 7
The effects of ARPE19 conditioned medium on the
immortalised retinal progenitor cells
7.1 Introduction
Several studies have demonstrated the ability of retinal progenitor cells to respond to 
environmental cues and undergo cell type determination and differentiation (Levine et 
al., 2000). Some of the first evidence of the multipotentiality of such progenitors came 
from observations that a diffusible factor from cultures of postnatal day one retinal cells 
in the mouse increases the probability that embryonic day 15 progenitors will give rise 
to rod photoreceptors (Watanabe and Raff 1992). The notion of neighbouring cells 
releasing factors that could induce differentiation has been shown to be true in the case 
of both retinal pigment epithelium and photoreceptors. Several studies have shown that 
the retinal pigment epithelium (RPE) is the source of putative diffusible factor(s) that 
effect photoreceptor survival and differentiation (Gaur et al., 1992). This is not entirely 
surprising given the close association between the RPE and the photoreceptors. The 
RPE is a highly specialised monolayer of cells, derived from the same sheet of 
neuroepithelial tissue as the neural retina during development (Chen et ah, 2003). The 
RPE develops prior to other retinal cells, which would be expected if it is to play a role 
in the development of successive retinal cell types. Due to its location adjacent to the 
developing neural retina, which is destined to become photoreceptor cells, it would be 
highly probable that RPE would influence photoreceptor cell differentiation (Sheedlo 
and Turner, 1996a). Not only are these two distinct cell types adjacent and physically 
bound to one another, but there is a high level of interdependence between them. The 
RPE provides critical functions for the rod and cone photoreceptors, including outer 
segment phagocytosis and visual pigment regeneration. These developmental 
observations provide the rationale for the investigation of diffusible factors that 
stimulate photoreceptor differentiation in vivo. In this chapter, the focus is on the effect 
of RPE conditioned medium (CM) on the differentiation, proliferation and survival of 
the immortalised human foetal retinal progenitor cell lines.
7.1.1 The retinal pigment epithelium and development of the neural retina
Expression of a toxin-encoding gene in the RPE of transgenic mice resulted in the 
ablation of RPE cells either prior to or during their differentiation. This ablation caused 
the disorganisation of the retinal layers, resulting in either anophthalmia (absent eye and
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complete degeneration of the pre-existing ocular structures) or microphthalmia (small 
eye). Interestingly, in some mice with microphthalmic eyes, the ablation was 
incomplete and some pigmented RPE cells survived. Directly adjacent to these RPE- 
rich areas the laminar structure of the retina was preserved but was devoid elsewhere. In 
all embryos analysed the inner layer of the optic cup was the most severely 
compromised by RPE ablation. This correlation between the absence of RPE cells and 
abnormal neural retina structure, specifically affecting the rod outer segments, indicates 
a major role of the RPE in the morphogenesis of the developing retina (Raymond and 
Jackson, 1995). This essential role of the RPE in the maintenance of the neural retina is 
highlighted further in the animal model of the Royal College of Surgeon (RCS) rat. In 
this rat, there is a defect in the RPE cells which has been proven to cause the subsequent 
loss of photoreceptors (Mullen and LaVail, 1976). All these examples point to the vital 
role of the RPE in the development of the neural retina, and in particular photoreceptors. 
This raises the question, can the RPE also contribute to the survival and differentiation 
of these cell types by the secretion of diffusible factors?
7.1.2 Neuronal differentiation induced by RPE conditioned medium
It has been known for many years that the RPE synthesizes and secretes proteins (Bryan 
and Campochiaro, 1986) such as platelet derived growth factor (PDGF) (Campochiaro 
et al., 1989), glycosaminoglycans (Stramm, 1987), and basic fibroblast growth factor 
(bFGF) (Bost et al., 1992) amongst many others. However, the factors responsible for 
the inductive effects in the development of the neural retina, in particular the 
photoreceptor cells, had not been identified. Work carried out by Tombran-Tink and 
Johnson (1989) found that human foetal RPE-cell conditioned medium caused Y79 
human retinoblastoma cells to express neuronal characteristics such as long neurite-like 
processes and to express neuronal markers, such as NF200 and neuron-specific enolase 
(a marker for mature neurons). For the first time this was clear evidence that RPE cells 
could induce neuronal differentiation via the factors secreted into the culture medium. 
This led to several other groups observing similar results on neuronal development in 
the presence of RPE-conditioned medium. In these studies, it was demonstrated that 
RPE conditioned medium, and more specifically the factor(s) secreted into the medium, 
caused an increased number of photoreceptor cells in the developing chick embryonic 
neural retina (Spoerri et al., 1988).
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Gaur and colleagues (1992), found that photoreceptor differentiation (confirmed with 
opsin positive cells) and survival were induced, this latter observation being reinforced 
by experiments that confirmed that RPE cells had the ability to stimulate retinal survival 
and increased cell proliferation rates (Liu et al., 1988). Most of these studies used 
freshly harvested RPE cells from either embryonic, foetal or early post-natal tissue. 
However, studies using spontaneously transformed neonatal rat RPE cell lines, and the 
conditioned medium from these cells also proved to have similar effects with the 
promotion of proliferation, neurite outgrowth and the expression of photoreceptor cell- 
specific markers (Sheedlo and Turner, 1996b).
128
7.2 Experimental design and objectives
ARPE19 cells were cultured in their normal medium of DMEM:F12 media plus L- 
GlutaMAX™ supplemented with 10% (v/v) Foetal Bovine Serum (FBS) and 1.0% (v/v) 
Penicillin/Streptomycin for 1 week until confluent. The cells were then washed 
thoroughly with PBS and cultured in serum-free medium (DMEM:F12 and 1.0% (v/v) 
Penicillin/Streptomycin for a duration of either 1, 3 or 5 weeks without medium change. 
This medium was then collected, centrifuged to remove any cell debris, and used as 
conditioned medium (CM) on the immortalised human foetal retinal progenitor cell 
lines. The GuRt09 and GuRt05 cell lines were seeded on to laminin-coated dishes or 
flasks at an initial seeding density of 1.0 x 104 cells/cm2 and cultured in either 100% 
CM or 20% CM (80% plain DMEM:F12). As a control, cells were cultured in plain 
DMEM:F12 and 1.0% (v/v) Penicillin/Streptomycin that had not been conditioned prior 
to use. All cells were cultured in CM or control medium for 7 days and then fixed with 
4% PFA for immunocytochemical analysis or flow cytometry. The rationale for leaving 
the medium to be conditioned by the ARPE19 cells for long periods was that extracts of 
certain secreted factors may increase in expression with time. Thus, extending the 
conditioning period enabled us to determine whether there was a temporal effect on the 
factors secreted by ARPE19 cells and their potency to induce differentiation.
7.2.1 AKPE19, a human retinal pigment epithelial cell line
The experiments in this chapter utilised a spontaneously arising and widely used human 
RPE cell line, ARPE19. The cell line was derived from the globes of a 19 year old male 
donor and has been extensively studied (Dunn et al., 1996). The cell line has a normal 
karyology and although non-pigmented, retains the characteristic ‘cobblestone’ 
morphology of epithelial cells. The cells also express some of the characteristic markers 
of differentiated RPE cells in vivo. Hence it was hypothesised that these cells would 
provide a reasonable source of secreted factors for these experiments.
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ARPE19 cells that were cultured until confluent and then used to condition DMEM:F12 
medium for a duration o f 1, 3 or 5 weeks survived reasonably well in the absence of 
FCS (figure 7.1). ARPE19 cells at the 1 week stage clearly retained their characteristic 
epithelial morphology. However, after 5 weeks in culture, some cells had adopted a 
spindle-like morphology, and although there were still living cells present they had little 
resemblance to the 1 week or 3 week cultures.
Figure 7.1 Human ARPE19 cell lines used to condition serum-free medium
H um an ARPE19 cells w ere  g ro w n  to  c o n flu en ce  for 1 w eek , a t  w h ich  p o in t se ru m -free  m ed ium  
w as a d d e d  to  th e  cells fo r 1 w eek , 3 w eek s o r 5 w eeks. (A) P hase  im ag e  o f cells a fte r 1 w eek  in 
th e  p re se n c e  o f  FCS a n d  th e n  c u ltu re d  in m ed iu m  for 1 w eek  to  yield c o n d itio n e d  m ed ium .
(B) Im age  o f ARPE19 cells le ft fo r 5 w eek s to  co n d itio n  DMEM:F12 m ed iu m .T h e re  w ere  still cells 
g row ing  in th e  c u ltu re  flask. (C) In teresting ly , so m e  cells had  a lte red  th e ir  charac te ristic  
c o b b le s to n e  m o rp h o lo g y  a n d  a d o p te d  a sp ind le-like  a p p e a ra n c e .
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7.3 Results
First the morphology of the GuRt09 (P22) cells was examined (figure 7.2) during 
culture for 1,4 and 7 days at 37°C in the presence of either DMEM:F12 alone (control), 
DMEM:F12 supplemented with 20% ARPE19 conditioned medium (CM) or 100% CM. 
The CM in this experiment was conditioned by confluent ARPE19 cells for 1 week 
before being used as culture medium on the human foetal retinal progenitor cells. As 
inter-experimental variability was minimal, results of representative experiments will be 
shown throughout this chapter to simplify data presentation.
Initial observations indicated that all cultures maintained in the presence of CM grew 
more rapidly than compared to the control. It was also apparent that at day 4 (figure 7.2, 
E and I) some cells were exhibiting altered morphology and becoming more elongated, 
with long processes, similar to the neurite outgrowth observed by Gaur et al., (1992). 
By day 7, the majority of cells in the control wells had died. However, the cells cultured 
in the presence of CM were growing robustly with approximately 50% confluence 
reached by cells in 20% CM, whilst those cells in the 100% CM were slightly less dense. 
To gain further insight into the proliferation rates, cell numbers were determined under 
all three conditions over an eight day period. Cells were seeded at an initial density of 
9.5xl04 per well (figure 7.3). By day 2, cells cultured in 100% CM had 3.8xl04 cells per 
well, whilst the cells in 20% CM had 2.0x104 and the controls had the lowest number of 
cells at 1.5xl04. On day 4, the number of cells in the 100% CM reached a peak of 
7.5x104 per well, and again both the 20% CM and the control had far fewer cells 
(3.0xl04 and 0.5xl04 respectively). By day 6, the number of cells cultured in 100% CM 
had dropped to 3.5x104, which was approximately the same number of cells in the 20% 
CM. The number of cells in the 20% CM continued to increase over the next 2 days 
whilst the cells in 100% CM continued to decline. By day 8, the number of cells treated 
with 20% CM was just under 5.0x104, almost double that of the cells treated in 100% 
CM. The number of cells in the control wells stayed consistent at 0.5x104. Thus, there 
was a marked increase in cell numbers when cells were cultured in ARPE19 CM 
compared to the control.
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DAY 1 DAY 4 DAY 7
Figure 7.2 M orphological differences betw een ARPE19 Conditioned M edium-treated and control cells
GuRt09 (P22) cells w ere  cu ltu red  in ARPE19 m edium  th a t had b een  cond itioned  for 1 week. (A,B,C) Control 
cells cu ltu red  in DMEM:F12 m edium  for 7 days. (D,E,F) Cells cu ltu red  in 20% CM and  80% plain m edium . 
(H,I,J) Cells cu ltured  in 100% CM for 7 days. N ote th e  arrow s identifying cells w ith long processes in 
(E,F,I and  J). C om pared  to  th e  contro l cells th e  cells cu ltu red  in CM have a high cell n um ber possibly due  to 
stim ulation of proliferation or eh n an ced  cell survival d u e  to  factors w ith th e  cond itioned  m edium .
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Figure 7.3 Proliferation of GuRt09 cells in the  presence or absence of ARPE19 Conditioned Medium
GuRt09 (P22) cells w ere seed ed  a t an  initial density  o f 95 ,000 cells per well and  cells w ere trypsinised and 
coun ted  each day for to ta l cell num bers.T he cells in control m edium  (DMEM:F12) had th e  least 
n um ber of cells th ro u g h o u t th e  course of th e  experim ent. Cells in th e  presence  of 100% and 20% ARPE19 
C onditioned M edium  (CM) had  g rea te r num ber of cells com pared  to  th e  control. Cells cultured in 100% CM 
had th e  g rea te st increase in cell num bers a t th e  beg inn ing  of th e  culture period w ith th e  h ighest value of 
approxim ately 75,000 cells in to tal a t 4 days. But by day 6 th e  num bers had d ro p p ed  to  35,000 cells. At this 
po in t th e  cells cultured  a t 20% had th e  h ighes t nu m b er o f cells in culture.The da ta  are  p resen ted  as th e  m ean 
total num ber of cells + SEM.
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Immunocytochemical analysis of the progenitor cell lines cultured in 3 week 
conditioned medium did not show a great deal of difference. GuRt09 (PI 8) cells after 7 
days treatment with 3 week ARPE19 CM (figure 7.4) revealed no change in protein 
expression when compared with cells cultured in control medium. Earlier results 
indicated that the addition of ARPE19 CM may increase the number of cells over the 
course of the experiment compared to the control. However, exposure to 3 week 
ARPE19 CM did not induce rhodopsin, Nrl, fi III Tubulin, S-Opsin or Crx expression, 
as judged by immunocytochemistry.
Results for GuRt05 cells cultured in 5 week ARPE19 conditioned medium (figure 7.5) 
showed a similar outcome to the 3 week ARPE19 CM. The cells expressed nestin, 
NF200, NF160, Ki67 and rhodopsin kinase as before. The cell numbers were not greatly 
dissimilar at this stage compared to cells cultured in 3 week ARPE19 CM.
Because initial experiments failed to demonstrate any advantage to using 3 week and 5 
week ARPE19 CM, further studies focussed solely on 1 week CM. Cells were analysed 
by immunocytochemistry and also by flow cytometry to calculate percentages of 
antigen positive cells in order to quantify any subtle changes in the expression patterns 
of the immortalised human foetal retinal progenitor cells in the presence of ARPE19 
CM. For rhodopsin kinase (figure 7.6 E) the histogram shows that ~ 58% of control 
cells are positive, whilst 20% CM-treated cells express ~ 58% and 100% CM-treated 
cells express ~ 72%. These values and those throughout this chapter were statistically 
analysed using the Student t-test, where p=<0.05 is significant. These results show that 
the expression patterns of rhodopsin kinase were not significantly altered in cells 
cultured with or without CM. Although not tested, it is likely that similar results would 
have been obtained for 3 week and 5 week ARPE19 medium, since the confocal images 
of rhodopsin kinase staining were not dissimilar to the 1 week ARPE19 CM.
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Figure 7.4 Expression profile of GuRt09 cells treated  with ARPE19 (3 week) conditioned medium
GuRt09 (PI 8) cells w ere either cultured  in 20% CM or 100% CM for 7 days and  th en  fixed and  stained for 
various markers. Cells w ere positive for n e s tin a n d  NF200 (A-D),NF160and Ki67 (E-H)and rhodopsin  kinase 
(l-K). Nrl, R hodopsin, Crx and  G III Tubulin w ere u n d e tec tab le  by im m unocytochem istry. Cells in th e  CM -treated 
cultures w ere m ore num erous than  in th e  control cultures, b u t th e re  w as no  visible difference in expression 
pa tte rn s be tw een  th e  conditions. The boxed regions in A and  E are  show n a t a h igher m agnification in B and  F 
respectively. Scale bar=  20 pm.
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Figure 7.5 Expression profile of GuRt05 cultured in 5 week ARPE19 Conditioned Medium
GuRt05 cells (P26-P28), were cultured in conditioned medium derived from ARPE19cells 
grown for 5 weeks prior to  removal of medium.The cells were grown in three different 
conditions (A,D,G) DMEM:F12 medium (which was the control for this experiment), (B,E,H) 
DMEM:F12 medium supplem ented with 20% (5 week) ARPE19 CM and (C, F, I) cells were 
grown in 100% (5 week) ARPE19 CM. Rhodopsin, Sox2, and G III Tubulin and Crx were also 
examined but these antigens were undetectable.There was no significant difference between 
the expression patterns of the cells under these different conditions. However, the cells grown 
in the conditioned medium did show an increase in cell numbers compared to the control. 
Scale bar=20 pm.
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Figure 7 .6  R hodopsin k inase exp ression  in retinal progenitor cells cultured in ARPE19 CM
(A,C) GuRt09 (P22) cells w ere cultured  in 1 w eek ARPE19 conditioned m edium  and then  fixed either 
for confocal im aging or flow cytom etry  analysis, scale bar= 20 pm. (B, D) Dot plots representing the 
percentage value for rhodopsin  kinase expression for cells in control m edium  (B) and in 20% CM (D). 
The results from th e  d o t p lo ts w ere coverted  into a histogram  (E) displaying total percentage as 
m eans ±  SEM (n=3). As th e  confocal im ages show  there  is no significant difference betw een the  levels 
of rhodopsin kinase expression of cells cultured in th e  presence or absence  of ARPE19 CM.
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Figure 7 .7  E xp ression  o f  n e stin  an d  N F200 in th e  p resen ce  and  a b se n c e  o f  ARPE19 
C on d ition ed  M edium
(A,C/ E) Confocal im ag es  o f  G uR t09 cells cu ltu red  in 1 w eek  ARPE19 co n d itio n ed  m edium  
a t varying p e rc e n ta g e s  (contro l, 20%  or 100%). Cells a re  positive  for b o th  nestin  a n d  NF200, 
scale b a r =  20pm . (B,D) Flow c y to m e try  analysis to  m easu re  th e  p e rc e n ta g e  o f  nestin  and  
NF200 positive  cells in th e  co n tro l a n d  20%  CM. (F) An im ag e  of th e  to ta l p o p u la tio n  analysed 
by th e  flow  cy to m ete r, th e  d raw n  q u a d ra n t ind ica tes th e  g a te d  p o p u la tio n  w hich excludes cell 
deb ris  an d  th e  m ajo rity  o f  d e a d  cells. (G, H) Flow cy to m etry  d a ta  w ere  co llec ted  an d  rep resen ted  
in th e  form  of h is to g ram s, d a ta  p re se n te d  as  to ta l p e rc e n ta g e  m ean  ±  SEM (n=3).
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Flow cytometry analysis was then used to investigate NF200 and nestin expression in 
GuRt09 cells. The results for NF200 (figure 7.7) were consistent with the observations 
made by confocal microscopy. The number of NF200 positive cells in the control 
sample was 0.43% (figure 7.7 H), substantially lower than 2.7% or 1.88%, the values 
for cells cultured in 20% CM and 100% CM respectively, although the differences were 
not statistically significant. Robust nestin expression was a constant feature of both 
progenitor cell lines, regardless of the medium in which they were cultured. The 
histogram (figure 7.7 G) appears to indicate a modest increase in nestin positive GuRt09 
cells, with the control cells expressing the lowest level of nestin, whilst the 20% CM has 
the medial value and the 100% CM had the highest level of nestin expression. However, 
the difference o f 6.44% between the control cells and the 100% CM was not statistically 
significant.
In order to examine photoreceptor markers, the expression patterns of recoverin and S- 
opsin were investigated either by immunocytochemistry or flow cytometry (figure 7.8). 
The confocal images (figure 7.8 A-C) show a similar level of expression of recoverin in 
all three experimental conditions. The flow cytometry data are presented as a single­
parameter histogram for recoverin (figure 7.8 D-F) as opposed to the normal dot plot. 
The x-axis represents fluorescence intensity and the y-axis represents the number of 
events per channel. This display is ideal for comparing the negative control (black) with 
the recoverin expression in control cells (red), and the recoverin expression in cells 
cultured in 20% CM (blue). Figure 7.8 F shows that the red and blue peaks overlap, 
which indicates that the fluorescence intensity for recoverin expression in the control 
cells and the 20% CM treated cells is approximately the same. There is only a 6.33% 
difference between the numbers o f  recoverin positive cells in the control compared to 
the 20% CM treated cultures. Recoverin levels in the 100% CM-treated cells was found 
to be lower at -73% , but again the differences were not statistically significant.
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Figure 7.8 Recoverin expression  in GuRt09 cells tre a te d  w ith ARPE19 C onditioned Medium
(A, B,C) Representative confocal images of cells grown in 1 week ARPE19 conditioned medium (CM) 
for 7 days and then fixed and stained for recoverin and S-Opsin. S-Opsin was undetectable in all 
conditions, scale bar= 20pm. (D,E, F) Flow cytometry analysis was also carried out on these cells and 
S-Opsin was undetected here also. Representative histograms overlays in (D) represents cells cultured 
in control medium stained for recoverin (red) or negative control (black). (E) The blue peak is 
representative of the  data for cells cultured in 20% CM and then stained for recoverin, the black peak 
represents the  negative control. (F) Merging both the peaks of control and 20% CM shows no great 
difference in mean fluorescence intensity (MFI). (G) Percentages obtained from flow cytometry were 
represented in the  form of a histogram showing the difference in recoverin expression across the 3 
conditions. Data is represented as total percentage mean +_ SEM (n=3).
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Figure 7.9 Expression p a tte rn s  and  flow cytom etry analysis of NF160 and Ki67 in GuRt09 cells 
cultured in 1 week ARPE19 conditioned m edium
GuRt09 (P22) cells were cultured in 20% or 100% CM for 1 week at which point they were stained for 
confocal analysis or flow cytometry analysis. (A,B,C) Representative images of cells stained for Ki67 and 
NF160, scale bar= 20 pnMD, E, F) Dot plots representating,from flow cytometry analysis, a negative 
control (Decontrol cells stained for Ki67 and NF160 (E) and cellscultured in 20% CM (F). (G, H) Histograms 
with all the data collected from the flow cytometry analysis for NF160 expression (G) and Ki67 (H). All 
values are presented as total mean percentages ± SEM (n=3).
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The expression patterns o f NF160 and Ki67 were also analysed (figure 7.9 A-C) and 
there did not appear to be any apparent difference between the culture conditions as 
viewed from the confocal images. During flow cytometry analysis, negative control 
samples were always tested in conjunction with the experimental samples (figure 7.9 D) 
to detect the presence o f false positives. Analysis of NF160 expression revealed that 
-35%  of cells in the control culture were positive for NF160 (figure 7.9 G), compared 
to -27%  in the 20% CM and -26%  for the 100% CM. There was no apparent difference 
in NF160 expression between the three conditions.
Despite the absence o f any changes in gene expression in cells grown in CM, figure 7.2 
shows increased numbers o f cells in the ARPE19-CM treated sample compared to the 
control. This suggests that factors within the CM have a stimulating effect on 
proliferation, but not on differentiation. On the basis of flow cytometry analysis (figure 
7.9 E, F and H) it was found that there was a significant difference in the level of Ki67 
expression in cells cultured in 20% CM compared to the control (p=0.004121), further 
substantiating the existence o f a proliferation stimulus attributed to the CM.
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7.4 Discussion
In this chapter, the immortalised human foetal retinal progenitor cell lines, GuRt09 and 
GuRt05 were cultured in the absence or presence of ARPE19 conditioned medium. 
Morphologic development, cell growth rates and immunocytochemical markers were 
examined visually and quantitatively.
The results here show that varying the time the medium was conditioned with ARPE19 
cells had little to no effect on the cell lines, and that regardless of the conditions there 
was no induction o f rhodopsin or apparent differentiation towards a photoreceptor 
lineage. The major discemable effect of cultures in CM was that a significant number of 
cells were mitotically active in 20% CM compared to the control. A similar effect on 
proliferation has been noted by Sheedlo and Turner (1996b). A possible candidate factor 
known to be secreted from the RPE and which has been shown to stimulate growth rates 
in these cells is bFGF (Bost et al., 1992), which could be acting alone or in combination 
with other factors. As has been shown in Chapter 4, bFGF can indeed increase Ki67 
expression in these cell lines.
However, the increase in Ki67 expression and cell proliferation could be one of the 
reasons differentiation does not occur. For a cell to differentiate, it must exit the cell 
cycle and commit to a particular lineage. Another diffusible factor identified in RPE 
conditioned medium, and known to have a potent effect on neuronal differentiation, is 
Pigment Epithelium-Derived Factor (PEDF) (Tombran-Tink and Johnson, 1991). At a 
concentration of 1 nM, PEDF has been shown to switch off proliferation in Y79 cells 
and cause neurite extensions and increased expression of antigens associated with 
differentiated neurons (Tombran-Tink and Barnstable, 2003). These observations 
exemplify the importance of terminating proliferation in order for differentiation to 
occur.
The age and source of the RPE cells could also have an effect on the properties of the 
CM as younger cells may deliver a more potent cocktail of diffusible factors. Since 
ARPE19 cells are immortalised and only have a partial RPE phenotype, their ability to 
secrete certain key factors may be compromised. However, transformed cells have been 
used in previous studies and positive effects have been observed (Sheedlo and Turner 
1996b). Some papers have commented on the need to co-culture the RPE with the 
progenitor cells to obtain differentiation (Liu et al., 1988). Perhaps the diffusible factors
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only function over a short distance and/or have a short functional half-life. In 
conclusion, these experiments demonstrate that ARPE19 CM has a significant effect on 
cell proliferation but has no effect on the differentiation of these immortalised human 
foetal retinal progenitor cell lines. The enhanced proliferation may prevent the cells 
from becoming post-mitotic and differentiating.
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Chapter 8
Transplantation of human foetal retinal progenitor 
cells into the diseased and developing 
in vivo environments
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Chapter 8 
Transplantation of human foetal retinal progenitor cells into diseased
and developing in vivo environments
8.1 Introduction
In previous chapters the aims were to elucidate the potential of immortalised human 
foetal progenitor cells to differentiate towards retinal specific cell types. The ultimate 
goal of this research has always been to demonstrate proof of principle that 
immortalised progenitor cells such as these might be used in a clinical setting to treat 
degenerative eye diseases by retinal cell transplantation. Restoring and replacing lost 
photoreceptors may alleviate disease and maintain some degree of functional vision in 
patients who would otherwise be blind. The most rigorous assay of a cell’s ability to 
develop and differentiate is to observe cell behaviour in an in vivo environment. This 
chapter assesses the effects of transplanting the unimmortalised human foetal retinal 
progenitor cells, GS076, and the immortalised human foetal retinal progenitor cell line, 
GuRt09, into immunosuppressed neonatal Lister, non-dystrophic and dystrophic RCS 
rats. Observations were made regarding the survival and integration of these cells in the 
host retinal environment.
Investigations into the ability of transplanted cells to restore visual components have 
been going on for decades. In 1986, Turner and Blair created lesions in rat retinae and 
grafted neonatal retinal tissue into these sites, observing the survival and possible 
integration o f tissue into the host neural structure. This established a paradigm for what 
could be achieved using this approach, and raised the possibility that with graft 
integration there was a possibility that appropriate connectivity between graft and host 
may be made to relay proper visual signals and thus restore sight in diseased animal 
models.
8.1.1 The Royal College of Surgeons rat
Several animal models have been used to experimentally test whether retinal transplants 
can preserve a damaged retina. In this chapter the widely studied and well established 
Royal College of Surgeons (RCS) rat was employed. This animal model has a recessive 
inherited retinal degeneration that leads to a defect in the retinal pigment epithelium 
(RPE), resulting in an abnormally low rate of rod outer segment phagocytosis 
(Litchfield et al., 1997). The accumulation of outer segment debris leads to the
146
progressive postnatal loss o f photoreceptor cells. With the use of positional cloning, the 
defect was discovered to be a deletion of 409 bases in the 5’ sequence of the gene 
encoding the Mer receptor tyrosine kinase (D’Cruz et al., 2000). During the first 3 
months the majority of photoreceptors degenerate (Dowling and Sidman, 1962), and 
due to certain similarities between the RCS rat and the degenerative diseases of age- 
related macular degeneration (AMD) and Retinitis Pigmentosa (RP), it has become a 
much used animal model for transplantation studies.
8.1.2 RPE transplantation and the RCS rat
Many attempts have been made to delay or arrest the degeneration of photoreceptors in 
the RCS rat. Several studies have shown that grafted RPE cells can slow degeneration 
and rescue some photoreceptor functionality (Little et al., 1996; Gouras et al., 1989). 
The use o f a SV40 immortalised RPE cell line has also been demonstrated to have 
functional efficacy when transplanted into the subretinal space o f RCS rats (Lund et al., 
2001). The potential to promote cell survival is not confined to RPE grafts alone, other 
cell types such as immortalised brain-derived cells have also been shown to promote in 
photoreceptor survival (Wojciechowski et al., 2002).
Administering growth factors either via cells genetically engineered to stably over­
express certain genes (Lawrence et al., 2004), or by direct injection of specific growth 
factors (Faktorovich et al., 1990) has also proven to be effective in delaying 
photoreceptor loss in the RCS rat.
8.1.3 Transplantation of photoreceptors and neural progenitors
Unlike RPE cell transplantation, that has been shown to promote photoreceptor survival 
and diminish further degeneration, the transplantation o f actual photoreceptors or neural 
progenitors offers the possibility o f a type of cellular therapy that would help those 
patients who have already lost their vision, providing that their inner retina remains 
intact (Fauser, 2007). Attempts have been made to transplant early postnatal mouse 
retinal photoreceptor cells into the subretinal space o f the receptorless (rd) mutant 
mouse and normal mouse, resulting in the development and survival of transplanted 
photoreceptors for extended periods (Gouras et al., 1994). The transplantation of human 
neural progenitors has shown promise, in that RCS rats receiving grafts (compared to 
treated rats) have retained near-normal acuity (Gamm et al., 2007). The use of human 
embryonic stem cells in transplantation experiments with the RCS rat has also shown
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promise in rescuing visual function, with no cells undergoing malignant transformation 
or overt immune rejection by the host retina (Lund et al., 2006). In any cell 
transplantation strategy an inevitable hurdle that needs to be overcome is the possibility 
of immunorejection. By transplanting cells into the subretinal space this may 
inadvertently compromise the partial immune-privileged status of the region by 
disruption of the blood retinal barrier.
8.2 Experimental design and objectives
Transplantation o f neuronal progenitor cells holds considerable potential for cellular 
therapy in degenerative eye diseases. In order to assess the potential of the 
unimmortalised and immortalised human foetal retinal progenitor cells in retinal cellular 
replacement, it is vital to observe their potential to integrate and express key antigens in 
a developing and diseased environment in vivo. It is hypothesised that this environment 
would be conducive towards driving differentiation of the retinal progenitor cells 
towards retinal neurons, and possibly rod photoreceptors.
Cells were trypsinized and resuspended in DMEM:F12 at 0.5 x 105 cells/pl (figure 8.1) 
o f which 2 pi was injected into the RCS rats or 1 pi into the neonatal rats. All animals 
were anaesthetised by intraperitoneal injection, and after opening the eyelid cells or 
carrier medium were injected transclerally into the vitreous or subretinal space using a 
fine glass capillary pipette attached to a Hamilton syringe. All host animals (sham and 
cell grafted) were immune-suppressed two days prior to transplantation until being 
killed. At 5 days, 26 days and 9 weeks post grafting, rats were deeply anaesthetised and 
perfused intracardially, and eyes were removed and processed for immunohistochemical 
analysis o f cryostat sections.
All grafting o f animals in this chapter was performed by Dr. A. Vugler. Staining and 
imaging was carried out in collaboration, with some staining, including EDI, being 
carried out solely by Dr. A. Vugler.
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G u R t 0 9 /  G S 0 7 6  c e l l  c u l t u r e s
Trypsinize and 
wash cells
-« v
Assess graft preservation and integration 
via im m unohistochem istry
Cell suspensions 
in medium 
at 0.5x10s cells/pl
Inject 1.0x10s (2 pi) human foetal 
retinal progenitor cells or medium alone 
(sham) into the subretinal space or vitreous 
of 4 week old RCS rat 
(only 1 pi of cells injected into neonatal rats)
F ig u re  8 .1  D ia g r a m m a t ic  r e p r e s e n t a t io n  o f  t h e  tr a n s p la n ta t io n  p r o c e d u r e
Cells were grown in culture medium, trypsinized from the flask, and resuspended in 
DMEM:F12 medium.The cell suspension was injected into either the subretinal 
space or the vitreous using fine diameter glass capillary tubing attached to a 10 pi 
Hamilton syringe. Animals were placed on immunosuppression, and sacrificed 
5 days, 3 weeks or 9 weeks post graft. After subsequent processing grafted cells 
were located via immunohistochemistry to assess cell preservation and integration. 
(Adapted from Lund et al., 2003)
Postnatal day 3 Lister hooded rats (GS076 n=10 and GuRt09 n=10) all received 
intravitreal grafts, RCS dystrophic and non-dystrophic (8 weeks) rats received grafts of 
unimmortalised cells (n=12) and immortalised GuRt09 cells (n=8). Four week old 
dystrophic rats received unimmortalised and immortalised cells intravitreally and 
subretinally (n =12 of each). Transplanted human cells were identified in host eyes 
using the human specific markers, human nuclear antigen and human mitochondrial 
marker (HNA-MIT). Host macrophages and microglia were identified using the EDI 
antigen that stains rat CD68 positive cells.
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8.3 Results
Immunohistochemical examination of sectioned eye tissue revealed transplanted 
unimmortalised human foetal retinal progenitor cells (GS076) in the host eyes using 
human specific markers (HNA-MIT). In postnatal day 3 Lister hooded rats, surviving 
human cells were found in the transplanted eye 3 days post graft (n=l) and 26 days post 
graft (n=2). Large aggregates o f nestin-positive cells were seen near the lens (figure 8.2), 
but Ki67 expression was undetected in the grafted cells. No GS076 cells could be 
identified in the host retinal layers. Within the human cell aggregate was a large 
infiltration of host macrophages/microglia, as evident by EDI positive staining (figure
8.2 C).
In the postnatal day 3 rats receiving grafts o f immortalised human foetal retinal 
progenitor cells (GuRt09), surviving human cells were also found surrounding the lens 
(figure 8.3). There was no evidence of retinal integration within the host eye at any of 
the time points assayed.
When unimmortalised cells were transplanted into vitreous o f 8 week old RCS 
dystrophic rats (n=12) there was no evidence of retinal integration 5 days post graft 
(figure 8.4 A, n= l) or 26 days post graft (figure 8.4 B-G, n=2). However, there was a 
great deal o f macrophage/microglia infiltration surrounding and migrating into the bolus 
o f human cells (figure 8.4 A) as early as 5 days post graft. Even at 26 days post graft 
EDI positive cells were clearly evident within the graft, suggesting possible immune 
rejection of the grafted cells. However, cells were nestin positive and a minority of cells 
expressed Ki67 (figure 8.4 B and C).
When unimmortalised cells were grafted into the subretinal space o f the RCS dystrophic 
rat, 5 days post graft (n=3) and 26 days post graft (n=l), there were numerous 
macrophages/microglia infiltrating the HNA-MIT positive human cells (figure 8.5). 
When the sections were analysed immunohistochemically, recoverin, NF200 and 
rhodopsin were all undetectable in the cells. Only nestin expression was evident in these 
cells in the diseased retinal environment.
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Figure 8.2 Expression p a tte rn s  and  location of unim m ortalised  cells transp lan ted  into developing retina
Confocal images of retinal sections from neonatal rats (postnatal day 3) grafted with the unimmortalised 
human foetal retinal progenitor cells, GS076. Images taken 3 weeks post graft. (A and B) Cells, stained with 
human nuclear antigen marker (HNA) migrated towards the lens.The transplanted cells are postmitotic due 
to the lack of Ki67 expression. Ki67 expression is seen but from host cells. (C and D) Cells were also stained for 
Nestin, HNA and ED1. GS076 cells were only positive for nestin expression other antigens were undetectable. 
Scale bar= 300 pm (A) and 40 pm (B-D).
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F igure 8 .3  L o ca tio n  o f  G u R t09  c e lls  g r a fte d  in n e o n a ta l  (P3) rats 3 w e e k s  p o s t  graft
Confocal images of the retinal sections stained with HNA-MIT marker to reveal transplanted 
cells of human origin. Cells were counterstained with DAPI (blue in all images) to reveal nuclei. 
There is no evidence of retinal integration as cells are found localised surrounding the lens.
(B) magnified image of boxed section in A. Scale bar = 200 pm (A); 20 pm (B).
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F igure 8 .4  U n im m o r ta lise d  c e lls  tr a n sp la n te d  in to  th e  v itr e o u s  o f  th e  RCS d ystrop h ic  rat
GS076 unimmortalised cells were grafted into the vitreous of 8 week old RCS dystrophic rats 
and analysed (A) 5 days post graft or (B-G) 26 days post-graft. Cells were stained with human 
mitochondrial and human nuclear antigen (HNA-MIT) Ki67, nestin and EDI (specific for host 
CD68 found on macrophage and microglia. (A) Cells in the vitreous are surrounded by ED1 
positive cells. (B,C) The majority of surviving cells, at 26 days post graft, were negative for Ki67 
implying there exit from the cell cycle. However, microglia infiltration into the bolus of grafted 
cells was still present. (D) Cells were positive for nestin but microglia was present also (E).
(F,G) Magnified image of the boxed region in (E) shows the HNA-MIT positive grafted cells 
also staining for the nestin anitgen at 26 weeks post grafting. ONL: Outer Nuclear Layer,
INL: Inner Nuclear Layer, and GCL: Ganglion Cell Layer. Scale bar= 100 pm (A, F,G) 40 pm (B,C).
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Figure 8 .5  U nim m ortalised  ce lls  tran sp lan ted  into  th e  subretinal sp ace  o f RCS dystrophic rats
GS076 unim m orta lised  h u m an  foetal retinal p ro g en ito r cells w ere grafted  into th e  subretinal 
space of a 4 w eek old RCS d ystroph ic  rat retina. All im ages a re  rep resen tative o f cells 5 days post 
graft (n=3). Nuclei w ere  s ta in ed  w ith  DAPI (blue in im ages A, C and  F). (A,B) G rafted cells stained with 
hum an  nuclear an tig en -m ito ch o n d ria l m arker are  su rrounded  by EDI positive cells in th e  subretinal 
space. (C,E) M agnified im ag e  o f g rafted  cells in th e  subretinal space  th a t are  associated  with ED1 
positive cells. (D,F) G rafted cells w ith in  th e  subretinal space  show ing patchy staining of HNA-MIT and 
substantial m ac ro p h ag e  infiltration. Scale Bar = 100 pm  (A,B);50 pm  (C-F).
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Figure 8 .6  E xpression pattern s o f u n im m orta lised  ce lls  tr a n sp la n te d  in to  th e  vitreous  
o f RCS dystrophic rats
GS076, unimmortalised cells transplanted into the vitreous of 8 week old RCS dystrophic rats 
and 26 days post graft were analysed immunohistochemically for the expression of various 
markers. (A) Recoverin expression was not detected in the grafted cells that were identified 
in host eyes by human specific antigens (human nuclear antigen and mitochondrial marker; 
HNA-MIT). (B) NF200 marker was not detected in the transplanted cells either. (C) Host retina 
expression of rhodopsin was localised to the outer nuclear layer (ONL) where the photoreceptor 
outer segments are located. (D) Host macrophage/microglia autofluorescence can lead to false 
results, the ED1 staining confirms that the apparent rhodopsin positive cells surrounding the 
HNA-MIT grafted cells are actually macrophage/microglia autofluorescence. All nuclei were 
stained with DAPI (blue in images A-C). Scale bar= 50 pm (A,B); 20 pm (C,D).
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Immortalised human foetal progenitor cells transplanted into the subretinal space of 4 
week old RCS dystrophic rats were analysed 5 days (n=4) post grafting. Sections 
examined at this time point failed to demonstrate any integration of grafted cells into the 
host retina. Here again there was evidence of macrophage/microglia infiltration with a 
plethora of EDI positive cells surrounding the grafted cells. The immortalised cells 
behaved like unimmortalised cells in that they also expressed nestin. However, there 
were also differences, most notably immortalised cells still expressed Ki67 antigen 
(figure 8.8), though there was no detection o f recoverin. S-opsin and rhodopsin were 
also analysed (figure 8.10) with no detection of S-opsin in the GuRt09 cells grafted into 
the subretinal space o f 4 week old RCS dystrophic rats. Interestingly, with regards to 
rhodopsin expression, the bolus o f human cells was embedded within rhodopsin- 
positive host cells, and what at first appeared to be rhodopsin expression in the GuRt09 
cells, on closer inspection was resolved as host rhodopsin positive cells migrating deep 
into the HNA-MIT positive cell bolus.
Four week old RCS dystrophic rats were left for 9 weeks post-grafting at which point 
eyes were examined for the presence of unimmortalised and immortalised cells. In all 
eyes from the dystrophic (n=4 and non-dystrophic n=4) rats it was impossible to detect 
any unimmortalised cells. However, the immortalised cells were found to be present 
(figure 8.9) in 25% of the eyes of dystrophic rats and 50% of non-dystrophic rats 
examined, mostly at the interface between the vitreous and the retina. These cells still 
expressed nestin and were still actively within the cell cycle as evident by Ki67 
expression. All transplantation results are summarised in table 8.1.
An unexpected result was the appearance o f the unimmortalised cells in close 
association with collagen IV-expressing structures (figure 8.11) within the host eye. 
Collagen IV is an extracellular matrix protein and is a major constituent of Bruch’s 
membrane. Collagen IV expression was also examined in the immortalised cell 
transplants, and interestingly, cells within the vitreous of 4 week old RCS dystrophic 
rats that were analysed 9 weeks post grafting, appeared to express collagen IV protein. 
It is therefore possible that the cells actually secrete their own extracellular matrix. 
Perhaps if  the unimmortalised cells had survived 9 weeks post grafting, a similar pattern 
of expression of collagen IV would have been observed.
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Figure 8 .7  Im m o rta lised  retin a l p r o g e n ito r  ce lls  g ra fted  in to  
th e  su b r e tin a l s p a c e  o f  RCS d y str o p h ic  rats
G uR t09 im m o rta lise d  h u m a n  fo e ta l re tina l p ro g e n ito r  cells w ere  g ra fted  
in to  th e  su b re tin a l s p a c e  o f  4  w eek  o ld  RCS d y stro p h ic  ra ts a n d  analysed  
5 d ays p o s t g ra ftin g . (A, B) Cells w e re  id en tified  using  a h u m a n  nuclear 
a n tig e n  a n d  m ito c h o n d ria l m ark er (HNA-MIT) th a t  sh o w ed  cells iso lated  
b e tw e e n  th e  re tin a l p ig m e n t e p ith e liu m  (RPE) cell layer a n d  th e  o u te r  
n u c lea r  layer (ONL). (C) H o w ev er w h e n  h o s t m ac ro p h ag e /m ic ro g lia  w ere 
e x am in ed , u s in g  th e  EDI m arker, th e re  w as an  a p p a re n t  h o s t m a c ro p h a g e / 
m icroglia  r e s p o n s e  to  th e  g ra f te d  h u m a n  cells. (D) G rafted  cells w ere  
a p p a re n tly  im m u n o -p o s itiv e fo r  n e s tin  ex p ressio n . All nuclei w ere  sta in ed  
w ith  DAPI (b lu e  in im ag es). INL: Inner N uclear Layer. Scale bar=  50 pm .
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Figure 8 .8  E xp ression  p ro file  o f  im m orta lised  ce lls  g ra fted  into  
th e  su b retin a l sp a c e  o f  th e  RCS d ystrop h ic  rat
GuRt09 cells w ere  tra n s p la n te d  in to  th e  subre tina l sp ace  o f 4  w eek old RCS 
d ystroph ic  ra t re tin ae . G raft s ites  w ere  analysed  5 days p o s t g rafting  to  observe  
th e  ex p ression  p a tte rn s  o f th e  im m orta lised  cells in vivo. Cells w ere located  using 
h u m an  specific a n tig e n s  o f h u m a n  nuclear a n tig en  an d  h u m an  m itochondrial 
m arker (HNA-MIT) a n d  fu r th e r  s ta in e d  for various m arkers. (A, B) Cells w ere su rrounded  
by recoverin  positiv e  cells from  th e  h o st retina, how ever th e re  w as no  d e tec tio n  of 
recoverin ex p ressio n  in th e  G uR t09 cells. (A) It is also a p p a re n t th a t ED1 positive host 
m ac ro p h ag e /m ic ro g lia  su rro u n d  th e  g ra fted  cells. (C) T ransplan ted  cells w ere 
im m u n o p o sitiv e  for Ki67, fo u n d  in all active p a rts  o f th e  cell cycle. (D,E,F) M agnified 
im ages o f th e  b o x ed  reg io n  in (C) show ing  th e  GuRt09 cells expressing  Ki67 an tigen . 
All nuclei w ere  s ta in e d  w ith  DAPI, b lu e  in im ages (A,B & E). Scale bar = 50 pm  (A, B);
20 pm  (C-F).
158
ID
Figure 8.9 Immortalised retinal progenitor cells survive 9 weeks 
post transp lan tation  in the  RCS dystrophic rat
GuRt09 im m ortalised  cells g rafted  into 4 w eek old RCS dystrophic rats 
survived in vivo  for 9 w eeks post graft. (B) Cells survived a t th e  interface 
b e tw een  th e  v itreous an d  retina as identified by th e  arrows. (C) Cells w ere 
s ta ined  for various m arkers, how ever th e  only m arkers th a t w ere d e tec ted  
w ere nestin  and  Ki67 (D & E). (C) Nestin w as de tec ted  in th e  g rafted  hum an 
cells as ind ica ted  w ith th e  arrows. (D, E) Grafted cells w ithin th e  vitreous w ere 
still actively w ithin th e  cell cycle d u e  to  th e  presence of th e  Ki67 anitgen .
INL: Inner N uclear Layer, GCL:Ganglion Cell Layer. Scale bar = 600 pm  (A,B); 
20 pm  (C, D, E).
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Figure 8 .10  Expression o f Opsins in im m ortalised cells grafted  
into th e  subretinal sp ace o f th e  RCS rat
GuRt09 im m ortalised cells w ere transplanted  into the  subretinal space of 
th e  4 w eek old RCS dystrophic rat and analysed for the  expression of rhodopsin 
and  S-opsin 5 days post graft. (A) A section through a non-dystrophic rat retina 
show ing o u te r segm en ts of s-cone photoreceptors. (B) Immortalised cells form ed 
bolus struc tu res in th e  subretinal space bu t there  was no detection  of S-opsin 
expression in th e  GuRt09 cells in vivo. (C,D) Magnified image of th e  boxed region 
in (B) cells are  su rrounded  by host m acrophages/m icroglia. (E) Rhodopsin expression 
is clearly seen  in th e  subretinal space w here shed outer segm ents are present.The 
bolus of GuRt09 cells are within this region. (F,G) Magnified im ages of th e  boxed 
region in (E),the cells seem  to  be  in close association with rhodopsin positive 
o u te r seg m en ts  how ever th e  rhodopsin expression does no t seem  to  be expressed 
by th e  transp lan ted  cells them selves. Scale bar = 20 pm (A); 100 pm (B);40pm (C, D) 
and  50 pm  (E,F,G).
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Figure 8 .11 C o llagen  IV e x p r e ss io n  in tra n sp la n ted  hum an fo e ta l retinal p ro g en ito r  cells
(A,B) GS076 u n im m o rta lised  cells w ere  g ra fted  in to  4  w eek  old RCS dystroph ic  rats an d  a fte r 5 
days p o st-g ra ft cells w e re  ana lysed . In terestingly, th e  cells s ta in ed  w ith h u m an  nuclear an tig en  
a n d  h u m an  m ito ch o n d ria l m ark er (HNA-MIT) b ec a m e  assoc ia ted  w ith co llagen  IV positive 
s truc tu res. C ollagen  IV a n tig e n  is an  ex tracellu lar m atrix p ro te in . (C-F) GuRt09 im m ortalised  
p ro g en ito r  cells w ere  g ra fte d  in to  th e  v itreous o f 4  w eek  old RCS dystroph ic  rats and  afte r 9 
w eeks p o s t g ra ftin g  th e  tis su e  w as analysed , th e  GuRt09 cells seem  to  b e  expressing  
co llagen  IV. (E,F) m ag n ified  im ag es  o f th e  boxed  reg ion  in (D). All nuclei w ere sta ined  w ith 
DAPI (blue in im ages). Scale b a r=  40  pm .
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Host Age at grafting Num ber
grafted
Unimmortalised/
Immortalised
Cells 5 days post- 
g raft
Cells 26 days 
post-graft
Cells 9 weeks 
post-graft
G raft location 
(SRS/vitreous)
Neonatal rat Postnatal day 3 N=10 Unimmortalised Yes (n=l) Yes(n=2) vitreous
Neonatal rat Postnatal day 3 N=10 Immortalised Yes (n=l) Yes(n=2) vitreous
RCS dystrophic 4 weeks N=12 Unimmortalised Yes (n=3)* None SRS
RCS dystrophic 4 weeks N=12 Immortalised Yes (n=4) None SRS
RCS dystrophic 4 weeks N=4 Unimmortalised None vitreous
RCS non-dystrophic 4 weeks N=4 Unimmortalised None vitreous
RCS dystrophic 4 weeks N=4 Immortalised Yes (n=l) vitreous
RCS non-dystrophic 4 weeks N=4 Immortalised Yes (n=2) vitreous
RCS dystrophic 8 weeks N=12 Unimmortalised Y es(n=l) Yes(n=2) vitreous
RCS dystrophic 8 weeks N=8 Immortalised None Yes(n=l) vitreous
Table 8.1 Summary of all transplantations undertaken using the unimmortalised GS076 cells and the immortalised GuRt09 cell line
Cells were either grafted into the vitreous or the subretinal region (SRS) of the host. Both cell types were present in the neonatal rat even 
though their localisation was confined to the lens region.
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8.4 Discussion
In this chapter the developmental potential of unimmortalised and immortalised human 
foetal retinal progenitor cells has been evaluated in vivo in developing and disease 
environments. It has been demonstrated in previous chapters that these two cell types 
may express some retinal cell markers under certain in vitro conditions. Following 
transplantation, the phenotype o f these human cells appeared to revert back to that of 
primary progenitor cells, with only the expression of nestin and in some cases Ki67 
being observed. The cell cycle marker Ki67, was used to assess cells that had exited the 
cell cycle or were still actively within the cycle. A very low level of proliferation of 
unimmortalised transplanted cells were observed, however there was obvious Ki67 
activity in the immortalised cells when grafted into the dystrophic rat retinae. This is 
consistent with the findings from the previous results chapters that while cells are 
actively with the cell cycle they are unlikely to be able to respond to the specific cues in 
order to commit and eventually integrate into the rodent retina. However, whilst the 
unimmortalised cells were Ki67 negative they did not show any degree o f integration 
either. This could mean that the age of the cells has an impact on the degree of 
multipotency and differentiation and thus on the overall success o f the graft (Armant et 
al., 1988).
The differentiation status o f retinal progenitor cells is an important determinant of their 
ability to integrate into the host retina. It is likely that induction of non-committed cells 
along specific lineages in vitro prior to engraftment, and modification of epigenetic 
signals in the host environment together with the grafting of the cells, is required to 
allow appropriate cell-specific differentiation and integration. However, as 
demonstrated in these experiments, induction o f specific markers such as NF160, 
NF200, recoverin and S-opsin is lost when the cells are transplanted in vivo. This 
reveals the limited plasticity o f the human foetal retinal progenitor cells, and also their 
apparent inability to respond to environmental cues.
This experimental strategy is further complicated by the appearance o f host rejection, as 
judged by EDI protein expression among the grafted cells. Original attempts at 
xenografting human neural progenitor cells (from foetal cortex) into rodent retina 
showed a failure o f graft integration (Mizumoto et a l , 2001) which is consistent with 
the data here. Microglia play an important role in removing apoptotic neurons, and there 
is much evidence o f increased numbers of activated microglia in animal models of
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degeneration such as the RCS rat (Thanos and Richter, 1993). Microglia infiltration 
could therefore be a contributing factor in hindering the integration of the grafted cells. 
The infiltration o f macrophages in a region believed to have some immune privilege 
may be due to the actual transplantation procedure itself, with the inevitable opening of 
the blood-retinal barrier (Lund et al., 2003). The poor survival of grafted cells is 
consistent with findings elsewhere that the majority o f transplanted neurons in CNS 
transplantation studies died by necrosis and apoptosis within 1 week o f transplantation 
(Boonman and Isacson., 1999).
It is o f great importance to avoid or control the potential immune or inflammatory 
responses that can occur as a response to transplantation. For several decades the eye, 
like the brain, has been known to possess a certain level of immune privilege that is not 
absolute, but which is relative to other organs. Immune privilege is not a passive 
process but is actively maintained (Streilein et al., 1997), so that the eye can protect 
itself and its function from sight-threatening inflammation. The blood-retinal barrier, 
which is integral to the maintenance o f immune privilege, is formed by an outer barrier 
in the retinal pigment epithelium and an inner barrier in the endothelial membrane, 
along with the junctional complexes, o f the retinal blood vessels (Cunha-Vaz, 1979). 
The barrier regulates the microenvironment of the neuroretina and in doing so maintains 
the vitreous, retina and posterior segment o f the eye as a ‘privileged site’ in the body 
(Cunha-Vaz, 2004). Alongside the blood-retinal barrier a host of components and 
secreted factors work together to deviate normal immune responses, including FasL 
(which functions to kill lymphoid cells invading the region), immunosuppressive 
cytokines, neuropeptides and a limited expression o f MHC class I and II molecules all 
o f which contribute to the immune privilege status of the eye (Ferguson and Griffith, 
1997). Under normal conditions MHC molecules play a key role in the antigen- 
presenting process, however with few MHC molecules there are no true antigen 
presenting cells residing in the retina. This however can change when the blood retinal 
barrier is breached via the transcleral transplantation approach. This breach permits 
surveillance and access by antigen-presenting cells. Therefore wherever possible the 
breaking o f the blood-retinal barrier should be avoided.
In conclusion, the xenografting model we described here has allowed us to assess the 
behaviour and functional capabilities o f the human foetal progenitor cells. However, 
problems o f graft rejection, failure of the graft cells to express photoreceptor markers,
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and the absence o f visible integration into the diseased or developing in vivo 
environment, suggest that significant obstacles remain if immortalised retinal 
progenitors are to be successfully developed as therapeutic tools.
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Chapter 9 
General discussion
The retinal dystrophies form an ever-expanding group o f incurable diseases. With the 
prevalence o f age-related macular degeneration (AMD) and retinitis pigmentosa (RP) in 
the developed world set to rise as a consequence o f increasing longevity, new treatments 
for blinding eye diseases would be advantageous to public health and benefit the 
economy. Cell-based therapies offer the prospect of a viable and realistic method of 
treatment. The discovery o f progenitor cells in the retina has driven forward research 
into the molecular cues required to direct these cells towards a particular lineage. 
However, the use o f progenitor cells is finite due to the limited supplies and ethical 
implications in extracting such cell types. This creates a pressing need to generate cells 
for transplantation that would be safe, stable, and importantly, that can integrate, 
survive and differentiate to restore functional vision. Ideally, such cells must possess the 
characteristics o f progenitor cells, but be expandable and easily generated. Immortalised 
progenitor cells could meet these objectives. The proliferative capacity of continuous 
cell lines would enable the preparation o f bulk stocks, and permit extensive safety 
checks to be carried out prior to clinical trials.
The aim o f work in this thesis was to characterise and evaluate the developmental 
potential o f two clonally immortalised cell lines derived from the neural retina o f 10-13 
week old aborted foetuses. Studies were undertaken to determine their proliferative rate, 
expression o f marker proteins and their ability to differentiate in various trophic 
conditions. The cells were also grafted into the retinae o f neonatal hooded Lister, and 
diseased RCS rats, to assess survival, integration and differentiation. In some 
experiments, the cell lines were compared with the unimmortalised retinal progenitors 
of the same origin, in order to gauge the effects of immortalisation.
The cell lines were conditionally immortalised using an attenuated large T SV40 virus 
that allows the oncogene to be switched off at the non-permissive temperature of 37°C, 
as opposed to the permissive temperature o f 33°C at which the cells actively proliferate. 
Conditional immortalisation is an important factor to consider if  immortalised cells are 
to be used in clinical trials. It allows the expansion of cells under the influence of the 
large T antigen, however when transplanted, or grown at the non-permissive
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temperature, the large T antigen should in theory be inactive. In effect, this creates two 
distinct populations o f cells to investigate.
The SV40 tsA58 mutant used in this study has a single point mutation (Ala-438—>Val) 
that renders it temperature sensitive (Reynisdottir et al., 1990). This mutant was used to 
immortalise the retinal cultures because it has been widely used, extensively studied and 
is regarded as the least “leaky” o f the temperature sensitive mutants (Tegtmeyer and 
Ozer, 1971). When cells are infected, gene A from the SV40 genome is transcribed into 
A protein, also known as T antigen. It is this T antigen that is the immortalising 
oncogene (Cepko, 1989). The point mutation causes the T-antigen to undergo a 
conformational change at the non-permissive temperature and is believed to inactivate 
its immortalising ability (Truckenmiller et al., 1997). The T antigen becomes defective 
in viral DNA replication at the non-permissive temperature, as it does not bind to the 
viral origin o f replication therefore this leads to a decline in T antigen levels 
(Reynisdottir et al., 1990).
Initial comparisons with retinal progenitor cell cultures isolated at the same 
developmental stage indicated that the cell-lines shared certain expression patterns with 
the ‘parent’ cell type. All cell types expressed the neuroectodermal stem cell marker 
nestin, as well as Ki67, NF160, NF200 and recoverin. However only the 
unimmortalised cells expressed markers o f later neuronal cell types, including B III 
tubulin and S-opsin. Interestingly, RT-PCR analysis revealed that these two markers 
were present at the mRNA level in both cell lines. It would be of considerable interest to 
determine, at the mechanistic level, the nature o f the molecular block that prevents 
translation o f these mRNAs. If  the block could be released, the cell lines may be more 
receptive to developmental cues. Although these data indicate that the unimmortalised 
cells may be more committed than the immortalised cell lines, it is important to keep in 
mind that the immortalisation procedure means that the GuRt09 and GuRt05 lines are 
individual clones, whereas the GS076 unimmortalised cells are composed of a 
heterogeneous population. This mixed cell population exhibited the variation in 
characteristics one would expect o f a primary cell culture. Despite the observation that 
some cells within the primary culture may have been more committed or differentiated, 
the expression patterns between the cell lines and primary cells were broadly similar. 
This suggests that cultures o f human retinal progenitor cells may indeed be transfected
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with oncogenes, yet still maintain at least some of the characteristics of the primary 
cultures from which they were derived.
During vertebrate central nervous system development the interactions of progenitor 
cells with other cells and the microenvironment are essential. These interactions are 
especially difficult to maintain in vitro, when the environment is artificially engineered 
in order to encourage the development and eventual commitment of the cells towards a 
particular neuronal phenotype (Bronner-Fraser, 1992). However, studies in rat, mice and 
human retinal cell cultures have shown that an engineered environment can indeed 
induce the desired effects in the cells investigated (Gaur et al., 1992; Angenieux et al., 
2006; Merhi-Soussi et al., 2006; Sheedlo and Turner, 1996).
In this thesis several approaches were adopted to gauge the differentiation potential of 
the cell lines, including withdrawal o f growth factors from the culture medium, addition 
of foetal bovine serum (FBS), addition o f retinoic acid (RA) at varying concentrations, 
and the use o f the ARPE19 cell line and its conditioned medium. With one exception 
(FBS), none o f the above conditions induced any noticeable signs o f differentiation in 
the GuRt09 and GuRt05 cell lines.
A major impediment in the a\\-trans-RA  experiments was the apparent sensitivity of the 
cell lines to all-/nms-RA, even at low concentrations. However, the ability of RA to 
induce cell death or growth arrest is well documented (Falasca et al., 1998; 
Campochiaro et al., 1991), and is consistent with the results observed here. In 
considering this issue, it is probably relevant that retinoic acid and its derivatives are 
used in anti-cancer treatments, as they inhibit cell proliferation and induce 
differentiation, growth arrest and apoptosis. Retinoic acid has been shown to induce 
growth arrest in specific tumour cells, including medulloblastomas, a type of human 
malignant brain tumour (Chang et al., 2007). The mechanism by which this occurs has 
not been fully elucidated, although retinoid/receptor complexes are known to target 
genes involved in transcriptional regulation, including the proto-oncogene c-myc, and 
cyclin D l, both o f which regulate cell cycle progression (Miller et a l ,  1999). Chang et 
al, (2007) found that after retinoid treatment of a medulloblastoma cell line, the 
expression levels o f cyclin D l and c-myc decreased, which resulted in cell cycle arrest. 
If these and very likely other oncogenes are affected by diM-trans-RA, it is tempting to 
speculate that the SV40 large T antigen oncogene may respond in a similar manner.
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However, this would still not answer the question of why the GuRt09 and GuRt05 cell 
lines were sensitive to RA at the non-permissive temperature. If  the large T antigen is 
properly inactivated at 37°C, then the cells should theoretically lose the sensitivity 
observed. One possibility, discussed later, is that the mutant large T is not sufficiently 
regulated by temperature.
When the cells were cultured in all-trans-KA in the presence o f 3% charcoal/dextran- 
treated FBS, there was a marked improvement in cell numbers. Thus, trophic factors 
supplied by the FBS appear to mitigate the potential problem of acute sensitivity to RA 
associated with transformation by the SV40 oncogene. The findings here contrast with 
other experiments (Kelley et al., 1995), in which there was no observation in human 
foetal retinal cell cultures o f diminished cell numbers, indeed with 500 nM aXX-trans-RA 
there was a significant increase in cell numbers and the expression of rhodopsin was 
observed. These discrepancies may be due to the fact that Kelley et al used primary 
cultures, thus comprising a heterogeneous population, within which different cells 
would have different responses to a\\-trans-RA, whilst the clonal GuRt09 and GuRt05 
lines were more limited in this respect.
In considering these issues, we have touched on the possibility that the conditional 
immortalisation technique may not be as highly regulated and efficient in switching off 
tsT at the non-permissive temperature as would be necessary for cells to exit the cell 
cycle. This is generally viewed as being essential for differentiation, as retinal 
progenitor cells retain their multipotency until their final cell division (Marquardt and 
Gruss, 2002). If  immortalisation using SV40 large T prevents cell cycle exit it would be 
extremely difficult to induce differentiation. However, it is essential to remember the 
nature o f progenitor cells and their innate self-renewing and proliferative characteristics. 
An alternative hypothesis is that the trophic factors used throughout out this study were 
not capable o f inducing differentiation. But since EGF, bFGF and RA and other 
agonists have been all been reported to induce retinal progenitor cell differentiation 
elsewhere, and in a variety o f species, this seems unlikely.
With respect to the ARPE19 conditioned medium (CM) experiments, the results showed 
no significant up-regulation o f any o f the neuronal markers investigated, and neither 
was there induction o f transcription factors or later cell markers including S-opsin, 
rhodopsin and Nrl. However, there was a significant elevation in Ki67 expression in
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20% CM treated cells compared to the control cells. This implies that more cells are 
actively dividing when cultured in 20% CM than in the control cells. Many factors have 
been shown to be secreted by cultured retinal pigment epithelium (RPE) cells including 
bFGF and EGF (Bost et al., 1992). bFGF and to a lesser extent EGF have been shown 
to affect differentiation o f photoreceptors in vitro (Hicks and Courtois, 1992b), and to 
favour survival and proliferation o f cells respectively. In experiments undertaken in 
Chapter 4, we observed an increased number of cells over a duration o f 7 days in 
cultures treated with bFGF and EGF, compared to the cells in control medium. However, 
statistical analysis did not show a significant difference in Ki67 expression between 
treated and control cultures. There was also no difference in expression patterns of 
several retinal markers between the treated and control cells when exposed to growth 
factors. In comparison, a similar study observed photoreceptor generation, with rod and 
cone specific antibodies, when immortalised human retinal precursor cells were treated 
in the presence o f bFGF or EGF. These results raise the possibility that even with the 
presence o f SV40 large T antigen activated (this was not a conditionally immortalised 
cell line) bFGF and EGF could have an inductive effect on photoreceptor generation 
whilst cells are in the cell cycle (Ezeonu et al., 2000).
These data, when taken together with the ARPE19 CM experiments, reveal that bFGF 
and EGF do have a proliferative effect on retinal progenitor cells, and that in 
combination with other trophic factors released from the ARPE19 cells, this may 
enhance the number o f dividing cells. However, these data also demonstrate the 
inability o f the immortalised human foetal retinal progenitor cells to exit the cell cycle 
at the non-permissive temperature o f 37°C, which as mentioned earlier probably 
contributes to the lack o f differentiation, or may simply reflect a developmental stage at 
which the cells have lost their progenitor cell characteristics.
The developmental potential o f these immortalised retinal progenitors may therefore be 
somewhat limited. The only trophic factor that had a discemable effect on 
differentiation was foetal bovine serum (FBS), which activated the translation of the 13 
III tubulin gene, a ganglion cell marker, in addition to the expression of NF160 and 
NF200 neurofilament proteins that are expressed in the axons of ganglion cells (Kivela 
et al., 1986). This shows the potential o f these cells to differentiate, even though the 
sustained expression o f nestin suggests that the cells retain certain ‘stem-like’ 
characteristics. In a temporal sense, the development of neuronal retinal cell types
171
begins with the emergence of ganglion cells, some markers of which were observed in 
the immortalised cell lines. A possible next step would be to culture the cells in FBS, 
and then to switch them into medium containing ARPE19 CM. As demonstrated by 
Lamba and colleagues (2006), the key to obtaining maximal retinal lineage commitment 
from human embryonic stem cells involves identifying the correct combinations of 
molecular cues to optimize efficiency of target cell derivation. In this way sequential 
exposure o f the cells to different factors over weeks or months would make sense, as the 
development o f rhodopsin positive cells occurs slowly in vivo. Perhaps cells cultured in 
vitro need just as long to adapt and respond to the developmental cues.
An approach that is well established at the Institute o f Ophthalmology for studying 
tissues and cells in retinal differentiation is transplantation into developing or diseased 
ocular environments. When the immortalised GuRt09 cell line and GS076 retinal 
progenitor cells were transplanted into neonatal hooded Lister rats, both cell types 
migrated towards the lens region in the eye. As the surface ectoderm (presumptive lens) 
plays a role in neural retinal specification (Hyer et al., 1998), it is not unexpected that 
the cells migrate to this region. Since the surface ectoderm is fully differentiated at the 
age the rats were used it is possible that the lens retains some vestigial ability to secrete 
factors that the developing progenitor cells might respond to, and that could be essential 
for their development. Unexpectedly, the cells did not integrate into the retina, which 
either implies that they are not competent to respond to the cues in the neural retina or 
that retinal membranes present a physical barrier to integration, or that the retina simply 
does not produce recruitment or attraction factors. In other studies integration and 
differentiation have been observed from human embryonic stem cells (Banin et al.,2006) 
and retinal progenitor cells (Chacko et al., 2000).
To address this problem, cells were transplanted subretinally into RCS dystrophic rats, 
though again there was no visible integration into the neural retina. Interestingly, in the 
retinal environment, the cells seemed to revert to a more multipotent state, with only the 
expression of nestin and Ki67 apparent. The expression of Ki67 in the immortalised 
cells at 37°C further indicates that the temperature-sensitive immortalisation may not be 
tightly regulated. However, this is not the case in every SV40 conditionally 
immortalised neural progenitor cell line. Embryonic rat striatal-derived neuronal 
progenitors that have been transplanted into rat foetuses have shown an inactivation of 
SV40 T-antigen between 6 and 24 hours after transplantation. This is coupled with a
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progressive reduction of mitotic activity of the immortalised cells (Cattaneo et al., 
1994). This suggests that although the conditional immortalisation in this study may not 
have been tightly regulated, it has been shown to be effective in other studies. A further 
possibility is that the SV40 retrovirus integrated into the genomic DNA in a critical 
region for the regulation o f cell proliferation.
Microglia play an important role in removing apoptotic neurons, and there is much 
evidence o f increased numbers o f activated microglia in animal models of degeneration 
such as the RCS rat (Thanos and Richter, 1993). Abundant microglia were also apparent 
in the transplants performed here, that seemed to engulf and surround the bolus of 
grafted cells. It is possible that pre-treatment o f either or both cell types with the trophic 
factors discussed earlier, may alleviate this problem by modulating their behaviour 
following transplantation. Especially with regards to the FBS-treated cells, it would 
have been interesting to observe whether partial differentiation of the immortalised 
human foetal cells in vitro might enhance integration in vivo.
A consistent feature throughout this study was that the immortalised cells always 
expressed Ki67, even in vivo following transplantation. This inability to become post­
mitotic is most likely the result o f a weak conditional immortalisation control, which 
contributes to residual cell proliferation at what should be the non-permissive 
temperature (May et al., 2005). For clinical use, a method of conditional 
immortalisation that is tightly regulated and which can be unequivocally switched off, 
would be essential for reasons o f safety, and would allow greater control of proliferation 
in vitro. In contrast to the results observed here, the ability of conditionally 
immortalised neural cell lines to accurately perform their in vivo functions has been 
demonstrated in studies elsewhere. Neural rat progenitors, taken from the embryonic 
hippocampus and striatum, differentiate into mature glia after transplantation into the 
adult rat brain with full integration into host cell populations (Lundberg et al., 1996). A 
possible reason the cells did not integrate in the RCS rat retinae may be due to the 
finding that immortalised transplanted cells tended to ‘avoid’ areas of lesion or damage 
(Shihabuddin et al., 1996), however this study did find differentiation and integration of 
the RN33B cell line when transplanted into intact dentate gyrus. This suggests that this 
cell line may require direct cell-cell interactions with intact neurons to differentiate. In 
contrast, it has been found that immortalised RPE cells respond well in a degenerating 
environment, and have shown preservation o f visual function in the RCS rat (Coffey et
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al., 2001). This still does not explain why the cells transplanted into intact neonatal 
retinae did not migrate towards or integrate within the retina.
Another aspect to consider is the stage at which the cells are immortalised. As each cell 
line presumably originates from a single cell within a heterogeneous population, it is 
possible that the original transfected cell was already partially committed. As the cells 
can be induced to express 13 III tubulin, this shows that they have the ability to begin to 
differentiate in the sequential manner expected of a progenitor cell. But it could be that 
they were already partially committed at the time of immortalisation to differentiate 
along this lineage, although other observations suggest this may not be the case. For 
example, the detection o f S-opsin at the mRNA level reveals they still possess some 
multipotency. Other human foetal cells studied to date have shown a high degree of 
plasticity, and the ability to differentiate (Kelley et al., 1995; Dutt et al., 1994), which to 
some extent was also evident here with the immortalised human foetal retinal progenitor 
cells.
In conclusion, the methods adopted in this thesis have shown that conditionally 
immortalised human foetal retinal progenitor cells retain a limited capacity to 
differentiate in vitro. This provides a basis from which to further investigate the 
possibility of using immortalised cells in a clinical setting. The real problem in this 
study was the inability o f the cells to exit the cell cycle, which prevented them from 
becoming post-mitotic, and responding to environmental cues that have been proven 
elsewhere to induce differentiation. This problem may not have arisen with a 
transcriptionally regulated immortalisation technique, and future studies would ideally 
utilise immortalised cells generated in this way. In parallel, it would be important to 
undertake a closer examination o f foetal progenitor cells in their primary state. Even 
though this has proven difficult in this thesis it is important to gain as much information 
as possible from progenitor cells in order to understand how best to manipulate them for 
future experiments and eventually for cellular therapy.
The aim is to build upon the studies presented in this thesis to provide a treatment for 
patients with retinal disease. Therefore it is important to evaluate what more could have 
been done to progress the field further.
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A key area that would benefit from greater exploration is the immortalisation technique 
used in this study. The SV40 tsA58 temperature sensitive (ts) mutant is regarded as the 
least “leaky” o f the ts mutants, however some studies suggest the propensity of the large 
T antigen to remain partially active even after incubation at the non-permissive 
temperature, requiring anywhere from 10-20 minutes in order to become fully heat 
inactivated (Reynisdottir et al., 1990). Therefore the switch is not absolute but a gradual 
process. Another aspect that may warrant further investigation is the non-permissive 
temperature the retinal progenitor cells are placed at. In other studies it has been found 
that the higher temperatures o f 41°C have shown total inactivation of the large T 
antigen.
It would also be advisable to sequence the DNA for the large T antigen (gene A) from 
each retinal progenitor cell line, in order to identify the tsA58 point mutation and ensure 
that it was present and that no other aberrant mutations had occurred. In a similar study, 
DNA sequence analysis showed that a cell line immortalised with the tsA58 mutation 
had reverted to the wild type T-antigen (Truckenmiller et al., 1997). Although reversion 
to the wild-type may be relatively rare, this could account for the continued proliferation 
o f the GuRt09 and GuRt05 cell lines at the non-permissive temperature.
It has previously been mentioned that the use of a transcriptionally regulated conditional 
immortalisation method as opposed to a temperature-sensitive method may provide a 
more definitive switch. A regulatable immortalising transgene suitable for this purpose 
is c-mycER. The use o f a fusion protein composed of an inactive mutant of the 
oestrogen receptor fused to the c-terminus of the c-myc protein could be more tightly 
controlled (Littlewood et al., 1995). The use o f a transcriptionally inactive mutant of the 
oestrogen receptor is vital as it is unable to bind to oestrogen, therefore any endogenous 
oestrogen present will not interfere with the activity o f the fusion protein. The proto­
oncogene’s expression is therefore activated with a synthetic ligand of 4 hydroxy- 
tamoxifen (OHT) instead. When OHT is present in the medium, the transfected cells 
will activate c-myc expression which in turn maintains the cells within the cell cycle, 
which is comparable to the SV40 large T antigen at the permissive temperature. 
Therefore, when cells are required to stop dividing and exit the cell cycle, OHT 
treatment is stopped allowing c-myc to be switched off. Perhaps this method of 
immortalisation would have been more tightly regulated, and would have enabled us to
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detect more significant differences in gene expression patterns in the two cell 
populations.
With regards to the ARPE19 conditioned medium (CM) experiments, rather than simply 
collecting the CM from the ARPE19 cells, in future work it might be more appropriate 
to co-culture the ARPE19 cells in transwell plates with the immortalised retinal 
progenitor cell lines. Previous studies have mentioned that co-culturing is pivotal for 
progenitor cells to become differentiated (Liu et al., 1988). Therefore, if  there were 
trophic factors present in the CM collected that were only viable over a short distance 
and/or had a short functional half-life there would be a higher probability that these 
factors would come into contact with the retinal progenitors in a co-culture set-up and 
perhaps exert some detectable influence.
A diffusible factor identified in RPE conditioned medium and known to have a potent 
effect on neuronal differentiation is Pigment Epithelium-Derived Factor (PEDF) 
(Tombran-Tink and Johnson, 1991). PEDF is now available commercially, therefore it 
would be interesting to investigate the effects, if  any, of this growth factor on the 
immortalised retinal progenitor cell lines. Even though this was one o f the factors we 
expected to be secreted from the ARPE19 culture it may not have been present, or may 
have been secreted at levels too low to show an effect. An investigation o f PEDF could 
help us gain more information on the mechanisms involved in retinal differentiation. 
Alongside the use o f PEDF, the use o f different RPE cell lines may yield distinct 
responses in the retinal progenitor cells. Even though ARPE19 cells share some traits 
with their parental cells they also differ in several key aspects. Ideally, any future study 
should include experiments that utilise primary RPE cultures instead of cell lines.
It would also be o f great interest to investigate the effects of co-culturing the 
immortalised retinal progenitor cell lines with early human retinal tissue. As the explant 
would have been in the process o f development, it is reasonable to assume that a larger 
and perhaps more beneficial set o f trophic factors would have been secreted, with a 
more direct role in mediating the differentiation of the cell lines. Several other studies 
have shown that co-culturing progenitor or stem cells with either developing retina or 
retina from a mouse model of retinal degeneration promotes photoreceptor 
differentiation (Ikeda et al., 2005; Lamba et al., 2006).
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If more time had been available I would have liked to repeat the bFGF and EGF 
experiments but investigate the effects of both mitogenic peptides separately in order to 
observe if  either one had a greater effect on proliferation or differentiation alone. With 
regards to bFGF there have been reports that this peptide plays a role in photoreceptor 
development (Hicks and Courtois, 1992b). However, the younger the cells the more 
effective the bFGF seems to be in inducing rhodopsin expression. If the unimmortalised 
retinal progenitor cultures were easier to maintain in culture it would have been of great 
interest to see if  these primary cells would have responded differently to the 
immortalised retinal progenitor cell lines when placed under the same culture conditions.
When cells are taken from late embryonic to early postnatal retina, higher 
concentrations o f the mitogens are required, than when compared to early embryonic 
cultures, where maximal effects are observed with the lowest o f mitogen concentrations 
(Lillien and Cepko, 1992). This seems to imply that foetal cells that are 
developmentally mid-way between these time points may require higher concentrations 
o f growth factors to elicit maximal effects. However, the experiments were carried out 
at concentrations for both bFGF and EGF reported to be effective in previous studies 
(Hicks and Courtois, 1992b). The possibility remains that with higher concentrations of 
both growth factors, in combination or separately, the treated cultures could show 
higher proliferation rates or signs of differentiation. This would be another area to 
investigate further.
Throughout this study the key aims have been to establish a cocktail of trophic factors 
in the cellular microenvironment that mimic the in vivo developing environment. In the 
longer term it should be possible to build on the results obtained in this thesis, which do 
show at least some potential o f these immortalised human foetal retinal progenitor cells 
to differentiate in vitro, and advance the application of retinal progenitor cells as a 
therapeutic option for retinal degeneration.
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